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ABSTRACT
The recent emergence of morbillivirus in marine mammals as the etiology of several large scale
mortality events raised questions about the role of immunosuppressive persistent organic
pollutants and natural toxins in the severity, extent and duration of events.  A morbillivirus of
marine mammals, Phocine distemper virus (PDV), had devastating population level effects in
Europe in 1988 and 2002. In 2006, a new isolate of PDV was determined to be responsible for
mortality during the 2006 Northeast US Pinniped Unusually Mortality Event. The recent North
American PDV mortality event provided a means to test several hypotheses designed to increase
our overall understanding of  different effects of PDV USA 2006 on harbor, harp and gray seals,
and the relationship between PDV susceptibility and both natural and anthropogenic chemical
stressors. The development of a sensitive duplex RT-qPCR assay utilizing the isolated North
American strain, PDV USA 2006, allowed investigation into differences in species susceptibility
in naturally infected as well as in-vitro infected host immune cells. In this study we demonstrated
that species differences in susceptibility do exist in the quantity of virus produced during the
course of infection. We also determined that differences in-vitro correlate with findings in seals
naturally infected with PDV USA 2006. Furthermore, we described the effects of Aroclor 1260
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on harbor seal peripheral blood mononuclear cell (PBMC) susceptibility in-vitro and show a
disruption in the timing of the infection eventually resulting in more severe infection. In contrast,
low levels of saxitoxin (STX) induced a transient increase in PDV replication during early
infection and affected T cell proliferation. This is the first in-vitro exposure of immune cells of
seals to STX  to determine an immunomodulatory effect  in a marine mammal, and this is the
first documentation of an effect of exposure to STX and resultant change in quantity of
morbillivirus after in-vitro exposure in harbor seal PBMCs. While it is impossible to assess all
factors, this research contributes to the collective understanding of why different outcomes are
observed in different seal species during PDV infection, with new insights into environmental
factors that may influence those outcomes.
iii
Assessing Differences in Species Susceptibility to Phocine Distemper Virus (PDV) in Harp
(Phoca groenlandica), Harbor (Phoca vitulina concolor) and Gray Seals (Halichoerus grypus) of
the Northwest Atlantic
Andrea Laura Bogomolni
B.A., University of California at Davis, 1999
B.S., University of California at Davis, 1999
M.A., Boston University, 2003
A Dissertation
Submitted in Partial Fulfillment of the
Requirements for the Degree of the Doctor of Philosophy
at the
University of Connecticut
2014
iv
Copyright by
Andrea Laura Bogomolni
2014
vAPPROVAL PAGE
Doctor of Philosophy Dissertation
Assessing Differences in Species Susceptibility to Phocine Distemper Virus (PDV) in Harp
(Phoca groenlandica), Harbor (Phoca vitulina concolor) and Gray Seals (Halichoerus grypus) of
the Northwest Atlantic
Presented by
Andrea Laura Bogomolni, B.S., B.A., M.A.
Major Advisor:_________________________________________________________________
Sylvain De Guise
Associate Advisor:______________________________________________________________
Salvatore Frasca, Jr.
Associate Advisor:______________________________________________________________
Ole Nielsen
Associate Advisor:______________________________________________________________
Guillermo Risatti
Associate Advisor:______________________________________________________________
Evan Ward
University of Connecticut
2014
vi
Acknowledgements
I would like to first thank my advisor, Sylvain De Guise, for agreeing to take me on as a
graduate student and giving me the skills to be a scientist – including focus, an elusive concept
that I could not have found without his patience and encouragement.
My advisory committee has been such an integral part of my research and I am grateful to
have had this amazing team of mentors: Salvatore Frasca, Jr, Ole Nielsen, Guillermo Risatti and
Evan Ward.  From across campuses and across the continent, you have always provided
guidance and support.
Every member of the De Guise lab has made the painstaking task of completing a PhD
worth the journey. In and out of the lab, they have been an incredible support system. From
technical help, to ice cream runs, conferences, late nights at Starbucks and dog walks, Erika
Cote, Lindsay Jasperse, and Milton Levin have made these last few years memorable, and fun.
I have been especially blessed to have incredible mentors: Becky Gast, Katie Moore and
Nathalie Ward, who made this PhD not just about a degree, but keeping me inspired as part of a
longer life-long goal to make a difference in this world. And I am especially grateful to Michael
Moore for all of his support as a mentor, a colleague and as a friend, and to all of the Moore
family for taking me in as family all these years.
I don’t think I have ever met anyone with as much patience and love as my husband
Mikey MacMahon. I know I couldn’t have made this happen without you. Thank you for
sticking with me through Dengue and Dissertation. I can’t wait for our adventures ahead.
vii
And no acknowledgement would be complete without a huge thank you to my wonderful
friends near and far. Fiona, Owen and Betty- You are the family I chose! And many thanks to
Coffee Obsession for my second office and the caffeine to keep me going.
At some part of our lives, we all have a choice about where we live, who we love, what
we want to be and what we want to contribute in this world. Sometimes those choices aren’t easy
or safe. They bring us out of our comfort zone and bring us to places that sometimes we would
rather not be. But the end goal of where it is and what is it we want to do is ultimately up to us.
There are so many things we don’t get to choose, that we have to make the most of what we can.
I am ever so grateful to have a family that let me choose, to let me succeed (and have been there
for me when I failed more than a few a times), and continues to love me unconditionally. To my
mom and dad, you have shown me what it is those sacrifices are really for and taught me to
remember to always make the best of what we have. This work is dedicated you both. Thank you
being my ultimate inspiration.
viii
Table of Contents
Chapter One: Introduction
1. Morbilliviruses 1
1.1 General Introduction to Morbilliviruses 1
1.2 Marine Mammals and Morbillivirus 1
2. Phocine Distemper Virus 4
2.1 Discovery of PDV 4
2.2 PDV Structure 5
2.3 Host Receptors 6
2.4 PDV Pathogensis 7
2.5 Detection and Diagnosis 10
3. PDV in the Northwest Atlantic 11
3.1 History of PDV in the NW Atlantic 11
3.2 PDV USA 2006 12
3.3 PDV and Conservation Concerns 13
4. Immunotoxins and PDV Susceptibility 14
4.1 Measuring Immunotoxic Effects in Pinnipeds 15
4.2 Morbillivirus and Anthropogenic Stressors 15
4.2.1 Anthropogenic Stressors- Pesistent Organic Pollutants (POPs) 18
4.2.1.1 PCBs 18
4.2.2 Harmful Algal Bloom Toxins (HABs) 21
4.2.2.1 Saxitoxin 22
5. Hypothesis 24
ix
6. Literature Cited 26
7. Tables and Figures 40
Chapter Two: Development of a One-Step Duplex RT-qPCR for the Quantification of Phocine
Distemper Virus.
Abstract 44
Introduction 45
Materials and Methods 46
Results 53
Discussion 56
Literature Cited 60
Tables and Figures 62
Chapter Three: Quantification and Tissue Tropism of Phocine Distemper Virus in Seals from the
2006 Northeast U.S. Pinniped Unusual Mortality Event (UME) Suggests Sub-Clinical Carriers.
Abstract 70
Introduction 71
Materials and Methods 73
Results 76
Discussion 79
Literature Cited 85
Tables and Figures 88
xChapter Four: In-vitro Phocine Distemper Virus (PDV) Infection Indicates Differences in Viral
Replication in Northwest Atlantic Harbor seal (P. vitulina concolor), Harp seal (P. groenlandica)
and Gray Seal (H. Grypus).
Abstract 99
Introduction 100
Materials and Methods 102
Results 108
Discussion 110
Literature Cited 118
Tables and Figures 124
Chapter Five: In-Vitro Exposure of Harbor Seal Immune Cells to Aroclor 1260 Alters Phocine
Distemper Virus Replication.
Abstract 130
Introduction 131
Materials and Methods 134
Results 141
Discussion 143
Literature Cited 152
Tables and Figures 161
Chapter Six: Saxitoxin Increases Phocine Distemper Virus Replication Upon In-Vitro Infection
in Harbor Seal Cells.
Abstract 166
xi
Introduction 167
Materials and Methods 171
Results 176
Discussion 178
Literature Cited 183
Tables and Figures 187
Chapter Seven: Discussion and Conclusions 191
Literature Cited 199
1Chapter 1
Introduction
1. Morbilliviruses
1.1 General Introduction to Morbilliviruses
Morbillviruses are a genus of enveloped, negative-sense, single stranded non segmented RNA
viruses within the subfamily Paramyxovirinae in the Paramyxoviridae family. They are 15,000-
16,000 nt in size with a helical nucleocapsid in a herring-bone appearance (Rijks et al., 2012).
Sunlight, heat and lipid solvents rapidly inactivate these viruses (Rijks et al., 2012).
Morbilliviruses infect a wide host range of terrestrial and aquatic animals globally and their
role in domestic and wildlife disease has important consequences for both conservation and
economic values.  In humans, the most well recognized viruses of the family Paramyxoviridae
include measles, Nipah and Hendra virus. The genus Morbillivirus includes measles virus
(MeV), canine distemper virus (CDV), peste de petits-ruminants virus, rinderpest virus and the
two species of marine mammal morbillviruses:  phocine distemper virus (PDV) and the Cetacean
morbilliviruses (CeMV): dolphin morbillivirus (DMV), porpoise morbillivirus (PMV) and pilot
whale morbillivirus (PWMV) (Soto and Domingo, 2013).
1.2 Marine Mammals and Morbillivirus
An outbreak of an infectious disease with high mortality spread among harbor seals (P.
vitulina) in northwest Europe in 1988 killing an estimated 30,000 harbor seals (Heide-Jorgensen
2et al., 1992). Serological data along with clinical signs and pathological lesions suggested that a
morbillivirus closely related if not identical to canine distemper virus (CDV) was the primary
cause of the 1988 outbreak (Osterhaus et al., 1988). Virus isolation and characterization studies
demonstrated that the virus was not identical to CDV, rather a new member of the genus
Morbillivirus, now referred to as phocine distemper virus or PDV (Blixenkrone-Moller, 1993;
Cosby et al., 1988b; Mahy et al., 1988; Visser et al., 1990). Definitive proof of the etiology of
the outbreak resulted from experiments whereby seals were protected from the disease upon
vaccination with inactivated CDV, and the virus was subsequently recovered from non-
vaccinated animals (Osterhaus et al., 1989b; Visser et al., 1989). This outbreak was the first
documented cases of morbillivirus infection in marine mammals.
Around the same time as the first  PDV event in 1988, a second seal epizootic in Baikal seals
(Pusa sibirica) in Lake Baikal, Siberia, was also attributed to a morbillivirus (Grachev et al.,
1989; Osterhaus et al., 1989a). This virus was called PDV-2, but later proved to be not only
different from PDV, but a strain of CDV (Visser et al., 1990; Visser et al., 1993b). Lesions
characteristic of the morbillivirus infection were well described in harbor seals from the die off
of 1988 in Europe (Kennedy et al., 1989b).
Subsequent to the first case of PDV in seals in 1988, cetaceans were soon found to be
affected by a similar virus.  Morbillivirus was found in harbor porpoises (P. phocoena) stranded
along the Irish and Dutch coasts (Kennedy et al., 1988; McCullough et al., 1991; Visser et al.,
1993a), and caused a striped dolphin (S. coerualba) die off in the Mediterranean Sea (Domingo
et al., 1990; Van Bressem et al., 1991). Those viruses were later named dolphin morbillivirus
(DMV) and porpoise morbillivirus (PMV) (Van Bressem et al., 1993; Visser et al., 1993a), and
were shown to be different from PDV, and in fact more closely related to the ruminant
3morbilliviruses then the carnivore morbilliviruses (Barrett et al., 1993). Lesions characteristic of
the morbillivirus infection were well described in striped dolphins during the Mediterranean Sea
epidemic (Domingo et al., 1992). Immunohistological studies (Lipscomb et al., 1994b) as well as
polymerase chain reaction (Krafft et al., 1995) demonstrated morbillivirus in compatible lesions,
which strongly suggested the involvement of morbillivirus in the U.S. east coast 1987-88 die off
of bottlenose dolphins which had previously been attributed to brevetoxin (Geraci, 1989b).
A second and equally severe epizootic event involving PDV arose in the spring of 2002
causing mortality in an estimated 23,000 harbor seals. As in the 1988 epizootic, the event arose
at the Isle of Anhold, Denmark (Hall et al., 2006b; McCarthy et al., 2011).
Antibodies against morbillivirus, suggesting previous exposure to the virus, have been
demonstrated in several species of marine mammals on a global scale. The distribution, number
and species involved in these large scale epizootics can be found in Table 1. In  North America
these include reports of seropositive confirmation since the early 1970’s in Canadian grey seals
(H. grypus) and harbor seals (Ross et al., 1992b), a harp seal (P. groenlandica) in the Gulf of St.
Lawrence, Canada (Daoust et al., 1993b; Henderson et al., 1992), harbor seals from New York
(Duignan et al., 1993b), walruses, harp, hooded and ringed seals from the Canadian Arctic
(Duignan et al., 1997b; Duignan et al., 1994) and several species of cetaceans from the western
Atlantic (Duignan et al., 1995). Morbillvirus has also been detected in Antarctic seals (Bengston
et al., 1991) and in stranded common dolphins (D. delphis) from the Pacific (Reidarson et al.,
1998).   More recently, dolphin morbillivirus (DMV) was implicated in large epizootic events; in
2006 and in 2011 in striped (Stenella coeruleoalba) and bottlenose (Tursiops truncatus) dolphins
in the Mediterranean sea; and in 2013 in bottlenose dolphins throughout the  U.S. mid-Atlantic
and northeast coast. Most recently, a new strain of morbillivirus, Hawaiian Cetacean
4Morbillivirus, was documented by PCR in a rare Longman's beaked whale (Indopacetus
pacificus) and other pacific cetaceans (West et al., 2013).
2. Phocine Distemper Virus
2.1 Discovery of PDV
Phocine distemper virus (PDV) was first recognized in 1988 after one of the largest
recorded epizootic events in wildlife killed over half the population of harbor seals in Europe
(Dietz et al., 1989; Osterhaus and Vedder, 1988). The event began in April of 1988 on Anholt
Island in the Danish Kattegat. PDV has since been identified either by serum neutralizing
antibodies, immunohistochemistry or by virus isolation primarily in phocid seals including harp
seal (Daoust et al., 1993a; Markussen and Have, 1992), harbor seal (Duignan et al., 1993a; Earle
et al., 2011a), gray seal (Hammond et al., 2005b; Pomeroy et al., 2005), hooded seal (Duignan et
al., 1997c), ringed seal (Duignan et al., 1997c) and Mediterranean monk seal (Osterhaus et al.,
1997). Previous exposure in walrus was determined through antibody detection (Duignan et al.,
1994).  The virus has yet to be detected in otarids or phocids of the Pacific (Goodman, 2013).
Detection by nucleic acid confirmation in other marine mammals includes sea otter (Goldstein et
al., 2009). Recent phylogenetic studies of paramyxoviruses in a worldwide survey of bats
indicate that bats are the origin of CDV and PDV (Drexler et al., 2012).
Phocine distemper is extremely contagious between seals, with the virus shed by respiratory,
urinary, fecal and ocular routes (Gage, 2013). The virus has a strong affinity for epithelial cells
of the respiratory and gastrointestinal mucosa.  Disease clinically presents with fever, lethargy,
5nervous signs, emphysema, serous mucopurulent occulonasal discharge, conjunctivitis and
coughing (Kennedy, 1990a; Phillipa, 2009). Immunosuppresion due to lymphocyte depletion is
generally a result of the morbillivirus infection (Schobesberg et al 2005, Beineke et al 2009), and
therefore secondary bacterial infection commonly occurs (Rijks J.M., 2008).  As with all disease,
the effects of morbillivirus in an infected individual and in populations depend on several factors
including the host, the strain, exposure of the host to environmental stressor and
immunocompetence of the individual and species. The impact of infectious diseases on the host
can be altered by risk factors which may increase host susceptibility.  Morbillivirus is known to
have greater impacts on immune suppressed individuals and marine mammals with higher
burdens of organochlorine contaminants exposed to morbillivirus infection were more at risk due
to immune suppression (Aguilar and Borell 1994). Determining these effects depends on
understanding the ecosystem and life history of the host, the pathogen and mechanism of
infection.
2.2 PDV Structure
There are six genes encoded by the 15.6 kilobase pair RNA genome including three core
proteins (N- nucleocaspid, P- phospho and L- large protein), three envelope proteins (M- matrix,
H-hemaglutinin, and F-fusion proteins) and two nonstructural polypeptide proteins (C and V
proteins encoded by the P- gene).  PDV genes are transcribed as they are in all morbilllvirus
genes in decreasing amounts relative to the distance from the promoter from the 3’ end to the 5’
end of the genome in the sequence:
6Nucleocapsid – Phosphoprotein (includes C and V) – Matrix – Fusion – Hemaglutinin –
Large
The N-protein protects the viral RNA and is responsible for folding of the genome.
Transcription and replication are controlled by the P and L protein. The M protein helps to link
the viral envelope proteins to the nucleocaspid. The F and the H proteins are important in
host:virus fusion between infected and non- infected cells as well as host and virus cell
attachment (Goodman, 2013). Therefore, the M, F and H proteins are all associated with the viral
envelope (Cosby et al., 1988a). The C and V proteins encoded by the P gene are believed to play
a role, as with CDV, to inhibit cytokines including IFN-α, IFN-γ, Il-2, IL-4 and IL-6 (Von
Messling et al., 2006).
2.3 Host Receptors
Signaling Lymphocyte Activation Molecule (SLAM), or CD150, has been identified as
the primary lymphoid cell receptor for morbillivirus infections (Tatsuo et al., 2001; Yanagi et al.,
2002). CD46 is also used by measles in vitro to infect cells (Santiago et al.; Wild et al., 1995).
The receptor on the host attaches to the protein encoded by the H gene of the morbillivirus.
The SLAM receptor is present on thymocytes, activated lymphocytes, mature dendritic
cells, platelets and macrophages (Sato et al., 2012).The receptor is responsible for the regulation
of T-cell activation and downstream signaling for the production of Th2 and macrophage
cytokines (Veillette et al., 2007).  The receptor has two extracellular immunoglobin superfamily
domains, V and C2 associated with the adaptor molecules (Sato et al., 2012). These domains
interact with SLAM on adjacent cells. In CD4+ T-cells, ligation of SLAM results in its binding to
these adaptor molecules, and combined with T-cell-receptor (TCR)-mediated signals, triggers
7downstream signaling for the production of  Th2 cytokines including IL-4 and IL-13 (Sato et al.,
2012; Veillette et al., 2007). All morbilliviruses bind to the V domain of SLAM (Sato et al,
2012).
Infection of host immune cells upon CDV infection, and specifically the binding of viral
H gene to the host CD150 receptor, results in the up-regulation of SLAM allowing for an
increase in viral amplification as the cells responsible for combating viral infection are targeted
for infection, leading to leukopenia caused by the destruction or impairment of host cells (Sato et
al., 2012; Von Messling et al., 2006; Wenzlow et al., 2007).
Morbilllvirus infection in epithelial, endothelial and neuronal cells is not believed to be
mediated by SLAM. Viral selection of the H gene for Nectin-4 and CD147 have been proposed
as alternate receptors for morbillivirus infection including the use of CypB to potentially escape
the host’s immune response in neuronal infection (Di Guardo, 2012; Sato et al., 2012). In
addition, it has been shown that measles (Mev) has two receptors, SLAM for cell entry and
propogation, and Nectin-4 for release of virus into the air. Epithelial cell blind mutant MeV
lacked the ability to allow virus to cross airway epithelium, therefore restricting spread of virus
(Leonard et al., 2008).
2.4 Pathogenesis
In-vivo studies were carried out soon after the 1988 epizootic to understand the
pathogenicity of the virus (Harder et al., 1992; Pohlmeyer et al., 1993).  Harbor seals were the
primary focus of these studies as this species was markedly impacted during the European events
(Rijks et al., 2005; Thompson et al., 1990). Grey seal were also subjected to in-vivo experimental
exposure and proved to be less susceptible than harbor seals to disease, though with similar sero-
8conversion results as harbor seals (Baker, 1992; Harder et al., 1990).  In-vivo studies using
ferrets and mink to understand the course of both PDV and CDV have also proven invaluable in
understanding the pathogenesis of morbillivirus infection (Blixenkrone-Møller et al., 1989;
Nielsen et al., 2008; Svitek and von Messling, 2007; Von Messling et al., 2003).
Initial viral replication occurs in epithelial cells at the entry site in the upper respiratory
tract, and the virus then spreads to target cells in local lymphatic tissue, then replicates in the
epithelial and endothelial cells, and in lymphocytes, monocytes and macrophages. Leukopenia
caused by apoptosis of host cells, a decrease in lymphocyte proliferation, and the dysregulation
of cellular communication, ultimately lead to the impaired immune system and fatal disease
caused by the morbillivirus or to secondary infection (Pillet and Messling, 2009; Rudd et al.,
2006).
PDV may be acquired while seals are in the water and on land as virus is shed in urine,
feces, respiratory exhalation droplets, ocular and nasal discharge and through lactation
(Hammond et al., 2005b; Rijks et al., 2012). Viral affinity for epithelial cells within the
respiratory and gastrointestinal mucosa leads to the clinical signs of PDV including interstitial
pneumonia and enteritis similar to CDV (Kennedy, 1990b).
In seals experimentally infected with PDV from the 1988 epizootic, cell associated
viremia was detectable between 11 and 16 days post infection (p.i.), with PDV only isolated in
one of 55 nasal swabs, and two seals that succumbed to PDV at day 16 p.i. had no detectable cell
associated viremia at day 11 and 12 (Harder et al., 1992).   In the animals that succumbed in the
3rd week of infection, PDV antigen was primarily found in the colon and tonsil. Early infection
presented with viral antigen in the lymphatics and detection was no longer possible in the later
9infection stage in spleen or lymph nodes (Harder et al., 1992).  PDV RNA was detected in these
experimentally infected seals in lung, liver, spleen, kidney, parotid gland, tonsil, colon and brain,
where in many instances, PDV was not isolated and PDV antigen not detected by
immunohistochemistry (Haas et al., 1991).  PDV was also associated with depletion of
submucosal lymphoid follicles and mild to moderate enteritis 11-16 days post infection (Harder
et al., 1992).
PDV may cause neurological signs and lesions including neurodegeneration,
polioencephalitis, mononuclear inflammation of the cerebral cortex with microgliosis and
neuronophagia,  white matter lesions including subepyndymal and submeningeal demylenation
as well as  characteristic cytoplasmic and intranuclear inclusion bodies (Kennedy et al., 1989a;
Muller et al., 2008; Muller et al., 2004; Stimmer et al., 2010).  Pathological changes in the
central nervous system characterized using CDV antibodies and canine cross reacting cellular
antibodies indicated inflammatory response due to virus dominated by activated
microglia/macrophages ad CD3+ T cells associated with strong MHC-II up-regulation
suggesting a virus specific immune response (Stimmer et al 2010). This is in contrast to dogs
with advanced demylenating brain lesions with decreased virus and increasing inflammation
whereby the process is due to an immune mediated disorder (Stimmer et al., 2010; van Moll et
al., 1995). In these cases, no viral mRNA was found in intra-nuclear inclusion bodies.  In some
regions of the brain, cells had abundant P-RNA but were devoid of viral P-antigen indicating
restricted viral protein expression and possible mechanism of viral persistence in the central
nervous system of seals. For morbillivirus strains that target the central nervous system, the brain
appears to be accessed through cerebral blood vessels and the choroid plexus as well as the
olfactory bulb through cell free virus associated with CSF (Rudd et al., 2006). Investigations into
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the viral protein response and phenotyping of inflammatory response of PDV in infected central
nervous system tissue of infected seals revealed a dominant viral specific immune response
caused by T lymphocytes, microglia/macrophages with indications of a neuron to neuron
transmission in the grey matter of affected seals (Stimmer et al 2010).
In ferrets experimentally infected with a neurotropic strain of CDV, virus was detectable
in the neural tissues at 14 days post infection, yet brain parenchyma and the olfactory bulb did
not show signs of inflammation (Rudd et al., 2006). The ability of the virus to persist, without a
strong host immune response, may enable the virus to spread to tissues of the central nervous
system (Vandevelde and Zurbriggen, 2005). One hypothesized explanation for the entry route
through the olfactory bulb detected in ferrets and dogs is the close association of olfactory
receptor neurons and respiratory epithelial cells in the olfactory mucosa (Rudd et al 2006).
Ultimately, the pathogenesis of a particular strain of PDV in a host depends on the
species, age and immune status of the host. Strong humoral response in CDV infections have
correlated with the outcome of disease (Vandevelde and Zurbriggen, 2005). Without this strong
antibody response within the first 10-14 days, acute disease results. Viral clearance or viral
persistence in the central nervous system is determined by the virus protein targeted antibodies
produced, cellular response, and complement mediated humoral cytotoxicity (Appel et al., 1982;
Beineke et al., 2009).
2.5 Detection and Diagnosis
The identification of characteristic histopathologic lesions of intranuclear or
intracytoplasmic viral inclusion bodies is specific enough to confirm the diagnosis of infection
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by PDV (Rijks et al., 2012).  Immunohistocytology and electron microscopy can support these
findings (Kennedy, 1999).
Detection of phocine distemper virus is best confirmed by virus isolation which remains
the gold standard for viral identification (Nielsen et al., 2008). From the isolated virus RNA can
then be extracted to determine the genomic sequence.  Detection can also be accomplished
through detection of specific immunoglobins (IgM).  Detecting phocine distemper in marine
mammals is often time challenging due to poor quality samples available and the cross reactivity
of neutralizing antibodies (Stanton et al., 2004).
Viral RNA can be identified through reverse transcription (RT)-PCR.  Detection of viral
RNA can be detected sooner than host antibody response to the virus and therefore is a useful
tool to determine early infection in an animal.  Real time, or quantitative (RT-qPCR) can be
developed to be more sensitive and specific than RT-PCR using sequence specific probes, in
addition to allowing for relative virus quantification.  A two fold increase in virus-neutralizing
antibody titer in serial serum samples or a single positive (IgM) titer measured by enzyme linked
immunosorbent assay (ELISA) can also be used to detect early infection (Rijks et al., 2012).
3. Phocine Distemper Virus in the Northwest Atlantic
3.1 History of PDV in the NW Atlantic
While several harbor seals collected in the northwest Atlantic between 1980 and 1993,
and specifically between 1991 and 1992, were shown to have PDV antibodies and lesions typical
of morbillvirus including bronchopneumonia and encephalitis, the virus was not isolated and
large scale epizootic events due to the virus had not been documented (Duignan et al 1995).
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Differences in prevalence rates of virus neutralizing antibodies to PDV were statistically evident
between grey and harbor seals with 92% of grey seals and 54% of harbor seals with antibodies.
No grey seals were determined to be clinically affected at this time (Duignan et al 1995).
3.2 PDV USA 2006
In 2006, large numbers of grey and harbor seal mortalities in Maine and Massachusetts
resulted in the declaration of an Unusual Mortality Event (UME). This UME was determined to
be caused by a new North American isolate of phocine distemper virus (PDV USA 2006),
representing the first case of clinical disease and death associated with PDV in grey seals in
North America (Earle et al 2011). The virus was isolated in SLAM transfected Vero cells and
characteristic syncytia of morbillivirus infection were observed (Earle et al 2011).
In both western and eastern Atlantic studies, PDV has been suggested to be enzootic in
grey seals with herd immunity resulting in the lack of mortality in the species (Duignan et al.,
1997a; Hall et al., 2006b; Kruetzer et al., 2008). The cases in 2006 in grey seals challenge that
assumption.  Harbor seals have also been suggested to be more susceptible to the virus while
grey seals undergo mostly sub-clinical disease enabling antibody production and therefore
passing on protection through maternal antibodies (Kennedy et al 1989). Population dynamics
and host behavior are also thought to alter pathogen transmission (Dugnain et al, 1995, Harkönen
et al 2006, Hall et al 2006).
Viral mutations noted in the 2006 virus are important in understanding some of the
changes of pathogenicity in the North American event compared to the European outbreaks.
Mutations in the F and M genes of PDV USA 2006 were found in virus isolated in brain tissues
which were not present in lung, liver, or blood, suggesting possible virus persistence in the
central nervous system (Earle et al 2011). Predominant findings in 1988 included pulmonary
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congestion, atrophy of lymphoid tissues, and mucosal degeneration (Baker et al 1992, Phillipa et
al 2009). The morbillivirus isolated during the 2006 unusual mortality event  has only a few
amino acid changes in the P, M and F genes compared to the 1988 European Ulster/Netherlands
strain of PDV, responsible for the mass mortality of  over half of the harbor seal population in
Europe in 1988 and 2002 (Earle, 2008; Harkonen, 2006).  The 2006 isolate from the United
States might have emerged independently from 2002 PDV strains and multiple lineages of PDV
might be circulating among enzootically infected North American seals (Earle et al 2011).
In contrast to the European event in 1988 and 2002, grey seals were notably affected as
well as harbor seals in 2006 (Harwood, 1989; Prendinville, 2007; Rijks, 2005). Given the
similarity of these strains of PDV, the differences seen in species susceptibility compared to
previous PDV, and the death and clinical signs caused by the virus, it is critical to better
understand the tropism and pathogenesis of PDV USA 2006 in order to model the natural and
anthropogenic risk factors to which seals are exposed in the northwest Atlantic that may cause
this virus to resurface as an epizootic.
3.3 PDV and Conservation Concerns
Of critical concern are the ramifications of PDV emerging in the Pacific where several
endangered species including Stellar Sea Lions and Hawaiian Monk seals reside (Rijks et al.,
2012). In a survey conducted in 1993, PDV antibodies and virus had not been found in harbor
seals of the Pacific (Osterhaus et al 1988, Steiger et al 1989, Duignan et al 1995). Between 2004
and 2007, PDV antibodies were detected in northern sea otters of Alaska. Sequencing of viral
nucleic acid from tissues and nasal swabs indicated PDV identical to the 2002 European strain
was present in these otters. The cause of death in these animals included meningoencephalitis
and/or sepsis with or without valvular endocarditis (Goldstein et al 2009). It is believed that
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changes in sea ice could have allowed carriers of the virus to enter the Pacific through Arctic
species. The presence of the virus in northern sea otters raises concern for cross species
transmission to potentially more vulnerable species.
During a workshop held in 2009 to address the priority areas of for pinnipeds in the Gulf
of Maine and northeast U.S.,  the areas of primary concern regarding health included population
input of morbillivirus, diseases of national security and food safety concern, ocean health, animal
welfare and natural history of diseases. Morbillivirus was identified as the most important
priority pathogen to address (Bogomolni et al., 2010).  In addition, it was determined that
baseline data for population prevalence is lacking. Changes in prevalence between species and
geographic region could potentially be used to predict the next large scale mortality events and
identify susceptible hosts in the region.
Morbillivirus movement through captive facilities to geographic regions currently
unaffected by epizootics also raises concern. In a recent CDV microneutralization sero-survey of
harbor and grey seals in U.S. captive facilities, a prevalence rate of 25.5% was observed (Clay
and Gamble, 2013).  Identification of risk factors that increase the likelihood of CDV positive
individuals included higher number of transfers from other institutions, sharing enclosures with
or water contact with other pinnipeds, cetaceans and other carnivores as well as the presence of
carnivores on premises (Clancy and Gamble, 2013). The idea of taxa specific marine mammal
morbillviruses was recently challenged by the infection and death of a seal due to dolphin
morbilllivirus with inferred transmission from stranded dead dolphins brought into the facility
(Mazzariol et al., 2013).
4. Immunotoxins and PDV Susceptibility
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4.1 Measuring Immunotoxic Effects in Pinnipeds
Knowledge of the immunology of pinnipeds including basic blood cell populations, blood
chemistry, and general health parameters are used extensively for captive, wildlife and stranding
science (Bossart et al., 2001; Ross et al., 2002). Over the years, many functional immune assays
used in laboratory animals have been validated for marine mammals (De Guise et al., 1996; De
Guise et al., 1995a; de Swart et al., 1993; Levin et al., 2005b). These assays and have been used
for immunotoxicity studies based on the knowledge of the immune system of seals (de Swart et
al., 1994; De Swart et al., 1996; Ross et al., 2002).
In-vitro immune function assays have allowed for the assessment of the potential for
lymphocytes to proliferate using mitogens known to stimulate specific cell populations.
Concavalin A (Con-A) and phytohaemagglutinin (PHA) can be used for T cells,
lipopolysaccharide (LPS) for B cells and pokeweed mitogen (PWM) for both T and B cells (de
Swart et al., 1993; Ross et al., 2002) The cytotoxic capabilities of natural killer cells (NK) have
also been validated in vitro, as well as phagocytosis and respiratory burst activity (Levin et al.,
2007b; Pillet et al., 2000; Ross et al., 1996b).
4.2 Morbillivirus and Immunotoxic Stressors
Before the devastating mortality event in seals of northern Europe in 1988, evidence for
the effect of anthropogenic contaminants on wildlife was recognized (Carson, 1962; Porter and
Wiemeyer, 1969).  Large scale mortality events occurred with increasing frequency in marine
mammals through the 1980’s and 1990’s in cetaceans and pinnipeds (Aguilar and Borrell, 1994;
Hutchinson and Simmonds, 1994). Many of these events identified morbilliviruses as a cause or
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contributor to cause of death (Aguilar and Raga, 1991; Barrett et al., 1993; Butina et al., 2003;
Duignan et al., 1996; Earle et al., 2011b; Geraci, 1989a; Haerkoenen et al., 2006; Kennedy et al.,
2000; Lipscomb et al., 1994a; Lipscomb et al., 1994b; Rima et al., 1992).The close association of
these mortality events to highly polluted regions led researchers to suspect that the immune-
suppressive effects of the products of industry contributed to these epizootics (de Swart et al.,
1994; Hutchinson and Simmonds, 1994; Lahvis et al., 1995; Martineau et al., 1994; Ross, 2002;
Ross et al., 1994; Safe, 1989; Safe, 1992).  Recent modeling of PCB hotspots and geographic
location of large scale mortality events of marine mammals also strongly support this association
(Handoh and Kawai, 2014).
The immunotoxicity of these persistent organic pollutants (POPs) was ultimately
quantified in harbor seas during a pivotal study through feeding exposure experiments (de Swart
et al., 1994; de Swart et al., 1995; Ross et al., 1992a; Ross et al., 1994). Many subsequent in-
vitro investigations of cellular immunity in marine mammals have indicated immunomodulation
does occur to the innate and adaptive immune system on exposure to a range of persistent
contaminants, including effects on natural killer cell activity, cytokine response, respiratory
burst, phagocytosis and lymphocyte proliferation (De Guise et al., 1996; De Guise et al., 1998;
Dufresne, 2010; Frouin et al., 2010; Levin et al., 2007a; Levin et al., 2007b; Mori et al., 2006;
Neale et al., 2005) . Correlative studies based on immune assays, histopathological findings  and
measured levels of POPs in tissues also suggest cellular and humoral immunity and endocrine
function can be influenced by these contaminants (Beckmen et al., 2003; Beineke et al., 2005;
Brouwer et al., 1989; Levin et al., 2005a; Mos et al., 2006; Schwacke et al., 2011).
Epidemiological studies examining the effects of polychlorinated biphenyls (PCBs) also suggest
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that animals with higher burdens of contaminants were at increased risk to die of infectious
disease (Hall et al., 2006a; Jepson, 1999).
The fitness of an individual and the host factors intrinsic to a species can play a significant
role in the outcome of infection and exposure to immunosuppressive contaminants (Brousseau et
al., 2012). The underlying differences of a host can lead to different outcomes upon exposure to
an immunosuppressive pathogen such as PDV.  Brousseau et al. (2012) described the resistance
to a pathogen based on the status of the host as sensitive, normal or resistant. With the
introduction of a pathogen and subsequent immunotoxic stress, the resulting changes from  a
normal baseline may in turn strongly, or mildly, affect the host (Figure 1).  The host would
therefore show clinical signs and disease compared to unexposed population (Brousseau et al,
2012).  Evidence for these differences of species susceptibility between gray and harbor seal and
differences in serological prevalence of PDV in seal populations are indications of underlying
risk factors that could make some seals more susceptible with the addition of anthropogenic or
natural immunotoxic stressors (Cornwell et al., 1992; Duignan et al., 1997a; Hammond et al.,
2005a).
The effect of immunosuppressive contaminants on host susceptibility to PDV in the
northeast U.S. is not known, though evidence suggests that levels of some contaminants are at
levels which alter immune host response in vitro. Levels of PBDEs and PCBs found in seals of
northwest Atlantic, and specifically seals in the northeast U.S., are at levels above the threshold
for adverse effects for immune and reproductive effects determined in PCBs of 17 ug/g lw in
blubber, (Kannan et al., 2000; Mos et al., 2010; Shaw, 2003).
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In addition, the effects of natural toxins produced by dinoflagellates and diatoms found in
seals of the northeast U.S are also unclear. Evidence suggests that these harmful algal blood
(HAB) toxins have been found in the northeast U.S. during die off events, can be measured in
phocid seals and could have immunotoxic effects (Geraci et al., 1989; Hall and Frame, 2010;
Roselli et al., 2006).
4.2.1 Anthropogenic Stressors - Persistent Organic Pollutants
Persistent Organic Pollutants (POPs) include a number of organic compounds including,
but not limited to, polychlorinated biphenyls (PCBs), polybrominated biphenyls (PBBs),
polycyclic aromatic hydrocarbons (PAHs), polychlorinated dibenzodionxins (PCDDs),
Polybrominated diphenyl ethers (PBDEs), tributyl tin and perflourinated compounds (PFCs).
This growing list includes pollutants recognized by the United Nations Environment Programme
Stockholm Convention on Persistent Organic Pollutants to cause harm to human and wildlife
health (UNEP, 1997). Many of these compounds are fat soluble, persistent in the environment
and have known toxicological effects (Van Loveren et al., 2000).
4.2.1.1 PCBs
PCBs are a legacy POP with a global distribution insomuch that they can be detected by
passive air sampling, are found in common food products as well as can be detected in the breast
milk of the most remote and non-industrialized populations on earth (Dewailly et al., 1989;
Jaward et al., 2004; Kalantzi et al., 2001). The persistence of PCBs is due in part to their
chemical structure consisting of a biphenyl with attached chlorine atoms. There are 209
congeners of PCBs, identified by specific IUPAC numbers which designate the location of
attached chlorine atoms.
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The highly lipophilic class of chemicals were produced starting in 1929 and used globally
in industrial and commercial applications for their chemical stability and electric insulating
properties (Penning, 1930). PCBs were used as insulating material in electrical transformers and
capacitors, in carbonless paper, plastics and as fire retardants (Safe 1994). In North America, the
Monsanto Company was the sole producer of PCBs which were given the name Aroclor,
followed by a number designating the weight of chlorine in the mixture such as Aroclor 1260,
1254, and 1248, representing 60%, 54% and 48% chlorine by weight in the mixture respectively
The concentration of dioxin-like PCB congeners varies per mixture of Aroclor (Rushneck et al.,
2004) (Table 2). In 1972, the US government task force established to review the effects of
PCBS recognized the potential for adverse human health effects (Agency, 1976).
Monsanto produced Aroclors from 1930-1977 when the U.S. EPA banned the
manufacturing, processing and distribution of PCBs. PCBs were used in Europe at least until
1987 (Simmonds and Hutchinson 1994). Despite the ban in production, PCBs are persistent and
therefore continue to bio-accumulate through trophic systems as they are released back into the
environment. Diet is considered the most common route of exposure of PCBs to humans when
invertebrates and other organisms living near PCB contaminated sediment are consumed by
organisms at higher trophic levels (Fitzgerald et al 1998). In marine mammals, PCBs are also
transferred from mother to pup through lactation and placental transfer (Reddy et al 2001). In
addition, mobilization of accumulated PCBs from blubber to the blood stream can occur during
normal molting and fasting.
The mechanism of PCB toxicity occurs by aryl hydrocarbon (Ah) receptor dependent or
non Ah receptor dependent pathways which can result in reduced immune response (Safe 1987,
Ross et al., 1996). Toxic effects of PCB exposure are known to include tumor production,
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immune suppression, hormone disruption, and correlations to reproductive impairment
(Reijnders et al 1986, de Swart et al 1994, Ross et al 1997, Brouwer et al., 1989),
The byproducts of PCB manufacturing and other industrial processes include the
production of the most toxic compound: 2,3,7,8-tetrachloro-dibenzo-p-dioxin (TCCD) (Safe
1987).  TCDD toxicity is based on the Ah receptor pathway which includes the mechanism of
toxicity for many mono-ortho and non-ortho PCBS. Due to TCDDs’ toxicity, it is used to
compare relative toxicity of PCB congeners based on toxicity equivalence factorss (TEFs) (Safe,
1990; Safe, 1992).
As the toxicity of TCDD varies in different species, the utility of TEFs to explain natural
exposures and toxicity in marine mammals has been questioned (Mori et al., 2006). In addition to
species differences, the additive assumption of toxicity equivalence values (TEQs) does not
represent experimental findings. Exposure to mixtures of contaminants may result in several
outcomes, not solely one, based on the action of TCDD or any single PCB congener.
Aroclors are by definition, mixtures of PCBs. Exposure to PCBs mixtures in seals have
resulted in correlations between contamination and pathology, including skeletal deformities
(Bergman et al., 1992),  endocrine abnormalities (Zakharov, 1990),  uterine occlusions (Bergman
1991 and Reijnders 1984) and reproductive failure (Addison, 1989).  In order to qualify the
association between exposure to pollutants and these potential effects, marine mammals around
the world have been assessed for baseline health parameters with indications that health status
based on these factors are worse due to or correlated with exposure to contaminants. Hall and
Jepson et al (2006) determined average risk estimate while others have determined causal links
and correlation (Aguilar and Borrell, 1994; De Guise et al., 1995b; De Swart et al., 1996; Hall et
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al., 1992; Kuiken et al., 1994; Levin et al., 2005a; Ross et al., 1996a). These studies are essential
in understanding the role of contaminants and presence of infectious disease in mortality events.
4.2.2 Harmful Algal Bloom (HAB) Toxins
Harmful algal blooms (HABs) are responsible for deaths, loss of income, sickness and
discomfort in humans (Carmichael, 2001; Etheridge, 2010). The frequency of the effects of HAB
toxins on both humans and wildlife is increasing and the effects of toxins produced have been
recognized not only for the overt effects of high levels of toxin, but also for low level exposure
(Hiolski et al; Van Dolah, 2000; Pierce et al., 2005; Levin et al., 2010; Lefebvre et al., 2012;
Fauquier et al., 2013; Hiolski et al., 2014).
Natural toxins have threatened marine mammals long before the production of PCBs and
other anthropogenic POPs. Red tides caused by massive blooms of marine phytoplankton have
long been recognized as a source of risk for human consumers of fish and shellfish as well as for
wildlife (Van Dolah et al., 2001). Written documentation of one of the earliest large scale
mortality events in marine mammals occurred in 1828. Captain Benjamin Morrell observed the
death of half a million Cape fur seals (Artcocephalus pusillus) around Possession Island in
Southwest Africa. The description left by Captain Morrell lead Wyatt (1980) to suspect the cause
of mortality to be caused by a dinoflagellate bloom (Harwood, 1998; Wy, 1980). Recent
archaeological evidence points to HABs as the cause of a mass mortality of whales, seals, marine
sloths and fish six to nine million years ago in Cerro Ballena, Chile (Pyenson et al., 2014)
Four classes of neurotoxic algal toxins have been documented to affect marine mammals:
saxitoxins, brevetoxins, domoic acid and ciguatoxins (Reynolds et al., 2005.) The mortality
events related to these toxins include a wide diversity of marine mammal species across the
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globe. Saxitoxin has been associated with mortality primarily in whales and dolphins in the
northeast US and in Mediterranean monk seal off of the coast of West Africa (Geraci et al. 1989;
Reyero et al., 1999). Brevetoxin has been associated with mortality in Florida manatees
(Trichechus manatus latirostris) and bottlenose dolphins (Tursiops truncatus) off the Florida
coast (Bossart et al., 1998).  Domoic acid has been involved in a growing number of events
including multiple cetacean species including odontocetes and mysticetes, as well as two
pinnpeds, California sea lion and harbor seal, off the west coast of the US (Gulland et al., 2002;
Reynolds et al., 2005). Exposure to ciguatoxin is suspected in Hawaiian monk seals (Gilmartin et
al., 1980). Several marine mammal epizootics have been closely linked to infectious disease as
well as to the toxins produced by these HABs. This close association has made determining the
direct cause of mortality in these scenarios difficult.
4.2.2.1 Saxitoxin
Saxitoxin has been implicated in three marine mammal mortality events. In two of these
events, Dolphin morbillivirus (DMV) or Phocine Distemper Virus (PDV) were isolated in
affected individuals. In the first, a large scale mortality event of endangered Mediterranean monk
seals (Monachus monachus) occurred in 1997 affecting over 60% of the population, ultimately
shifting the age class structure of the remaining population. Clinical findings and histopathology
indicated death due to the acute effects of STX rather than PDV. The second event occurred
during 2001-2002 and affected bottlenose dolphins (Tursiops truncatus) of the Indian River
Lagoon, Florida. DMV as well as STX were detected in tissues and ingested prey items. The
toxin was suspected as the cause of the event but never confirmed.
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Saxitoxins are a class of highly water soluble neurotoxins produced by three genera of
dinoflagellates: Alexandrium, Pyrodinium and Gymnodinium and several cyanobacteria (Pearson
et al., 2010). The toxin accumulates in the tissues of animals and can be biomagnified through
the food web, most notoriously in shellfish which are largely resistant to the toxin. Seafood
poisoning caused by the ingestion of STX causes Paralytic Shellfish Poisoning (PSP) with
affected individuals first experiencing tingling of lips, tongue and throat, numbness of the face,
vomiting and diarrhea within the first 30 minutes of ingestion.  In more severe poisoning, loss of
motor coordination and paralysis are evident with cardiovascular failure due to respiratory
muscle paralysis in cases of acute lethal poisoning (Llewellyn, 2006; Pearson et al., 2010).
During acute illness, patients exposed to PSP had STX levels of 2.8-47 nM in serum and 65-
372 nM in urine, with clearance from serum within 24 hours (Gessner et al., 1997). Saxitoxin
binds to site 1 of voltage dependent sodium and potassium channels (Llewellyn, 2006). These
channels are important in neurotransmission, hence the effects of the toxin are responsible for its
classification as a potent paralytic shellfish poisoning toxin. The toxin can also block calcium
channels, and can prolong the gating of potassium channels in heart muscle cells (Llewellyn,
2006; Pearson et al., 2010; Su et al., 2004). Biotoxins have yet to be implicated in the mortality
of other pinniped species and the role of biotoxins contributing to disease findings is
unclear. While STX is notorious for its neurotoxicity, immunotoxic responses have also been
described at low levels (Pípole et al., 2011).
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5. Hypothesis
Overall, while much is known about PDV and the deleterious health effects of exposure to
man-made or natural toxins on the health of marine mammals, our understanding of the
interactions between exposure to immunomodulatory toxins and the outcome of infection
with PDV remains elusive. Further, much has to be done to better understand issues
associated with species susceptibility, in particular with PDV USA 2006.
I propose to test the following hypotheses:
1. All species of seal are equally susceptible to PDV 2006 USA upon in vivo and in-vitro
infection.
2. Natural and man-made toxins do not alter susceptibility to PDV 2006 USA.
The hypotheses will be tested using the following specific aims:
1. Aim 1- Develop a sensitive duplex RT-qPCR assay to determine levels of host RNA and
target PDV RNA.
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2. Aim 2- Quantify viral loads in various tissues from harbor, harp and gray seals naturally
infected with PDV from the northeast U.S. during the 2006 Northeast U.S. Pinniped Unusual
Mortality Event.
3. Aim 3- Quantify differences in PDV replication in-vitro using mononuclear cells from harp,
harbor and gray seals in the northeast U.S.
4. Aim 4- Quantify differences in PDV replication in-vitro over time using harbor seal
mononuclear cells exposed and un-exposed to a persistent organic pollutant, specifically
Aroclor 1260.
5. Aim 5- Quantify differences in PDV replication over time in harbor seal mononuclear cells
exposed and un-exposed to a natural toxin, specifically saxitoxin.
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Table 1.  Large scale epizootics in marine mammals due to morbillivirus infection.
Year Location Species Number
affected
Morbillivi
rus
Reference
1987-
1988
USA Atlantic Coast Tursiops
truncatus
>2,500 CMV Lipscomb et al.,
1994
1987-
1988
Lake Baikal Phoca sibirica >18,000 CDV Grachev et al.,
1989
1988 North and Baltic Sea Phoca vitulina >18,000 PDV Osterhaus 1988
1990 Mediterranean Sea Stenella
coeruleoalba
>2,000 CMV van Bressem et
al.,  1991
1993 Gulf of Mexico Tursiops
truncatus
>1,000 CMV Lipscomb et al.,
1996
1997 Caspian Sea Phoca caspica >2,000 CDV Forsyth et al.,
1998
2000 Caspian Sea Phoca caspica >10,000 CDV Kennedy et al.,
2000
2002 North and Baltic Sea Phoca vitulina >21,000 PDV Haerkonen et al.,
2006
2006 Northeast USA
Atlantic Coast
Phoca vitulina >100s PDV Earle et al., 2011
2007 Mediterranean Sea Stenella
coeruleoalba,
Globicephala
melas
>100s CMV Raga et al., 2008:
Fernandez et al.
2008
2011 Mediterranean Sea Stenella
coeruleoalba
>100s DMV Rubio-Guierri et
al., 2013
2010-
2014
Gulf of Mexico Tursiops
truncatus
>1000s CMV NOAA, 2014
Adapted from Rijks et al, 2012
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Table 2. Concentration of dioxin like PCB congeners in Commercial Aroclors (ppm).
PCB
Congener
Arolcor
1221
Aroclor
1232
Aroclor
1016
Aroclor
1242
Aroclor
1248
Aroclor
1254
Aroclor
1260
Aroclor
1262
Aroclor
1268
77 12.6 2150 40.9 2590 4440 174 33.8 84.6 36.1
81 0.51 111 1.96 156 221 16.4 3.33 4.63 1.35
105 55.9 3030 69.5 4840 173000 33800 434 764 107
114 4.04 248 6.03 443 1320 1930 17 46 5.86
118 88.1 4460 110 6980 24200 78900 5610 1980 101
123 3.33 164 4.72 277 806 1150 5.02 27.8 3.24
126 0.28 21 0.56 33.6 98 37.3 2.13 2.28 1.76
156 7.49 90.7 3.72 255 654 8440 4860 946 17.6
157 1.46 22 1.03 70.9 171 1870 252 63.8 7.92
167 2.52 32.4 1.1 80.7 207 3100 1990 278 4.96
169 0.08 0.17 0.13 0.11 0.21 0.81 0.82 0.4 0.32
189 1.17 4.36 0.12 4.53 11 246 1290 451 4.4
Adapted from Rushneck et al., 2004
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Figure 1. The resistance of a host to a pathogen and immunotoxic stressor may be
determined by host factors. These factors may result in a host that is strongly (left shift solid
line) or mildly affected (left shift thin line).  The sensitive population may result in clinical signs
and disease while those that are resistant are less affected (from Brosseau et al, 2012).
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ABSTRACT
Worldwide, stranded marine mammals and the network personnel who respond to marine
mammal mortality have provided much of the information regarding marine morbillivirus
infections. An assay to determine the amount of virus present in tissue samples would be useful
to assist in both routine surveying of animal health and monitoring large-scale die-off events.
False negatives from poor quality samples prevent determination of the true extent of infection,
while only small amounts of tissue samples or archived RNA may be available at the time of
collection for future retrospective analysis.  In this study, a one-step duplex real-time reverse
transcriptase-PCR assay (RT-qPCR) based on Taqman probe technology was developed to
quantify the relative expression of Phocine Distemper Virus (PDV) isolated from an outbreak in
harbor (Phoca vitulina concolor) and gray seals (Halichoerus grypus) along the northeast US
coast in 2006. The glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) gene was selected to
assess RNA quality. This duplex assay is specific for PDV and sensitive through a range of 100
to 109 copies ds-plasmid DNA. For the GAPDH target, the reaction in duplex amplified 100 to
109 copies of ds-plasmid DNA and was detectable in multiple seal species.  This assay reduced
the likelihood of false negative results due to degradation of tissues and well-to-well variability
while providing sensitive and specific detection of PDV, which would be applicable in molecular
epidemiologic studies and pathogen detection in both field and laboratory investigations
involving a variety of seal species.
KEYWORDS
Duplex quantitative real-time reverse transcription polymerase chain reaction (RT-qPCR),
marine mammal strandings, Northeast USA, Phocine Distemper Virus, RNA quality, seal
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INTRODUCTION
In 2006, large numbers of gray seal (Halichoerus grypus) and harbor seal (Phoca vitulina
concolor) mortalities in Maine and Massachusetts, USA resulted in the declaration of an Unusual
Mortality Event (UME). A new north American isolate of phocine distemper virus, (PDV USA
2006) was identified with the event, representing the first case of clinical disease and death in
seals associated with an isolated strain of PDV in north America (Earle et al., 2011).
Mutations in the genome of PDV USA 2006 are important in understanding some of the
changes in pathogenicity compared to the 1988 and 2002 PDV European epizootics. Mutations
in the F and M genes of PDV USA 2006 were found in virus isolates from brain, that were not
present in isolates from lung, liver or blood, suggesting possible virus persistence in the central
nervous system (Earle et al 2011). PDV USA 2006 also has a few amino acid changes in the P,
M and F genes compared to the 1988 European Ulster/Netherlands strain of PDV (PDV 1988),
responsible for the mass mortality of  over half of the harbor seal population in Europe
(Harkonen, 2006; Earle, 2008). PDV USA 2006 is most closely related to the 1988 strain and is
believed to have emerged independently from 2002 European strains, allowing for multiple
lineages to arise and circulate among enzootically infected North American seals (Earle et al
2011).
Most of what we know about the effects of PDV on seal populations comes from the
successful amplification of viral RNA from tissue samples collected from stranded animals.
Determining the amount of virus present in tissues from beach cast seals during large scale die-
offs offers several challenges. Tissue degradation in the field and adequate cold storage of
samples are common limiting factors (Lipscomb et al., 1996; Wilson et al., 2010). False
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negatives resulting from poor quality samples may prevent the true extent of infection from
being known. Given these limitations, there is a need to develop a specific and quality-controlled
test that will confidently detect PDV in field collected tissue samples.
In this study, a one-step duplex RT-qPCR assay based on Taqman probe technology was
developed to quantify the relative expression of PDV USA 2006 and to assess RNA quality by
amplification of the glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) gene. The PDV H
gene was targeted for its importance in determining host-virus specificity, tropism and
cytopathogenicity (Von Messling et al., 2004; Von Messling et al., 2006; Ohishi et al., 2008).
GAPDH was selected to allow detection of host RNA in a wide variety of seal species. The
quantitative duplex RT-qPCR developed here is highly sensitive and reduces the likelihood of
false negative results due to degradation of tissue. As such, it represents a significant
improvement in the accurate identification of PDV infected seals.  Additionally, this method can
also be used to determine copies of virus relative to infectivity based on TCID50 calculations,
allowing for the quantitative estimation of virus load in infected tissues.
MATERIALS AND METHODS
RNA extraction
Tissue samples of lung, liver and kidney stored at -80 ⁰C from harp seal (Phoca
groenlandica), harbor seal (Phoca vitulina concolor) and gray seal (Halichoerus grypus) were
obtained from the University of New England Marine Animal Rehabilitation and Conservation
Center in Biddeford, Maine USA (UNE MARC) for GAPDH sequencing. RNA was extracted
using an RNeasy plus mini kit (Qiagen) after tissue homogenization on dry ice, and further
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processed through a Qiashredder column (Qiagen). The same RNA isolation procedure was used
to extract RNA from cultured PDV USA 2006 for PDV H gene sequencing. RNA quantity
(ng/ul) was determined using a Nanodrop 1000 Spectrophotometer (Thermo Scientific).
Virus culture
PDV USA 2006, isolated from a harbor seal collected by UNE MARC that died of
morbillivirus infection, was kindly provided by Ole Nielsen, Department of Fisheries and Oceans
Canada as well as viruses utilized for testing assay specificity. A transfected Vero cell line
(VeroDogSLAMtag) expressing canine signaling lymphocyte activation molecules (SLAM) was
provided by Dr. Y. Yanagi (Nielsen, 2008) and used to quantify the TCID50 and viral titer for
assay sensitivity. VeroDogSlamtag cells used for passaging and TCID50 were cultured and
maintained in medium consisting of Dulbecco’s Modified Eagle Medium: Nutrient Mixture F-12
(DMEM/F12) (1:1) with L-glutamine and HEPES (Gibco, Grand Island, NY, USA), 10%
Cosmic Calf Serum (HyClone, USA), 200 ug/ml penicillin/streptomycin (Gibco) and 0.25 µg/ml
Fungizone (Gibco). Viral isolation medium contained the above with serum reduced to 2%,
double the concentration of penicillin/streptomycin (400 µg/ml) and an additional 0.5µg/ml
gentamicin (Gibco).
PDV H gene sequencing
The sequence of PDV USA 2006 virus was unknown at the beginning of this project.
Therefore, the nucleotide sequence of the H gene of the virus was determined by PCR
amplification and Sanger dideoxynucleotide chain termination sequencing using the nucleotide
sequence of the H gene of the DK 2002 PDV virus (Genbank FJ648456.1) to design forward and
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reverse primers. The primers designated H-For and H-Rev were produced by Applied
Biosystems (Table 1).
RNA extracted from PDV USA 2006 was reverse transcribed using a Superscript III First
Strand Synthesis System for RT-PCR (Invitrogen, Carlsbad, CA, USA). For each 20 ul reaction,
6 ul- H-Rev reverse primer 1:10, 3 ul of RNA and 1 ul (10 mM) dNTPS were incubated in a
thermocycler (Mastercycler Personal Eppendorf) at 65⁰C for 5 minutes, then placed on ice for 1
minute. The cDNA synthesis mix containing 10x RT buffer (2 ul), 25 mM MgCl2 (4ul), 0.1 M
DTT (2 ul), RNasOUT (1ul), and Superscript III RT (1 ul) was then combined with the
RNA/primer mixture, mixed gently and incubated at 50⁰C for 50 minutes followed by 85⁰C for 5
minutes to terminate the reaction. Samples were collected by centrifugation and 1 ul of RNAse H
was added for a 20-minute incubation at 37⁰C.
For amplification of the cDNA, mix 1 was prepared on ice containing 1 ul (10 mM) dNTP, 1
ul H-For Forward primer, 1 ul (10 mM) H-Rev Reverse primer, 3 ul PDV cDNA , 14 ul H2O and
subsequently combined with mix 2 containing 5 ul 5x Buffer A, 5 ul 5% Buffer B , 2 ul Elongase
enzyme (Clonetech, Mountain View, CA, USA) and 18 ul H2O. The PCR cycling conditions
were as described in Table 2a. PCR products were analyzed using a 1% agarose gel stained with
5 ul Sybersafe DNA gel stain (Invitrogen) using 8 ul PCR product per lane with 2 ul loading dye
and 1 kb and 500 kb Gelpilot standards (Qiagen, Valencia, CA, USA). The gel-isolated product
was purified using standard protocols in the Qiaquick gel extraction kit (Qiagen). The band-
isolated PDV 2006 H gene PCR product was cloned into a TOPO TA Cloning pCR2.1 plasmid
vector (Invitrogen). Qiaprep Spin Miniprep (Qiagen). Purified DNA product was sequenced
using the vector’s M13 forward and reverse priming sites (Genewiz). The derived H gene
sequence was compared to the DK2002 and PDV 1988 sequences (Genbank accession no.
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FJ648456 and AF479277) and to the published PDV 2006 USA H gene sequence (Genbank
accession no. HQ007902.1).
RNA quality/housekeeping gene sequencing
A previously published 197 bp GAPDH sequence was chosen as an internal control for RNA
quality (Grant et al., 2009). The primer sets were designated GRANT GAPDH-F and GRANT
GAPDH-R (Table 1). A 197 bp GAPDH ds-DNA standard was created by comparing multiple
clones derived from amplification products of harp, harbor and gray seal RNA derived from
multiple liver, lung and kidney samples from each species. The Qiagen One-Step RT-PCR kit
was used with extracted RNA in 25 ul total reaction volumes including 14 ul RNAse free water,
5 ul 5x buffer, 1 ul (10 mM) dNTPs, 1.5 ul (10 nM) forward primer, 1.5 ul (10 nM) reverse
primer, 2 ul Qiagen One-Step RT-PCR enzyme Mix and 1 ul (5-20 ng) RNA. Cycling conditions
were as follows in Table 2b. The expected 197 bp amplified product was recovered by band
isolation from agarose gel and inserted into a plasmid vector (TOPO TA Cloning pCR2.1
Invitrogen or pGEM-T Easy Vector System; Promega, Madison, WI, USA). Qiaprep Spin
Miniprep (Qiagen) purified plasmid DNA was sequenced using the vector’s M13 forward and
reverse priming sites (Genewiz). The derived GAPDH sequences were then compared to
published sequences in Genbank.
ds-DNA Standards
Double stranded DNA plasmid standards (ds-DNA) were developed using a 116 bp PDV
USA 2006 H gene PCR product and a 197 bp GAPDH PCR product cloned into the plasmid
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vectors used for sequencing. Copies of the H gene fragment/ul plasmid were calculated using the
following equation (Whelan et al., 2003):
(1) = 6.02 x1023 (copies /mol) x DNA amount (g)
DNA length (dp) x 660 (g/mol/dp)
Ten-fold dilutions of plasmids were made from 109 copies to 1 copy of plasmid per reaction plate
for standard curves.
The 116 bp PDV USA 2006 H gene sequence was amplified using primers for PDV 2002
H gene (Table 1). The PCR reaction utilized 34.5 ul H20, 5 ul 10x Buffer (Clonetech), 1 ul (10
mM) dNTP (Clonetech), 0.5 ul polymerase 50x (Clonetech), 2 ul PDV 116 forward primer (10
nM), 2 ul PDV 116 reverse primer (10 nM) and 3 ul cDNA. PCR cycling conditions for PDV
USA 2006 cDNA using 116 bp H gene forward and 116 bp H gene reverse primers were as
described (Table 2c). Amplified product was used to create a ds-DNA plasmid by cloning the
116 bp sequence from purified gel product into a plasmid vector (TOPO TA Cloning pCR2.1,
Invitrogen).  Qiaprep Spin Miniprep (Qiagen) purified DNA product from this plasmid was
sequenced using the vector’s M13 reverse priming site (Genewiz). The derived 116 bp H gene
sequence was compared to the PDV DK2002 sequence, the PDV 1988, and PDV USA 2006
sequence (Genbank accession no. HQ007902.1, Earle et al 2011).
Development and optimization of primers and probes for duplex RT-qPCR
For singleplex RT-qPCR, each primer and probe set was tested independently using a
Quantitect Probe One Step RT-PCR reaction mix (Qiagen) on the Applied Biosystems 7500 Real
Time Cycler. Targets were run in singleplex in 96 well plates (Table 2d.). A minimum of eight
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log dilutions of each plasmid standard were used as the positive control, as well as a no template
control (NTC) and a reverse transcription negative (RT-) reaction per sample.
The reaction targeting PDV included 12.5 ul 2x Q Buffer, 0.75 ul PDV 116  forward primer
(300 nm), 0.75 ul  PDV 116 reverse primer (300 nm), 0.5  ul of  PDV probe  (50 nm), 0.25 ul Q
mix, 5.25 ul RNAse free water and 5 ul template RNA at 500 ng/ul. Standards for PDV in
singleplex were run from 100-109copies/ul. A Taqman probe (FAM/TAM) (SIGMA) and primer
set previously designed for the PDV DK2002 H gene were optimized and used to detect the
2006 PDV virus (Hammond et al., 2005).
The reaction targeting GAPDH included 12.5 ul 2x Q Buffer, 0.5 ul Grant GAPDH-F forward
primer (200 nm), 0.5 ul Grant GAPDH-R reverse primer (200 nm), 2.4 ul of 1:40 GAPDH probe
(240 nm), 0.25 ul Q mix, 3.85 ul RNAse free water and 5 ul template RNA at 500 ng/ul.
Standards for GAPDH in singleplex were run from 100-109copies/ul. The fluorescent reporter
dye was modified from VIC/TAM to HEX/TAM (SIGMA-Aldrich) (Grant et al 2009).
The PDV 2006 and GAPDH primers and probes were optimized for a duplex reaction using
Qiagen Quantifast Multiplex RT-PCR +R in 96 well plates. Copies were determined using a 100
ng/ul sample RNA in duplicate for each sample. Controls were plated as in singleplex. Each 20
ul sample reaction contained:  10 ul Quantifast Master mix, 0.4 ul ROX, 0.6 ul PDV forward
primer (300 nm), 0.6 ul PDV reverse primer (300 nm), 0.4 ul PDV probe (50 nm), 0.4 ul
GAPDH forward primer (200 nm), 0.4 ul GAPDH reverse primer (200 nm), 1.92 ul GAPDH
probe (240 nm), 0.2 ul RT-mix and up to 5 ul of RNA with sterile RNAse free water.
Concentrated RNA was first diluted to 100 ng/ul with sterile PCR water. Standards were run
under the same conditions with additional 3.08 ul water and 1 ul of each of the PDV and
GAPDH standard ds-DNA plasmid in 10-fold serial dilutions from 100 to 109 (Table 2e.) Each
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fluorescent reporter signal was measured against ROX added to the reaction mixture above. The
lowest level of detection was the lowest dilution of the standard to amplify. The baseline cycle
threshold value was set at the exponential increase phase of the reaction for each standard.
Precision and efficiency of the singleplex and duplex assay
Precision was calculated based on the R2 of the standard curve. PDV standards were diluted
from ds-DNA plasmid standards of 7.89 x 109 copies/ul, and GAPDH standards were diluted
from plasmid standards of 8.89 x 109 copies/ul. PCR efficiencies were calculated for each
singleplex reaction and for each channel in a duplex reaction.  Percent efficiency was calculated
by the following formula (Rasmussen 2001).
(2) E (PCR Efficiency) = (10 (1/slope) – 1) x 100%
Based on this equation, a PCR efficiency of a 100% is equal to a slope of -3.32.
Repeatability and reproducibility of the singleplex and duplex assay
The coefficient of variation (CV, CV=standard deviation/mean) was used to calculate the
intra-assay variability. Three different plasmid standards (103, 105, 107) in eight replicates within
a single experiment for the singleplex assay and three replicates for the duplex assay were
measured. Inter-assay variability CVs were measured from three independent experiments using
the same three standards quantified in the intra-assay variability measurements.
Specificity of the singleplex and duplex assay
Specificities of the singleplex and duplex assay were performed using virus cultures. A
QiaAmp Viral RNA Mini extraction kit was used to isolate RNA from viruses in culture,
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including dolphin morbillivirus (DMV), Steller sea lion reovirus (SSL) (Palacios et al., 2011),
canine distemper virus (CDV) Lederle strain, Cetacean Morbillivirus (CeMV) isolated from
Tursiops truncatus 2013, PDV (Osterhauns 1988) and a seal picornavirus (Kapoor et al., 2008).
Viral RNA aliquots were diluted 1:10 in sterile PCR water. Quantity of RNA (ng/ul) was
assessed using a Nanodrop 1000 Spectrophotometer (Thermo Scientific) and 100 ng/ul of viral
RNA was used in the duplex and singleplex assay as described above.
Assay sensitivity based on TCID50 equivalents of the PDV ds-DNA plasmid standard
The log10 TCID50 of PDV USA 2006 was calculated using 10-fold dilutions of virus grown
on SLAM- transfected Vero cells. Results were analyzed using the Spearmann-Karber Titre
calculator. The known TCID50 stock virus was made into 10 fold dilutions, and RNA was then
extracted using the Qiagen Mini Viral RNA Isolation Kit (Qiagen). PDV RNA was used in
duplex RT-qPCR as described above and to calculate TCID50 equivalents from measured ds-
DNA standards, and therefore infectious PDV equivalents in duplex reaction samples.
RESULTS
A subset of the resulting bands from RT-PCR, singleplex and duplex RT-qPCR reactions
were sequenced and indicated specificity of the PDV H gene (1824 bp), GAPDH (197 bp) and
PDV (116 bp) sequences. Comparison of the H derived from first passage of PDV 2006 USA
indicate three differences when compared with the previously sequenced 1952 bp PDV DK2002
(Genbank accession no. FJ648456.1) within the 116 bp sequence detected by the primers used
for this assay (Figure 1). Two of these differences correspond to changes previously described in
the 1824 bp 2006 sequence (Genbank accession no. HQ007902.1, Earle et al 2011) and one does
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not. In the DK2002 sequence, at amino acid 200, there is a change from P (Proline) to S
(Serine). This change is seen in our sequence as well as in the recent 2006 PDV virus sequence
of the H gene corresponding with a silent base pair change at base 618, from “t” to “c”. There is
also a silent mutation at base 683 from “a” to “t” in both 2006 sequences when compared with
the DK2002 sequence. The differences between the two PDV 2006 USA sequences lie at amino
acid 218 at base 673 and results in an amino acid change of N (Asparagine) to T (Threonine).
The probe used in the development of this assay utilizes a region conserved in the 1988, 2002,
and 2006 isolates (Figure 2) (Hammond et al., 2005).
The 197 bp GAPDH plasmid sequences derived from harbor, gray, and harp seal tissues were
compared to the previously published sequences and to GAPDH sequences in Genbank (Grant et
al 2009). At least three clones from three individuals of each species were sequenced.
Differences exist within the probe region at positions 54 and 55 of the 197 bp sequence (Figure
3). All plasmids of the three species amplified using the GAPDH primer and probe set despite
the mismatches. The final GAPDH plasmid standard was derived from harbor seal lung tissue.
The previously published primer and probe sequence used to amplify 2002 PDV was used in
a singleplex reaction to compare with the duplex reaction. The singleplex PDV real time RT-
PCR reaction amplified PDV ds-plasmid DNA standards, detecting 101-109 copies with an R2 of
0.9849, a slope of -2.88, and an efficiency of 121.94%. The singleplex GAPDH real time RT-
PCR reaction amplified ds-plasmid DNA in triplicate, detecting 102-108 copies with an R2 of
0.9815, a slope of -3.3223, and percent efficiency of 99.984% (Figure 4).
Intra-assay variability for the singleplex PDV assay for the three different plasmid standards
(103, 105, 107) were 1.58%, 5.6%, 5.54% and 4.85%, 7.05%, 4.44% for the singleplex PDV and
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GAPDH assays, respectively. Inter-assay variability for the same standard dilutions for PDV
were 5.89%, 7.86%, 9.91% for PDV and 5.36%, 1.89%, 6.81% for GAPDH.
The duplex real time RT-PCR experiments amplified PDV ds-plasmid DNA from 100-109
copies with an R2 of 0.981, a slope of -3.15897, and an efficiency of 107.28%. For the GAPDH
ds-plasmid DNA, the reaction amplified 100-109 copies with an R2 of 0.9865, a slope of -2.998,
and an efficiency of 115.55% (Figure 5).
With three randomly selected replicates of the duplex assay, the sensitivity of PDV detection
ranged from 102 to 109 copies with an R2 of 0.9781. With the lower detection limit of 101 to109
copies, the R2 diminished to 0.9682.  The sensitivity of the GAPDH detection in the same three
replicates ranged from 101 to 109 copies with an R2 0.9733. With the lower detection limit of
100 to109, the R2 diminished to 0.9654.
Intra-assay CVs for the duplex assay for the three different plasmid standards (103, 105, 107)
were 2.73%, 1.38%, 3.69% and 2.24%, 1.33%, 3.14% for PDV and GAPDH, respectively. Inter-
assay CVs for three separate duplex assays for PDV were 4.75%, 16.84% and 9.03%. The inter-
assay CVs for GAPDH were 2.4%, 5.47%, and 4.76%
Both singleplex and dubplex assays were determined to be highly specific for PDV. No
detection occurred with DMV, CeMV, CDV, Steller sea lion reovirus or seal picornavirus (data
not shown).
PDV was calculated to have a TCID50 of 4.4 (log10TICD50/ml) equivalent to 25,118
infectious particles per ml with a limit of detection and sensitivity of the assay of 2.5 infectious
particles, equivalent to 6.25 copies of PDV standard, to 25,118 infectious particles with an
equivalent of 479,656 copies PDV standard.
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DISCUSSION
The assay developed here was able to simultaneously assess RNA sample quality by
measuring GAPDH, as well as quantifying the target virus, PDV. The use of an endogenous
housekeeping gene to assess RNA quality has previously been used in RT-PCR and RT-qPCR
studies (Inderwies et al., 2003; Hammond et al., 2005; Persson et al., 2005; Grant et al., 2009;
Takano et al., 2010; Brisco and Morley, 2012). The primer and probe set used here has
previously been shown to amplify 14 marine mammal species in singleplex RT-qPCR (Grant et
al 2009). The duplex assay offers benefits over using one-step and two-step RT-qPCR methods,
including the reduction of template RNA necessary, reduced chance for contamination over two-
step assays, and simultaneous assessment of sample quality. Interpretation of the results is
facilitated by the fact that the target PDV gene is quantified in the same reaction as the
endogenous control gene.
Interpreting RT-qPCR results from samples collected from stranded and often
decomposing carcasses, is essential in appropriately and unequivocally diagnosing cases of
infection, while avoiding false negative samples. Despite that viral nucleic acid may be protected
from degradation compared to host nucleic acid, a means to assess interpretable samples as a
whole is necessary. Low RNA integrity can be assessed through a multiplexed endogenous
control gene. The use of an endogenous LNA primer and probe set in duplex, validated by
sequencing in an additional two species of seal, will be useful in detecting false negative PDV
samples (Fleige and Pfaffl, 2006; Hall et al., 2006).
Previously published serial dilution of ds-DNA plasmid standards based on the N gene of
PDV using a singleplex RT-qPCR recorded a sensitivity of 101 (Grant, 2008). Using a ds-DNA
plasmid standard, detection was reported to be ten-fold more sensitive for PDV over RNA
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standards allowing for smaller amounts of detectable RNA (Grant, 2008). The singleplex assay
used here for the H gene amplicon is equally as sensitive as those previously reported. The
duplex assay gave greater sensitivity measuring 1 copy of PDV ds-DNA standard. GAPDH in
singleplex detected 102 copies while the duplex assay was able to detect GAPDH to 101 with
high precision. The variability between assays was higher in duplex, illustrating the importance
of running standards in each assay.
While the sensitivity of qRT-PCR is one of the most useful benefits of the assay, it does
not provide biological relevance as to the infectious nature of the virus. Calculating the
corresponding TCID50 of the virus stock allows for more relevant quantification of the viral load.
The sensitivity of the TCID50 assay not only relates to copies of standard, but to the number of
infectious particles detectable.  Measuring PDV through the duplex assay is therefore more
sensitive than quantifying virus through viral titers. Furthermore, using the TCID50 equivalents
gives the value of viral copy number biological relevance.
Optimizing multiplex reactions offers several challenges.  Accurate quantification is
dependent on optimization of all components of the reaction mixture to address unequal rates of
gene expression and RNA quantity of the target genes (Persson et al., 2005). While the PDV and
GAPDH singleplex reactions had excellent precision, there was a slight loss of precision and
PCR efficiency in duplex. Efficiency over 110% could suggest possible over amplification of
the more abundant target in the duplex reaction, or a decrease in the theoretical doubling of DNA
in reaction amplification at the far ends of the range of detection (Bio-Rad Laboratories, 2006;
Applied-Biosystems, 2007; Karlen et al., 2007). In addition, the duplex reaction may favor the
LNA based probe and primer set. Designing an LNA primer and probe for the PDV H gene
target could increase efficiency without reducing precision (R2).  A recent study targeting
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cetacean morbilliviruses in singleplex RT-qPCR using the Universal Probe Library (UPLs)
could similarly be used for developing an H gene probe for PDV with higher efficiency in
multiplex (Rubio-Guerri et al., 2013). This approach to designing LNA probes could also be
useful for detecting multiple targets within the same limited sample. Future development and
optimization of an exogenous RNA control would also aid in a more robust multiplex assay.
Determining the identity and quantity of infectious disease agents present in stranded
marine mammals presents several unique challenges. Degradation of RNA is an inevitable
limitation of diagnostic testing in marine mammal mortality events and continues to be a
challenge even with increasingly sensitive molecular methods (Stroud and Roffe, 1979; Krafft et
al., 1995; Saliki et al., 2002). This assay helps address some of these challenges. This assay
provides a useful method to eliminate false negative samples due to degradation of RNA of
tissues as well as provide sensitive levels of detection of PDV. The sensitivity of this assay may
also provide a useful method to assess risk of exposure from subclinical carriers of the virus,
thereby enhancing the ability to manage and prevent spread of the virus in rehabilitation
facilities. This assay can also provide a useful means to investigate the pathogenicity and
epidemiology of PDV in field and laboratory settings to improve our understanding of the
ecological impact of PDV.
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Table 2. Cycling conditions for PCR, One-step RT-PCR, One-step RT-qPCR and
Duplex RT-qPCR
Reaction Cycling step Temperature Time
# of
Cycles
a. PCR PDV, H Gene Initial Denaturation 94 ⁰C 30 sec 1
Denaturing 94 ⁰C 30 sec 35
Annealing 57 ⁰C 30 sec 35
Extension 68 ⁰C 2 min 30 sec 1
Hold 4 ⁰C
b. PCR PDV, H gene 116
bp amplicon Initial Denaturation 95 ⁰C 2 min 1
Denaturing 95 ⁰C 30 sec 35
Annealing 57 ⁰C 30 sec 35
Extension 68 ⁰C 30 sec 35
Final Extension 68 ⁰C 5 min 1
Hold 4 ⁰C
c. One-Step RT-PCR,
GAPDH Reverse Transcription 50 ⁰C 30 min 1
Activation 95 ⁰C 15 min 1
Denature 94 ⁰C 1 min 40
Annealing 60 ⁰C 45 sec 40
Extension 72 ⁰C 1 min 40
Final Extension 72 ⁰C 10 min 1
Hold 4 ⁰C
d. One-step RT-qPCR,
GAPDH and PDV Reverse Transcription 50 ⁰C 30 min 1
Activation 95 ⁰C 15 min 1
Denature 94 ⁰C 15 sec 40
Annealing/Extension 60 ⁰C 1 min 40
Hold 4 ⁰C
e. Duplex RT-qPCR,
GAPDH and PDV Reverse Transcription 50 ⁰C 20 min 1
Denature 95 ⁰C 5 min 40
Annealing 95 ⁰C 15 sec 40
Extension 60 ⁰C 32 sec 40
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Figure 1.  Sequence comparison of the PDV H gene from PDV USA 2006 sequenced in this
study PDV USA 2006 (Genbank accession no. HQ007902.1) and PDVDK2002 (Genbank
accession no. FJ648456.1) between nucleotide 597-712. Bold underlined nucleotides indicate
differences between sequences. Nucleic acids underlied with a zig-zag line indicate silent
mutations. Below nucleotide sequences are corresponding in amino acid sequences with changes
underlined.
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a.
b.
Figure 4. Singleplex PDV and GAPDH reaction sensitivity and efficiency. The singleplex
PDV real time RT-PCR reaction amplified PDV ds-plasmid DNA standards at (a). 101 to 109
copies with an R2 of 0.9849, a slope of -2.88, and an efficiency of 121.94%. (b) The singleplex
GAPDH real time RT-PCR reaction amplified ds-plasmid DNA in triplicate amplifying 102 to
108 copies with an R2 of 0.9815 a slope of -3.3223, and percent efficiency of 99.984%.
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a.
b.
Figure 5. Duplex PDV and GAPDH reaction sensitivity and efficiency. The duplex PDV
reaction amplified PDV ds-plasmid DNA at a (a) 100 to 109 copies with an R2 of 0.981, a slope of
-3.15897 and an efficiency of 107.28%. (b) GAPDH ds-plasmid DNA in the same duplex
reaction amplified 100 to 109 copies with an R2 of 0.9865, a slope of -2.998, and an efficiency of
115.55%.
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ABSTRACT
Numerous gray seal (Halichoerus grypus) and harbor seal (Phoca vitulina concolor) mortalities
in New England during 2006 were confirmed to be the result of a North American isolate of
phocine distemper virus (PDV USA 2006), representing the first cases of clinical disease and
death associated with an isolated strain of PDV in Northeast U.S. seals.  Evidence from natural
pinniped population exposures to PDV 2006 and PDV strains in 1988 and 2002 suggests that
differences exist in seal species susceptibility to infection and progression to clinical disease.
Tissues from stranded seals collected during the 2006 Northeast U.S. Pinniped Unusual
Mortality Event (UME) were obtained to evaluate how the organ distribution and abundance of
the virus might differ between seal species.  Clinical findings, gross necropsy reports and
histopathology reports were reviewed for each case file.  Host and viral RNA was isolated and
quantified by our recently developed duplex qRT-PCR. Seventy-six tissues, representing seven
organs from 19 animals of three species (gray, harp (Phoca groenlandica) and harbor seal), were
assayed. Two of four gray seals, three of five harp seals, and six of ten harbor seals were infected
with PDV in at least one tissue. Commonly positive tissues in all species included lung, liver,
spleen and kidney, with virus only observed in lungs of gray seals, and in tracheobronchial
lymph nodes, liver and kidney, but not in lungs of harp seals. The numbers of positive tissues per
individual were highest in harbor seal (1-5 tissues), followed by harp seal (1-2 tissues) and gray
seal (1tissue). Quantity of virus ranged from 195 to 3.26x108 viral ds-DNA plasmid copies/100
ng RNA. Harbor seals positive for PDV were clinically affected and often presented with PDV
associated histopathology including syncytia, whereas gray seals exhibited histological changes
supporting morbillivirus infection with clinical findings. Harp seals positive for PDV did not
exhibit clinical signs, suggesting that they could serve as asymptomatic carriers of PDV USA
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2006. These findings shed light on the role of different species in the transmission PDV in North
American seals.
INTRODUCTION
From January through May of 2006, several harbor, harp and gray seals entered the
Marine Animal Rehabilitation Center of the University of New England (UNE MARC) with
neurological and respiratory clinical findings commonly associated with phocine distemper virus
(PDV) infection. Over the next year, hundreds of live and dead stranded seals were assessed in
the 2006 North Atlantic Pinniped Unusual Mortality Event (UME) with PDV ultimately declared
the etiology of the mortality event (Earle et al., 2011). This event included the first cases of
clinical disease and death associated with PDV in gray seals in North America (Prendiville,
2007; Earle et al., 2008; Earle et al., 2011).
PDV was first identified in 1988 among European seals (Cosby et al., 1988; Kennedy et
al., 1988). Predominant histopathology findings in the European 1988 PDV epizootic event
included pulmonary congestion, atrophy of lymphoid tissues, enteritis and mucosal degeneration
(Baker, 1992; Pohlmeyer et al., 1993; Philippa et al., 2009). While several thousand harbor seals
were found dead during this time, only 185 gray seals were found with similar pathological
changes as harbor seals infected with PDV. The prevalence of sero-positive animals however
was similar among species (Harwood, 1989a; Swinton et al., 1998). While fewer gray seal deaths
were definitively diagnosed with PDV, gray seal birth rates declined by 12% during the epizootic
(Baker, 1992). During 18 years of surveillance, only during the event were aborted gray seal
fetuses ever recorded in the region (Baker, 1992).
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In the 2002 European epizootic, harbor seals were once again primarily affected, again
killing nearly half the population in the North Sea (Muller et al., 2004; Rijks et al., 2012).
Primary findings included moderate to severe pulmonary alveolar and interstitial emphysema
and pulmonary edema. Occasional neuronal pathologic changes were observed and neurons and
glial cells tested positive for morbillivirus antigen using immunohistochemistry. No
demyelination was noted as in 1988 (Muller et al., 2004).
The first seals identified in the United States with clinical signs of PDV were harbor seals
stranded on Long Island, NY in 1992 (Duignan et al., 1993).  PDV presence was determined
through serum virus neutralization assay with supporting clinical and histopathological findings
in two animals. Clinical signs included respiratory distress, fever and depression.  Gross findings
included pneumonia and diffuse pulmonary congestion (Duignan et al., 1993). Histopathological
findings included diffuse broncho-interstitial pneumonia in one harbor seal and non-suppurative
meningoencephalitis in the other harbor seal (Duignan et al., 1993).
Differences in the presentation of PDV disease in these mortality events may be
associated with differences in tropism and pathogenicity among the PDV strains, potentially
associated with differences in host susceptibility.  The 2006 isolate from the United States is
thought to have emerged independently from 2002 PDV strains, and it is believed that multiple
lineages of PDV might be circulating among enzootically infected North American seals (Earle
et al 2011). The morbillivirus isolated during the 2006 unusual mortality in the northeast U.S.
event also has only a few amino acid changes in the P, M and F genes compared to the 1988
European Ulster/Netherlands strain of PDV, but these few changes are thought to be responsible
for differing disease presentations among harbor and gray seals. Viral mutations were only
identified in brain tissue, suggesting viral persistence in the central nervous system (Harkonen,
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2006; Earle, 2008; Earle et al., 2011). In addition to the genomic differences between these PDV
strains, gray seals were often clinically affected in 2006, in contrast to both European events in
1988 and 2002, countering the notion that gray seals have innate resistance to clinical disease
(Harwood, 1989b; Duignan et al., 1995; Pomeroy et al., 2005; Rijks, 2005; Prendinville, 2007;
Prendiville, 2007).
Despite these findings, there is little known about the tissue tropism of PDV USA 2006
during the mortality event and the degree to which PDV infected the three most common seal
species in the northeast U.S.: harp, harbor and gray seals. Viral quantification in tissues from
seals during this UME was performed to potentially help understand differences seen in tissue
tropism and pathogenesis between species compared to previous PDV epizootics.
MATERIALS AND METHODS
Cases, Clinical Findings, Necropsy and Histopathology
Nineteen pinnipeds, including 10 harbor, 4 gray and 5 harp seals were used in this study,
and the demographics and stranding locations for those animals are provided in Table 1. Seals
were screened for PDV including PDV-confirmed/suspect cases (n=10) and non-PDV or cause
of death undetermined (n=9) cases. Multiple tissues from multiple individual harp, harbor and
gray seals were obtained retrospectively from UNE MARC.  Seventy-six tissues from 19
stranded seals were assessed for viral quantification.  The seals analyzed included 4 gray seals,
10 harbor seals and 5 harp seals temporally associated with the UME during 2006-2007 and
further supplemented with cases of known PDV status based on histopathology findings.
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These seals were collected by stranding networks along the northeastern US coast
between Maine and Massachusetts. Some individuals presented alive and were placed into
rehabilitation, while others were found dead in various states of decomposition and brought to
UNE MARC for necropsy.  Tissues frozen at -80˚C included brain, spinal cord, lung, liver,
kidney, lymph node and spleen.  Findings, gross necropsy reports and histopathology reports
were reviewed for each case file. Necropsies of fresh carcasses were conducted by the staff of
UNE MARC.  Tissues were sampled and placed in 10% neutral buffered formalin and processed
for histopathologic evaluation. Results were used to determine primary findings and indications
of PDV infection in each case. The overall interpretation of the clinical, gross and histological
findings was as follows: PDV: Compatible lesions with inclusions, syncytia, sero-conversion or
virus isolation; PDV likely: Compatible CNS lesions, with or without compatible lung lesions or
lymphoid depletion, and with or without associated neurological signs; PDV possible:
Compatible but less characteristic lesions or clinical signs; and Not PDV: No suggestion of PDV
compatible lesions.
RNA extraction from Seal Tissues
RNA was extracted using an RNeasy plus mini kit (Qiagen) after tissue homogenization
on dry ice, and further processing through a Qiashredder column (Qiagen). This kit includes a
DNA eliminator column for DNAse treatment.  RNA quantity (ng/ul) was determined using a
Nanodrop 1000 Spectrophotometer (Thermo Scientific). RNA was cryopreserved at -80 ⁰C until
analysis.
TCID50 of PDV USA 2006
75
PDV isolated from a seal collected by UNE which died of the morbillivirus infection
(PDV USA 2006), and the cell line that was used for its isolation, were provided to the
University of Connecticut, Department of Pathobiology and Veterinary Science by Ole Nielsen,
Department of Fisheries and Oceans Canada. The transfected Vero cell line (VeroDogSLAMtag)
expressing canine signaling lymphocyte activation (SLAM) molecules used for the isolation and
characterization of PDV was provided by Dr. Y. Yanagi (Seki et al., 2003).   The transfected
Vero cells were used to perform the TCID50 of the first passage of the virus to determine viral
titer as well as for assay sensitivity. Methods used are described in Chapter 2, Bogomolni et al.,
in review.
Viral RNA extraction
A Qiagen RNA Plus Mini Kit with Qiashredder columns (Qiagen) was used to extract
RNA from cultured PDV USA 2006 for creation of ds-DNA plasmid standards as previously
described (Chapter 2). RNA quantity (ng/ul) was determined using a Nanodrop 1000
Spectrophotometer (Thermo Scientific).
Ds-DNA Standards
Double stranded DNA plasmid standards were developed using a 116 bp PDV USA 2006
H gene sequence and a 197 bp GAPDH sequence as previously described in Chapter 2.
Duplex RT-qPCR
Quantification of tissue viral RNA loads was performed using a recently described
duplex RT-qPCR (Chapter 2, Bogomolni et al., in review).  Briefly, PDV and GAPDH primers
and probes were used in a duplex reaction with copy numbers of PDV and GAPDH determined
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using a 100 ng/ul of sample RNA in duplicate for each tissue sample.  For each run, at least eight
log dilutions of each plasmid standard in duplicate were used as the positive control.  The lowest
level of detection was determined to be that of the lowest amplification dilution of the standard.
Quantities are reported as mean values.
Assay Sensitivity based on TCID50 Equivalents of standard PDV ds-DNA plasmid standard
As previously described (Chapter 2, Bogomolni et al., in review), the PDV isolate was
calculated to have a TCID50 of 4.4 (log10TCID50/ml), equivalent to 25,118.54 infectious
particles per ml. The limit of detection and sensitivity of the assay was 2.5 infectious particles,
equivalent to 6.25 copies of PDV standard, to 25,118.86 infectious particles with the equivalent
of 479,656.5 copies PDV standard.
RESULTS
Quantification of PDV in Species infected with PDV
Two of four gray seals, three of five harp seals, and six of 10 harbor seals were infected
with PDV in at least one tissue available for testing using RT-qPCR. In total, 11 of 19 seals
tested were positive in at least one tissue for PDV (Table 2).
Quantity of virus in tissues – Tissue tropism
The quantity of PDV detected in tissues ranged from 195 to 3.26x108 viral plasmid
copies/100 ng RNA. The amount of PDV copies varied between species and tissues in the 11
individual seals (Figure 1). PDV (PDV plasmid copies/100 ng RNA) in gray seal was restricted
to lung tissue (4.39x105), although brain tissue was only available for one of the four animals
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tested. In contrast, harp seals were the only species for which PDV was not found in lung.  Virus
was present for harp seals in tracheobronchial lymph nodes (1.96x105), liver (1.41x104), and
kidney (3.84x106). PDV was present in a wide variety of tissues in harbor seals including lung
(1.44x103), liver (4.12x106), tracheobronchial lymph node (2.50x103), kidney (3.70x104), spinal
cord (1.65x103) and spleen (4.88x107).  The greatest quantity of virus was present in a harbor
seal spleen.  Of the three species, harbor seals most often presented with multiple PDV positive
tissues per individual. Three tissue samples from two individuals were excluded from analysis as
the value of GAPDH fell below the level of detection as determined by the standard curve of
each run.
Clinical and Histopathology Findings
Clinical and histopathology findings for all cases are summarized in Table 3. The two
gray seals (MARC07-015 Hg and MARC07-023 Hg) with demonstrated PDV in lung tissues did
not present with inclusion bodies or histopathological findings associated with PDV to definitely
diagnose PDV as cause of mortality.  However, PDV compatible clinical neurological signs and
histopathological findings such as neuronal necrosis, pneumonia with interstitial edema and
reactive lymph nodes would support a diagnosis of PDV when coupled with our RT-qPCR
results. We failed to amplify PDV in one gray seal (MARC06-019 Hg) considered PDV positive
based on histopathology of brain tissues and serological evidence; however, no brain tissues
were available for our study, which happened to be the location of PDV histological lesions.
Overall, according to our concordance definitions, the two gray seals positive by RT-qPCR were
PDV and PDV possible, one of the negative animals was missing key tissues for testing was
PDV likely, and the other negative animal was not PDV (Figure 4).
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Of the six harbor seals that tested positive by RT-qPCR, indications of PDV infection and
disease were clearly evident. Clinical evidence in harbor seals included seizures and neurological
disorders with histopathological support of PDV in three cases including few to moderate
syncytia in lung and in the central nervous system. Broncho-interstitial pneumonia, encephalitis,
demyelination and associated inflammation were also common in PDV positive harbor seals.
Two harbor seals (MARC06-024Pv and MARC06-035Pv) had histological brain and lung
lesions compatible with PDV infection, along with compatible clinical signs and sero-conversion
in one of the animals (MARC06-024Pv) with RT-qPCR evidence of morbillivirus; however,
brain and lung tissues were not available for those individuals. Overall, the six harbor seals that
tested positive by RT-qPCR were PDV (3) or PDV likely (3), two of the negative animals were
not PDV, and the other two were PDV and PDV likely, but were missing key tissues for testing
(Table 4).
Of the three PDV positive harp seals, significant findings included general lymphoid
depletion, cerebral vasculitis and polioencephalitis with no etiology determined. These harp seals
were found dead or died upon entry to rehabilitation and therefore no clinical data were
available, with the exception of one animal with seizures which were not attributable to brain
lesions. Overall, no evidence of PDV specific lesions or clinical signs was observed in these
animals. Overall, the three harp seals positive by RT-qPCR were PDV possible, and the two
negative animals were not PDV (Table 4).
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DISCUSSION
This retrospective study increases our understanding of the tropism of PDV USA 2006
and reveals a potential predictive transmission of the virus through carrier hosts. Possible
differences among species in tissue distribution and abundance of virus in naturally infected
seals may explain differences in pathogenesis and influence the epidemiology of PDV infection
including inter-species and intra-species transmission among geographically overlapping species.
In this preliminary investigation to understand the distribution and abundance of PDV in
seals affected during the 2006 UME, intra-species, inter-species, and individual variability was
observed in the quantity of PDV in tissues. The proportion of harbor seals and harp seals for
which PDV was amplified in at least one tissue, was highest at 60%, whereas gray seals tested
positive in 50%.  Interestingly, some of the higher values of PDV were found in tracheobronchial
lymph nodes and kidney of harp seals without outward morbillivirus related disease. Many of
these seals died of secondary bacterial infection, potentially associated with lymphoid depletion.
It is not known at what stage of infection these animals may have presented and not all tissues
were available for analysis to determine a more complete body burden or aid in possible
determination of pathogenesis.
Findings of viral RNA in tissues did not always correlate to clinical and histopathological
findings in the three species. Of the three species, harbor seals had the strongest relationship
between clinical presentation, histological findings and PDV RNA detection, harp seals had the
weakest relationship, and gray seals were intermediate (Table 4). Of the seals positive for PDV
examined in this study, only harbor seals presented with overt morbillivirus-associated clinical
signs and pathognomic morbillivirus lesions including the presence of syncytia.  The differences
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in strength of association between PDV and characteristic lesions would suggest differences in
pathogenicity for morbillivirus in different species of pinniped. Further, the relative lack of
clinical signs and specific microscopic findings in association with demonstrable PDV in tissues
might suggest that harp seals undergo subclinical PDV infection or act as asymptomatic carriers
of the virus.
The likelihood of transmission among species is difficult to assess, though the ability to
quantify tissue specific viral copies and determine equivalent infectious particles, allows for
some useful insight regarding epidemiology of PDV both in the wild and in a rehabilitation
setting. As with previous PDV epizootics, harbor seals were most often clinically affected by
PDV, yet by examining PDV by duplex RT-qPCR in multiple species of seal, it is apparent that
the three most common species of seal in the northeast US are infected at approximately similar
frequency. Viral tropism appears to differ between species. In this study, gray seal lung tissues
were positive for PDV at 103 to 105 copies of virus whereas no harp seal lung tissue tested
positive. Given these results, admittedly without knowledge of the timing of PDV infection in
those animals, dispersion of virus through respiratory routes (coughing or sneezing) may be more
likely from gray seals rather than harp seals.
By definition, most seals entering rehabilitation are sick or injured and can be suffering
from a multitude of insults. Determining the stage of infection of one virus may not be critical to
the care and management in individual animals. Whereas each seals’ individual status of
infection may not be known, determining the distribution of the virus may help to predict the
pathogenesis and potential ability to transmit virus. This information can be vital in preventing
cross infections of other non-infected animals in rehabilitation.
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The ability of virus to not only infect a susceptible host, but also enter and multiply in the
host cells, may affect animal to animal transmission. Infection by PDV as with other
morbilliviruses is dependent on the receptivity and permissiveness of the host. The signaling
lymphocyte activation molecule (SLAM), also designated as CD150,  is considered the primary
host cell receptor, interacting with the H protein of the virus and activated lymphocytes,
macrophages, platelets and dendritic cells (Tatsuo et al., 2001; Sidorenko and Clark, 2003).
Most recently, Nectin-4 has also been identified as a host cell receptor important in release of
morbillivirus infection on polarized epithelial cells (Mühlebach et al., 2011). These receptors and
their interaction with viral proteins influence the course and outcome of infection. For example,
it has been shown that measles (MeV) has two receptors, SLAM for cell entry and propagation,
and the epithelial cell receptor, Nectin-4, for release of virus, and likely for dissemination of the
virus into the air through respiratory pathways (Tatsuo et al., 2001; Mühlebach et al., 2011;
Noyce and Richardson, 2012; Ohishi et al., 2012; Pratakpiriya et al., 2012).  In a study conducted
to understand the importance of host and viral receptors, Nectin-4 blind mutant MeV were
shown to lack the ability to allow virus to cross airway epithelium, therefore restricting spread of
virus (Leonard et al., 2008).  Despite the presence of virus, without the ability to transmit the
virus to other hosts, virus transmission may be hampered.  Further, understanding the distribution
and mechanism of host and virus receptors in various pinniped species could help to understand
potential infection differences.
As a retrospective study, limitations existed on the opportunistic samples available for
analysis. It was therefore impossible to document PDV distribution in all tissues. Given the
suggestion of the ability for this virus to become neurotropic and utilize multiple host cell
receptors, or for the host to survive the initial pneumonia at different stages of life as seen with
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canine distemper virus (CDV) infection in old dog encephalitis (Vandevelde et al., 1980),
measuring virus in cerebral spinal fluid, spinal cord and brain tissues would be useful and should
be taken as part of a routine suite of archived frozen samples in stranded seals (Lincoln et al.,
1971; Vandevelde et al., 1980; Rijks et al., 2008). A few seals with no definitive cause of death
presented here with seizures and with histological findings commonly found in PDV infections,
yet no frozen brain or spinal cord tissues were available for quantitative RT-PCR testing in the
same individuals. In one gray seal (MARC06-019 Hg), histopathological findings allowed for the
positive designation of morbillivirus infection, yet frozen brain tissue was not available to assess
tissue tropism through RT-qPCR viral quantification.
The tissues being tested for PDV and the infection stage at which an animal presents are
important considerations in our ability to measure detectable virus.  In seals experimentally
infected with PDV from the 1988 epizootic, cell associated viremia was detectable between 11
and 16 days post infection (p.i.), PDV was only isolated in one of 55 nasal swabs, and two seals
that succumbed to PDV at day 16 p.i. had no detectable cell associated viremia at day 11 and 12
(Harder et al., 1992).   In the animals that succumbed in the 3rd week of infection, PDV antigen
was primarily found in the colon and tonsil. Early infection presented with viral antigen in the
lymphatics and detection was no longer possible in the later infection stage in spleen or lymph
nodes (Harder et al., 1992).  PDV RNA was detected in these experimentally infected seals in
lung, liver, spleen, kidney, parotid gland, tonsil, colon and brain, where in many instances, PDV
was not isolated and PDV antigen was not detected by immunohistochemistry (Haas et al.,
1991).  PDV was also associated with depletion of submucosal lymphoid follicles and mild to
moderate enteritis 11-16 days p.i. (Harder et al., 1992). Therefore, considering alternate
pathways and sampling for assessing viral shedding that may not be routinely examined, such as
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through feces or saliva, should be considered for studies of transmission (Harder et al., 1992). No
nasal, fecal, saliva or conjunctival swabs were available for this study to test potential routes of
shedding.
Serology is commonly used in rehabilitation to follow exposure to disease agents, yet
shedding of virus may occur well before seroconversion, as described in experimental infections
of harbor seals with PDV.  Infection leads to an incubation time of 5-12 days with serum
neutralizing antibodies measurable at 16 days post infection (Harder et al., 1990; Harder et al.,
1992; Goodman, 2013). This delay in measurable antibody emphasizes the importance of
quarantine in rehabilitation centers and the routine testing by RT-qPCR of potential routes of
transmission (Harder et al., 1990). Serological screening therefore may not be the best diagnostic
tool to determine infection state and exposure to PDV, although this criterion is used as a
common management tool (Matassa et al., 2008; Philippa et al., 2009; Gilbert et al., 2013).
The overall differences observed among species in tissue distribution and abundance of
virus in naturally infected seals in the U.S. Northeast suggests that harbor seals might be the
most susceptible host, with the most systemic dispersion of high loads of virus, which is closely
associated with characteristic lesions. Grey seals appear to experience some disease, but although
they have limited tissue distribution, high loads in their lungs suggest the potential to shed the
virus through coughing and sneezing. The identification of potential sub-clinical disease or
asymptomatic carriers with high viral load in harp seals in the northeast U.S. suggests that they
may be able to disseminate the virus across populations. Overall, this study starts to address the
previously identified need to critically examine intra-species transmission and susceptibility
(Hammond et al., 2005; Hall et al., 2006). This study also emphasizes the need to adopt a rapid
and sensitive RT-qPCR method for PDV testing in order to reduce the likelihood of spreading
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PDV among seals entering rehabilitation. Expanding the screening and collection of tissues for
PDV testing outside of UMEs can also help increase our understanding of the role of subclinical
carriers in the overall transmission of PDV.
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Table 1. Demographics and stranding location of the seals sampled.
ID SPECIES Age Class Sex Stranding location
MARC06-019Hg H. grypus sub-adult M Coast Guard Beach, Eastham, MA
MARC07-015Hg H. grypus pup F Wildwood, Cape May Co, NJ
MARC07-023Hg H. grypus yearling F Sandy Neck, Barnstable, MA
MARC09-004Hg H. grypus yearling M Cape Hedge Beach, Rockport, MA
MARC09-008Pg P. groenlandica sub-adult F Fortune's Rock, ME
MARC10-014Pg P. groenlandica yearling M Southport, ME
MARC10-009Pg P. groenlandica sub-adult F Biddeford Pool, Biddeford, ME
MARC10-003Pg P. groenlandica yearling M Plum Island, MA
MARC07-008Pg P. groenlandica yearling M Wallis Sands Beach, Rye, NH
MARC06-024Pv P. vitulina pup F Wells Beach, Wells, ME
MARC06-034 PV P. vitulina adult F Duck Island, Isle of Shoals, ME
MARC02-028Pv P. vitulina yearling F Nauset Beach, Eastham, MA
MARC06-043 Pv P. vitulina adult M Little Diamond Island, ME
MARC06-035 Pv P. vitulina adult F Pemaquid point, Pemaquid ME
MARC06-066 Pv P. vitulina sub-adult F Camp Ellis, Saco, ME
MARC06-056 Pv P. vitulina adult F Hills Beach, Biddeford, ME
MARC06-027 Pv P. vitulina pup M Goose Rocks Beach, Kennebunk, ME
MARC06-036 Pv P. vitulina pup M Wells Beach, Wells, ME
MARC06-097Pv P. vitulina pup F Biddeford Pool, Biddeford, ME
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Table 3. Clinical, necropsy and histopathology findings relevant to potential PDV infection,
as well as overall RT-qPCR results for PDV in harp, harbor and gray seals.
ID PDV
qRT-
PCR
CLINICAL FINDINGS GROSS/HISTOPATHO
LOGY FINDINGS
Interpretation
MARC06-
019Hg
Negative Very thin upon entry, good
body condition at necropsy.
Bathed to remove possible
diesel fuel. After a month in
rehabilitation, animal presented
with head tilt, mild anemia,
runny feces. Euthanized.
Meningioencephalitis,
neuronal necrosis and
axonal sheath swelling
with intra-axon
macrophages,
demyelination. No viral
inclusions. Diagnosis:
Morbillivirus.
PDV likely
MARC07-
015Hg
Positive Presented with high white
blood cell count (WBC), jaw
injury, Euthanized.
Pneumonia and
interstitial edema,
verminous pneumonia
without evidence of viral
infection, alveolar
histiocytosis, reactive
lymph nodes and
necrotizing hepatitis.
PDV possible
MARC07-
023Hg
Positive Animal found in one corner of
pool floating vertically, tilting
head severely towards the right
with occasional
floating/swimming laps
counterclockwise around the
pool. Ocular discharge,
multiple cutaneous ulcerations.
Euthanized due to neurological
behaviour.
Neuronal necrosis
without viral inclusions,
astrocytosis, microgliosis,
neovascularization,
ulcerative dermatitis.
PDV
MARC09-
004Hg
Negative Sponataneous death. 1000 ml of fluid found in
abdominal cavity.
Poxviral dermatitis,
ulcerative glossitis,
pulmonary thrombosis
and vasculitis.
Not PDV
MARC09-
008Pg
Positive NA Lymphoid depletion,
inflammation of the brain
in grey matter present
with no etiology
determined, cerebral
vasculitis.
PDV possible
MARC10-
014Pg
Positive Animal died after initial
treatment.
Brain grossly very
congested. Spleen and
lymph show histologic
lymphoid depletion,
PDV possible
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necrosuppurative
dermatitis.
MARC10-
009Pg
Negative Animal found dead in morning. Abscess in lower jaw.
Histopathological
evidence of bacterial
myositis, cellulitis,
adrenal necrosis (suspect
sepsis).
Not PDV
MARC10-
003Pg
Negative Inflammed conjuctiva,
diarrhea, green discharge in
eyes. Found dead in pen soon
after arrival.
Purulent discharge from
right eye, conjuctiva with
inflammation. Mild
histilogic lymphoid
depletion in spleen and
lymph nodes, intracorneal
pustules in skin. No
evidence of systemic
disease. Cause of death
undetermined.
Not PDV
MARC07-
008Pg
Positive Seizures on arrival. Mild multifocal
microgliosis, hepatitis,
granulomatous, focal
mild; conjunctivitis,
neutrophilic mulitfocal;
congestion in lymph
nodes; tonsilitis,
neutrophilic, multifocal,
mild.  All lesions were
considered incidental and
not contributing to the
observed clinical signs of
seizure. No evidence of
inflammation or viral
infection in the brain,
lymph nodes or lung.
Cause of death was not
determined.
PDV possible
MARC06-
024Pv
Negative Pink umbillicius, labored
breathing, yellow pasty semi
watery yellow fecal material,
small amount of vomit. After
three weeks in rehabilitation,
presented with low absolute
lymphocyte count. Animal
presented after three weeks in
rehabilitation with muscle
twitch on left facial proceeded
to grand mal seizures.
Bronchointerstitial
pneumonia (bacterial, no
viral inclusions
observed), hepatic
lipidosis, neuronal
necrosis, nonsuppurative
meningoencephalitis,
lymphoid depletion and
necrosis. Diagnosis:
Morbillivirus.
PDV
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MARC06-
034 PV
Positive Labored breathing,
unresponsive while on haul out
site. Eyes closed, twitching
with nasal discharge visible.
Died within an hour of
observation.
Isolation of PDV USA
2006 from liver (Matassa
et al. 2008, Earle et al.,
2011). Striking central
nervous system disease
including demylenation
and degeneration of
axons, neuronal necrosis,
and rare viral inclusions.
Ulcerative stomatitis,
lymphoid delpletion. No
bronchointerstitial
pneumonia. Diagnosis:
Morbillivirus.
PDV
MARC02-
028Pv
Negative Nasal discharge, elevated white
blood cell count, large abcess
on head, abdominal wounds
otherwise in good body
condition. Euthanized due to
blockage of ear openin by
abcess.
Localized
bronchopneumonia.
Not PDV
MARC06-
043 Pv
Positive NA Demyelination and
damaged white matter,
digestion chamber
formation, most likely
due to PDV infection,
renal papillary necrosis,
pulmonary edema,
lymphoid depletion. No
viral inclusions observed,
no evidence of
bronchointerstitial
pneumonia, neurotropic
virus effects seen.
Diagnosis: Morbilllvirus.
PDV likely
MARC06-
035 Pv
Negative NA Panopthalmitis,
encephalitis-
nonsuppurative,
bronchointerstitial
pneumonia, bacterial,
hepatic lipidosis, sepsis.
Evidence of brain
demylenation and
inflammation unlikely to
be of  bacterial origin.
Findings are consistent
with viral infection,
specifically morbillivirus.
No viral inclusions.
Immediate cause of death
was likely acute
PDV likely
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septicemia and bacterial
bronchopneumonia.
Diagnosis: Morbillvirus.
MARC06-
066 Pv
Positive Found dead, no other history
given.
PDV PCR positive.
Single viral inclusion
found in lung with
bronchointerstitial
pneumonia, lymphoid
depletion, granulomatous
lyphadenitis,
demylenation. Diagnosis:
Morbillivirus.
PDV
MARC06-
056 Pv
Positive NA Axonal degeneration in
brain and spinal cord,
histocytosis and
hemmorhage in lung,
leptomeningitis. Axonal
degeneration and
lymphoid depletion of
lymphoid organs would
be consistent with PDV
but no viral inclusions
found. Pneumonia not
typical bronchointerstitial
associated with PDV.
Suspect Brucellosis.
PDV likely
MARC06-
027 Pv
Positive Pink umbillicus at entry. After
three months in rehabiliation,
animal observed "twitching"
violently with flippers, upper
body and head. Sedated and
could not be revived after
medical procedure.
Neuronal necrosis,
multifocal,
granolomatous
lymphadenitis. Cause of
death under anaesthesia
undetermined.
PDV likely
MARC06-
036 Pv
Negative NA Periportal bile stasis,
minimal gastroenteritis.
Findings do not suggest
morbillivirus. Cause of
death undetermined.
Not PDV
MARC06-
097Pv
Positive On initial evaluation, presented
with vacant look, neurological
head bobbing, labored
breathing and breath holding,
then seizured. Euthanized.
Grossly, brain vessels
appear congested,
suspected morbillivirus.
Fibrin thrombi-lung,
hepatocellular Kupffer
cell reactivity, vascular
lesion in brain, all
PDV
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suggestive of septicemia.
Possible that this seal had
morbillivirus infection
and bacterial infection
was secondary. Suspect
morbillivirus with rare
syncytia in lung.
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Table 4. Concordance between clinical signs as well as gross and histological lesions, and PDV RT-
qPCR results
Gray seals PDV PDV likely
PDV
possible not PDV
RT-qPCR + 1 0 1 0- 0 1* 0 1
Harp seals PDV PDV likely
PDV
possible not PDV
RT-qPCR + 0 0 3 0- 0 0 0 2
Harbor seals PDV PDV likely
PDV
possible not PDV
RT-qPCR + 3 3 0 0- 1* 1* 0 2
*missing key tissues for testing
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Figure 1. Quantity of PDV determined by qRT-PCR in harbor seal, harp seal and gray seal
tissues. The three fractions (x/x) above each tissue indicates the number of tissues which tested
positive for PDV out of the total number positive animals of each species.
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ABSTRACT
During 2006, Gray seal (Halichoerus grypus) and harbor seal (Phoca vitulina) mortalities in
New England were the result of a new North American isolate of phocine distemper virus (PDV
USA 2006), representing the first cases of clinical disease and death associated with an isolated
strain of PDV in north American seals.  Evidence from natural pinniped population exposures to
PDV USA 2006 and European PDV strains in 1988 and 2002 suggests that differences exist in
the susceptibility to infection between seal species. To determine if such a difference exists in
north American seals, peripheral blood mononuclear cells (PBMCs) from harp (Phoca
groenlandica), harbor and gray seals were isolated and in-vitro infection by PDV USA 2006 was
carried out until 11 days post infection. Viral copies were quantified by RT-qPCR in
lymphocytes, monocytes and supernatant fractions. Viral loads in monocytes differed between
species with gray seals exhibiting greater replication of PDV early on (day 5) during the course
of infection compared to harp seal (p=0.003), whereas harp seals had significantly more virus at
the end of infection (day 11) compared to both gray and harbor seal (p=0.037, p= 0.021).  In
lymphocytes, viral load was greatest early on (day 5) in gray seal compared to both harp and
harbor seal (p= 0.012, p=0.01). Gray seals had higher viral load than harp seal on day 5
(p=0.003) and 7 (p=0.24), whereas harp seal had more virus than gray seal at the end of the
experiment (p=0.042) in the supernatant fraction. The monocyte fraction exhibited significantly
higher viral load in all species. Differences seen during the time course of this in-vitro infection
study may help explain the outcome of natural infection and transmission of PDV in these
pinniped species.
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INTRODUCTION
Viruses within the genus Morbillivirus are responsible for a wide range of devastating
disease in the animal kingdom, including measles in humans, peste de petit-ruminants in sheep
and other small ruminants, the distemper viruses affecting dogs and seals, as well as similar
morbilliviruses affecting dolphins, whales and porpoise collectively called Cetacean
morbillivirus (CeMV) (Kennedy, 1998; Bellini et al., 1994; Appel and Summers, 1995; Domingo
et al., 1995; Hall, 1995; Krafft et al., 1995; Barrett and Rossiter, 1999; Griot et al., 2003; Rubio-
Guerri et al., 2013). Due to the devastating effects to livestock and human livelihood, a global
campaign to eradicate Rinderpest (RPV), a morbillivirus of cattle and large ruminants, was
declared a success in 2011 (Morens et al., 2011).  Most recently, tubulointerstitial nephritis has
been described in association with a newly identified feline morbillivirus (Woo et al., 2012).
When in their appropriate host, morbilliviruses are highly contagious and cause a defining
lymphopenia and resulting immunosuppression (Tatsuo et al., 2001). Each virus can lead to a
range of diseases that can preferentially involve the respiratory, neurological and gastrointestinal
systems with survivors acquiring life-long immunity (Griffin et al., 2007; Sato et al., 2012).
Marine mammal morbillviruses are some of the most recently described in the genus.
Phocine distemper virus was first described in 1988 as the etiology responsible for the mass
mortality of harbor seals throughout European waters (Cosby et al., 1988; Liess et al., 1989;
Rima et al., 1992).  Harp seals and gray seals were implicated as potential carriers of PDV to
harbor seals, and while infrequent, these two species did exhibit disease associated with PDV as
described in harbor seals (Bergman et al., 1990; Baker, 1992; Daoust et al., 1993).
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In-vivo studies were carried out soon after the 1988 epizootic to understand the
pathogenicity of the virus as well as the relationship to anthropogenic contaminant exposure
believed to have magnified the severity of disease (Harder et al., 1992; Pohlmeyer et al., 1993).
Harbor seals were the primary focus of these studies as this species was markedly impacted
during the European events (Thompson et al., 1990; Rijks et al., 2005). Grey seal were also
subjected to in-vivo experimental exposure and proved to be less susceptible than harbor seals to
disease, though with similar sero-conversion results as harbor seals (Harder et al., 1990; Baker,
1992). Further in-vivo studies of PDV in pinnipeds are unlikely due to ethical considerations
(Ross et al., 1996). In-vivo studies using ferrets and mink to understand the course of both PDV
and CDV have proven invaluable in further understanding the pathogenesis of morbillivirus
infection (Blixenkrone-Møller et al., 1989; Von Messling et al., 2003; Svitek and von Messling,
2007; Nielsen et al., 2008).
In the spring of 2006, a new north American strain of PDV (PDV USA 2006) was
implicated in the disease and death of both gray seals and harbor seals along the New England
coast with the virus successfully isolated from a harbor seal (Prendiville, 2007; Earle et al.,
2011). The large increase in seal deaths prompted the declaration of an Unusual Mortality Event
(UME). Unlike the European events, both gray and harbor seals were notably affected
succumbing to respiratory and neurological disease.  The virus was also present in harp and
hooded seals but was not implicated as the cause of mortality in these cases (Chapter 3, Matassa
et al., 2008). Compared to the 1988 and 2002 European strains, PDV USA 2006 has several
sequence differences which may have enabled the virus to become neurotropic (Earle et al.,
2011). The reason for the apparent increase in susceptibility of North American gray seals
compared their European counterparts is not clear.
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The dynamics of canine distemper (CDV) and PDV infection in-vitro, specifically in
peripheral blood mononuclear cells (PBMCs), has allowed for a better understanding of viral
replication in multiple species and has enabled quantification of multiple end points including
production of viral proteins, immune response, chemokine and cytokine production (Visser et al.,
1993; Lu et al., 2003; Valli et al., 2010).  As new strains of PDV emerge and new host species
become at risk for infection, in-vitro studies along with improved diagnostic methods can
provide insight on the interactions that may be occurring between host and virus.  The isolation
of PDV 2006 USA allowed for the opportunity to increase our understanding into the observed
differences in species susceptibility seen during the 2006 UME.  Here we use in-vitro infection
of harp, harbor and gray seal PBMCs with the isolated strain of PDV 2006 USA to determine if
and what differences in viral quantity exist between species over time in targeted fractions,
specifically lymphocyte, monocyte and supernatant, using a duplex RT-qPCR.
MATERIALS AND METHODS
Animals and Blood Sampling
Fifteen seals in total, representing five individual seals of each species: harp, harbor and
gray seal, were used for the in-vitro infections (Table 1).  Samples were collected between 2010
and 2011. Blood samples from seals without PDV infection were used for this study. RNA from
PBMCs was processed as stated below to detect infection in PBMCs prior to use in the infection
experiment. Blood samples from stranded seals were collected before release back into the wild
by members of the Northeast US Regional Stranding Network including the University of New
England Marine Animal Rehabilitation and Conservation Center (UNE MARC), the Riverhead
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Foundation for Marine Research and Preservation, and Mystic Aquarium & Institute for
Exploration. Blood was collected from the extradural vein or hind flipper and collected into
sterile Vacutainer tubes containing sodium heparin (Becton Dickson, Franklin Lakes, NJ),
shipped overnight on cold packs and processed within 24 hrs.
Virus culture
PDV USA 2006 isolated from a harbor seal collected by UNE MARC that died of
morbillivirus infection, was kindly provided by Ole Nielsen, Department of Fisheries and Oceans
Canada. A transfected Vero cell line (VeroDogSLAMtag) expressing canine signaling
lymphocyte activation molecules (SLAM) was provided by Dr. Y. Yanagi (Seki et al., 2003;
Nielsen et al., 2008) and was used to quantify the TCID50 and viral titer for assay sensitivity as
previously described (Chapter 2, Bogomolni et al., in review).
Serology
Detection of PDV antibodies was conducted by serum neutralization assay at the
Oklahoma Animal Disease Diagnostic Laboratory or by The University of Georgia Veterinary
Diagnostic Laboratories Athens, Georgia.  Up to 1 ml of serum was collected and submitted
during the course of rehabilitation.
PBMC isolation
Peripheral blood mononuclear cells (PBMCs) were collected from heparinized blood by
Ficoll density gradient centrifugation. To compare blood leukocytes prior to and after PBMC
isolation, erythrocytes from a subsampled one ml aliquot of blood were first lysed using 0.15 M
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ammonium chloride lysing buffer solution (Brosseau et al., 1999) at room temperature (37 ⁰C).
Briefly, 9 ml of lysing buffer solution was added to 1 ml of blood and rocked gently for two
minutes. The sample was washed thrice at 1000 rpm for 10 minutes with Hanks Balanced Salt
Solution (HBSS, Life Technologies, Grand Island, NY). Blood warmed to room temperature for
PBMC isolation was diluted 1:1 in HBSS, placed 1:1 over Ficoll 1077 (Amersham Biosciences,
Uppsala Sweden) and centrifuged at 990 G for 45 minutes. The interface layer was isolated using
a sterile pipette and washed 10:1 in HBSS at 1000 rpm for 10 minutes. Erythrocytes were lysed
twice using lysing buffer. Leukocytes were re-suspended in HBSS and washed 3x with HBSS at
1000 rpm for 10 minutes each.   The PBMCs were counted and viability of cells assessed using
the exclusion dye trypan blue. The proportion of leukocytes in lysed blood and Ficoll density
gradient isolated PBMCs was assessed by flow cytometry and cells cryopreserved in ice cold
fetal bovine serum (Hyclone, Logan, UT) with 10% DMSO (Sigma, Sigma-Aldrich, St. Louis,
MO).
PDV Infection of PBMCs
Cryopreserved cells were washed thrice in DMEM/F-12 supplemented with L-glutamine
and HEPES (Gibco), 10% Cosmic Calf Serum (CCS, Hyclone, Logan, UT) and (all from Gibco)
200 µg/ml penicillin/streptomycin and 0.25 µg/ml Fungizone. Cells from each animal were
plated in triplicate (5x104 cells in 100 µl per well) in a 96 well round bottom plates (Falcon,
Becton Dickinson, Lincoln Park, NJ), with infected and non-infected cells in parallel in separate
plates placed in separate incubators (Siebelink et al., 1992; Visser et al., 1993). Before infection
with PDV, cells were plated with 50 µl additional medium and 50 µl concavalin-A (Con-A,
Sigma) at 0.1 µg/ml to stimulate proliferation. Plated cells were incubated at 37°C with 5% CO2
for 72 hours. After three days, cells were washed. Plates were centrifuged for 5 minutes at 500 g,
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medium replaced, cells pipetted to mix, and kept for 24 hours in medium with 10% CCS and
human recombinant IL-2 (IL-2hr) at 100 IU/ml (Sigma) to activate IL-2 receptors (Siebelink et
al., 1992). Plates were then centrifuged for 5 minutes at 500 G and media replaced for infection
at a multiplicity-of-infection (MOI) of 1.0. Cells were infected with PDV USA 2006 for 1 hour
at 37°C with 5% CO2.  Controls underwent similar procedures with the equivalent volume of
medium added (100 µl) and placed in a different incubator.  Cells were then washed to remove
virus or control tissue culture media, and re-suspended in 200 ul new medium supplemented with
IL-2hr (100 IU/ml).  Media used for virus infection contained the above with serum reduced to
2%, double the concentration of penicillin/streptomycin (400 µg/ml) and an additional 0.5 µg/ml
gentamicin. Cells were maintained by adding 20 µl of IL-2hr supplemented media to wells
throughout the remainder of the infection study at days 3,5,7 and 9.
RNA collection
Control and infected plates were sampled for RNA in separate biosafety cabinets. Three
factions were collected from each well:  tissue culture supernatant (S), lymphocytes (L) and
monocytes (M). Tissue culture supernatant was carefully pipetted along with suspended cells,
and lymphocytes were isolated from the supernatant using centrifugation for 30 seconds at 8,000
rpm. Monocytes adhered to the bottom of the well were then collected from the plates using 200
µl of 0.25% (1x) trypsin (Hyclone). Plates were placed in the corresponding incubator at 37°C
with 5% CO2 for 7-10 minutes to resuspend previously adhered macrophages. Trypsin was
subsequently removed by centrifugation for 30 seconds at 8,000 rpm.  Samples for RNA were re-
suspended in RLT buffer (Qiagen, Valencia, CA) and used in RNA extraction.
RNA extraction
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Cryopreserved PBMCs from each seal and samples from each fraction of the experiment
were extracted using an RNeasy plus mini kit (Qiagen) after tissue homogenization on dry ice,
and further processed through a Qiashredder column (Qiagen). This kit includes a DNA
eliminator column for DNAse treatment.  RNA quantity (ng/ul) was determined using a
Nanodrop 1000 Spectrophotometer (Thermo Scientific). Samples were kept at -80⁰C until
analysis.
Duplex RT-qPCR
PDV 2006 and GAPDH primers and probes were used in a multiplex reaction using
Qiagen Quantifast Multiplex RT-PCR +R in 96 well plates as previously described (Bogomolni
et al., in review). Relative copy numbers of PDV USA 2006 and GAPDH were determined
using  100 ng/µl sample RNA in duplicate for each cell fraction at each time point (fractions S,
L, M at day 3, 5, 7, 9, and 11). PBMCs isolated from seals were also analyzed under the same
conditions to detect active infection with PDV. For each run, at least eight log dilutions of each
plasmid standard were used as the positive control, as well as two no-template control samples
(NTC). Each 20 µl sample reaction contained:  10 µl Quantifast Master mix, 0.4 µl ROX, 0.6 µ l
PDV forward primer (300 nm), 0.6 µl PDV reverse primer (300 nm), 0.4 µl PDV probe (50 nm),
0.4 µl GAPDH forward primer (200 nm), 0.4 µl GAPDH reverse primer (200 nm), 1.92 µl
GAPDH probe (240 nm), 0.2 µl RT-mix and up to 5 µl of RNA. Concentrated RNA was diluted
to 100 ng/µl with sterile RNAse free water. Standards were run under the same conditions with
an additional 3.08 µl water and 1 µl of each of the PDV and GAPDH standard ds-DNA plasmid
in 10-fold serial dilutions from at least 100 to 108 copies.  The reaction was initiated with a
reverse transcription step at 50⁰C for 20 minutes, followed by a denaturation step at 95 ⁰C for 5
minutes, and amplification for 40 cycles each including annealing at 95 ⁰C for 15 seconds and an
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extension at 60⁰C for 32 seconds. Each fluorescent reporter signal was measured against ROX,
an reference dye added to the reaction mixture designed to normalize the fluorescent reporter.
Samples, controls and standards were run in duplicate. The lowest level of detection was
determined to be the lowest dilution of the standard that yielded amplification product. The
baseline cycle threshold value was set to be at the exponential increase phase of the reaction for
each of the two standards detected.
Assay Sensitivity based on TCID50 Equivalents of standard PDV ds-DNA plasmid standard
The log10 TCID50 of PDV USA 2006 was calculated using 10-fold dilutions of virus
grown on SLAM transfected Vero cells and results were analyzed using the Spearmann-Karber
Titre calculator as previously described (Chapter 2, Bogomolni et al. in review). The PDV virus
was calculated to have a TCID50 of 4.4 (log10TICD50/ml) equivalent to 25,118 infectious
particles per ml. The limit of detection and sensitivity of the assay was 2.5 infectious particles,
equivalent to 6.25 copies of PDV standard, to 25,118 infectious particles with an equivalent of
479,656 copies PDV standard (Figure 1).
Statistics
Comparison of the intensity of infection in each cell fraction (S,L,M) at each time point
(3,5,7,9,11) between species (Pv, Hg, Pg)  was performed using a generalized linear mixed
model two-way repeated measures analysis of variance with a Holm-Sidak post hoc test for each
time point for the three species tested using SigmaPlot 12.5 (Systat Software, San Jose, CA).
Outliers were first removed based on each RT-qPCR assay run for each cell fraction using SPSS
(IBM). When necessary, data were transformed using a Johnson transformation to obtain
normality using Minitab (Minitab Inc., State College, PA) and analyzed using SigmaPlot as
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described above. The Johnson transformation determines an optimal transformation from three
different distribution families (Kotz and Johnson, 1993). Statistical significance was determined
using a p value <0.05.  Line graphs were constructed using Microsoft Excel and box plots by
using Minitab (Minitab Inc.) Data represented as mean +/- standard deviation (SD).
RESULTS
Animal Samples
RT-qPCR of PBMC samples indicated that no animals used in the study had active PDV
infection. GAPDH levels in PBMCs were within range of detection of the standards indicating
good quality RNA of sufficient quality to support amplification reactions, thereby reducing the
likelihood of false negative PDV infection.
PBMC isolation and cell viability
Isolation of cells by Ficoll Density centrifugation provided high purity isolation of
PBMCs (Figure 2). GAPDH was used as an indicator of cell viability in a subset of samples from
control plates at day 3,5,7,9 and 11 from all three species. GAPDH levels in all cell fractions for
all three species declined through the study and were undetectable at day 11 for all fractions.
Copies of GAPDH plasmid for all species (2 individuals per species, n=6) in monocyte and
lymphocyte fractions ranged from (mean +/- SD): 20,893 +/- 14,599 at day 3; 1,935 +/- 287 at
day 5; 2,386 +/- 4,627 at day 7; 301 +/- 650 at day 9; 0 at day 11.
Infection of seal PBMCs with PDV
PDV Comparison by Cell Fraction for Each Species
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PDV quantity differed between species in all cell fractions over the course of in-vitro
infection. No virus was detected in control samples.
Lymphocyte Fraction
Viral quantity in the lymphocyte fraction was significantly greater in gray seal than harp
seal (p=0.012) and harbor seal (p=0.01) at day 5 in the lymphocyte fraction (Figure 3a). During
the course of infection, significant changes in viral load were only apparent for gray seal, with an
increase between day 3 and 5 (p=0.004) and a decrease between day 5 and 11 (p=0.005).
Monocyte Fraction
In the monocyte fraction, virus was also significantly more abundant in gray seal than
harp seal (p=0.003) at day 5. At day 11, this relationship inversed with harp seal having
significantly more virus than harbor seal (p=0.021) or gray seal (p<0.001), and gray seal having
significantly less virus present than harbor seal (p=0.037) (Figure 3b).  Harp seal monocytes had
significantly more virus at the end of the infection (day 11) than at the start (day 3) (p<0.001).
At day 9, virus quantity was significantly higher than at day 3 for harbor seal (p=0.016). Viral
quantity did not significantly differ at the end of the experiment (day 11) for harbor or gray seal.
Supernatant Fraction
The supernatant fraction mirrored the differences of the monocyte cell fraction with
greater quantity of virus in gray seal than harp seal at day 5 (p=0.003) as well as at day 7
(p=0.024). At day 11, harp seal exhibited greater virus than gray seal (p=0.042) (Figure 3c).
Harp seal supernatant had significantly more virus at the end of the infection (day 11) than the
start (day 3) (p=0.008).
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PDV Comparison between Cell fractions for each Species
To better understand differences in viral distribution, virus quantity in each fraction was
compared within a species. In harp seals (p<0.001), harbor seals (p=0.024) and gray seals
(p=0.026), monocytes had greater viral loads when compared to the supernatant fraction at day 9
(Figure 4).  Harp seals also had higher viral loads in monocytes when compared to lymphocytes
(p=0.013) at day 9.  Greater amount of virus in monocytes was also found at day 11 compared to
the supernatant fraction (p=0.019) in harp seals.  As noted above, viral quantity did not
significantly differ between day 3 and day 11 for harbor or gray seal, but a significant decrease in
virus was noted at day 3 and day 9 for both species (harbor seal p=0.002  ; gray seal p=0.033)  in
the monocyte fraction.
Total Virus in All Cell Fractions
Total virus combined from all cell fractions was not significantly different between
species. Median values indicate high variability in the dataset between some individuals,
specifically at later time points.  Variability between individual gray seals was relatively less
compared to harbor and harp seals. Highest overall concentrations of virus were encountered in
harp seals, which occurred at day 9 of the infection.
DISCUSSION
This is the first study to document in-vitro infection with PDV USA 2006 in North
American harbor seal, gray seal and harp seal. Differences in viral load between species were
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dependent on the time point examined. If in-vitro infection mirrors the susceptibility and
permissiveness of host PBMCs during natural infection, the differences in viral loads quantified
may explain the differences in the course of disease during epizootic events. This is especially
relevant in conditions where multiple species overlap may occur.
Monocytes were the primary target for PDV replication in all three species of phocids as
determined by quantity of virus measured.  When comparing infection of monocytes between
species, gray seals had greater viral load early, whereas harp seals had higher loads at the end of
the infection study. Viral loads increased significantly over time for harp seal and significantly
decreased over time in gray seal and harbor seal.
The progressive loss of GADPH expression over time suggests a reduction in the number
of host cells, which may be a limiting factor to the replication of virus in this study. This in turn
may potentially occur through pathogenicity. Higher viral loads early in the process (day 5) in
grey seals may accelerate the rate of host cell death, therefore explaining the declining viral loads
at later time points due to lack of viable host cells. Conversely, the continuously increasing viral
loads in harp seals may be explained by reduced cytotoxicity in this species, allowing for the
maintenance of viable cells for viral growth. This would be compatible with the weaker
relationship between presence of PDV and associated disease in harp seals observed in natural
infection (Chapter 3, Bogomolni et al, in preparation). While it appears the virus preferentially
replicates in monocytes, determining the number of cells present of each cell type would help
better understand this relationship. For comparison, in experimental CDV infection in ferrets,
74% of infected cells were lymphocytes and 14% of cells affected were monocytes. Of these
lymphocytes, the majority of cells infected were T cells (Nielsen et al., 2009). The proportion of
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cells infected here is not known, though RT-qPCR quantification indicates a difference in viral
load within the cell fractions isolated.
When examining the dynamics of PDV infection over time, gray seal monocytes
exhibited a unique bimodal infection pattern (Figure 4c). This infection pattern was previously
described during in-vitro infection of bovine cells by rinderpest virus (RPV), a morbillivirus with
similar mode of infection to PDV (Nores et al., 1995).  In RPV infection, several days were
required for differentiation of monocytes to macrophages. In-vitro maturation of monocytes into
macrophages has been associated with increased permissiveness to infection by several viruses
(Gendelman et al., 1986; Maury, 1994). The prolonged infection of RPV was hypothesized to
occur as monocytes differentiated into macrophages allowing for a primary and a secondary
infection in the host which presented as a bimodal infection (Nores et al., 1995). Similar to
bovine PBMCs in-vitro, it is possible for gray seal monocytes to have activated and
differentiated into macrophages during in-vitro infection. Harp and harbor seals did not exhibit
this pattern of infection. Prolonging infection could cause an increase in the amount of virus
produced, leading to earlier death of cells in-vitro, consequently decreasing measurable virus at
the end of the experiment.  In experimental in-vivo infection studies with PDV, a gray seal (n=1)
did not exhibit disease as did harbor seals (Harder et al. 1990). Both species seroconverted yet
only harbor seals exhibited clinical signs and one succumbed to infection. Differences in quantity
of viral replication early on during infection in lymphocytes and monocytes may explain some
species differences seen during natural infection. One interpretation of the outcome of this effect
in-vivo may be that if the PDV cell associated viremia is more profound early, without the spread
of virus to other tissues, the host may be able to increase antigen presentation and mount a
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stronger and more targeted cellular and humoral immune response against the virus rather than
after the systemic spread of lower levels of virus.
Systemic spread of morbilliviruses occurs through infected macrophages and
lymphocytes transporting the virus to permissive epithelial, mesenchymal and neuroectodermal
tissues (Caswell and Williams, 2007). Interestingly, in-vivo studies of CDV indicate that the
highest numbers of CDV-infected monocytes were found in dogs which developed
demyelinating lesions (Stein et al., 2008).  One of the defining characteristics of the 2006 PDV
virus is its potential to become more neurotropic (Earle et al., 2011). Evidence for this potential
is also found in neurological clinical and pathological findings noted in gray seals during the
2006 PDV UME (Prendiville, 2007).
The spread of morbillivirus is also dependent on the ability of the virus to replicate in
host cells. PDV infection in lymphocytes was significantly greater earlier in gray seals, then
decreased, while in harp seals virus in lymphocytes continued to increase during infection.
Leukopenia resulting from morbillivirus infection has been shown to correlate with the
destruction of virus infected immune cells expressing the CD150 receptor (Sidorenko and Clark,
2003). The time course of infection in this experiment suggests that viral replication is
significantly greater early on in gray seals. This increase therefore could lead to an earlier
lymphopenia caused by the destruction of lymphocytes.
In addition to cell lysis, different morbillivirus have different effects on host cell
responses, including  influence on host receptor, activation of cell mediated response signals and
inhibition of in-vitro leukocyte proliferation (Minagawa et al., 2001; Heaney et al., 2002;
Sidorenko and Clark, 2003; Ohno and Yanagi, 2006). Binding of virus to cells, and therefore
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infection of morbillivirus in the host, is dependent on host cell receptors, specifically CD150, as
well as CD46 and nectin-4 (Tatsuo and Yanagi, 2002; Dhiman et al., 2004; Noyce and
Richardson, 2012; Pratakpiriya et al., 2012).  The activation of the CD150 or Signaling
Activation Molecule (SLAM) receptor leads to the activation of interferon-γ (Sidorenko and
Clark, 2003), an antiviral cytokine which aides in the recruitment of Th1 and NK cells. The
CD150 receptor is the target of many viruses in order to evade host immune response. Binding of
measles virus to the CD150 receptor mediates virus uptake, syncytium formation and viral entry
into monocytes (Minagawa et al., 2001). PDV infection here may also alter host responses
independent of lysis as occurs with measles.
Differences in the rate and quantity of PDV infection in harp, harbor and gray seals may
also be a result of the relationship between host receptors and virus. Not all morbilliviruses
utilize cellular receptors equally and PDV USA 2006 may utilize receptors differently in
different species compared to previous PDV isolates (Barrett, 1999; Earle et al., 2011). During
in-vivo experiments with CDV infection, a marked increase in SLAM expression was noted,
potentially enabling SLAM expressing cells to be more susceptible to infection and therefore a
higher viral load (Wenzlow et al., 2007).  After in-vitro stimulation with antigen or mitogen, T
cells have been shown to express SLAM, potentially increasing infection in these cells (Farina et
al., 2004; Yanagi et al., 2009). PDV USA 2006 may similarly preferentially bind to these SLAM
expressing immune cells differently between species (Ohishi et al., 2012). Activation of other
cell receptors such as IL-2R can also influence morbillivirus infection (Yanagi et al., 2009). It is
therefore possible that differences in virus replication between species could be explained by
differential cell activation and cell surface expression upon activation. These differences in
experimental models and virus strain illustrate the importance of conducting experiments and
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interpreting results based on the target species and virus of interest. While ferret, dog and mink
models described in the experiments referenced are useful in understanding the pathogenesis of
morbillivirus infection, the effects of PDV on seals may be dependent on the specific virus strain
as well as by the species of seal infected.
In addition to infection of target cells, morbillivirus infections can also control early
innate and antiviral response in the host. CDV is known to cause phenotypical changes including
down regulation MHC class II and co-stimulatory molecules of canine dendritic cells with the
production of corresponding increases in IL-10, an immune inhibitory cytokine (Qeska et al.,
2014). In lethal CDV infection, low to undetectable cytokine response in the first 7 days was
noted in mink, dogs and ferrets (Gröne et al., 1998; Von Messling et al., 2006; Svitek and von
Messling, 2007; Nielsen et al., 2009). In experimental conditions, animals that survived CDV
infection were able to produce early cytokine expression. The effects of virus on host antiviral
response, specifically IFN-γ producing lymphocytes, was alleviated at week one post infection
(Nielsen et al., 2009). Gray seals and harbor seals in this study responded with a decrease in
virus over time in monocytes, while harp seals exhibited an increase in virus in monocytes. Cell
mediated cytokine response may explain the different responses between species. Viral
permissiveness or receptivity may decrease in time with gray seals, but be weak early during
infection, favoring viral replication. Similar to the model species in previous studies, measuring
cytokine response of each species during infection could help to explain some of the species
differences seen (Gröne et al., 1998; Svitek and von Messling, 2007; Valli et al., 2010).
Before the 2006 outbreak of PDV in the US, harbor seals within European waters were
considered to be highly susceptible while other species, such as harp and grey seals, were
determined to be more resilient (Harkonen, 2006). Harp seals did not appear affected in the 1988
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and 2002 events and are believed to be responsible for the introduction of the virus to naïve
European seals (Stuen et al., 1994).  Morbillivirus seropositive harp seals were reported without
associated disease prior to the events, while all tested harbor seals were negative before the first
epizootics, supporting the notion of a naïve population (Dietz et al., 1989). The evidence of PDV
positive serum neutralizing antibodies confirmed that harp seals could be considered a vector of
the virus to the naive harbor seal population, resulting in the first severe 1988 epizootics (Stuen
et al., 1994). The in-vitro results here indicate measurable differences in viral replication during
the time course of infection between harp seal as compared to gray seal and harbor seal.
In-vitro infection studies using sensitive quantification methods offer an opportunity to
assess infectivity of PDV in species affected by the virus and predict potential impacts on species
that have not yet been exposed to the virus. It also enables comparison between species that may
interact in natural settings with unknown consequences. The in-vitro data presented here suggest
that harp seals react differently to infection by PDV with less virus at the beginning of infection
and a marked increase in virus throughout the period of study, unlike harbor and gray seals. Gray
seals in contrast exhibit an increase in virus early on. Monocytes produce the greatest amount of
virus in all species, with gray seals exhibiting more virus early on compared to harp seal, while
harp seals exhibit the opposite pattern, i.e. with higher quantity of virus at the end of the
infection.  While comparisons in-vitro cannot be used as definitive predictors in-vivo, the data
add to a growing understanding of viral replication in immune cells of different species of seal
infected with PDV.
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Figure 1. Assay Sensitivity based on TCID50 Equivalents of standard PDV ds-DNA plasmid
standard. PDV was calculated to have a TCID50 of 4.4 (log10TICD50/ml) with a limit of
detection and sensitivity of 2.5 infectious particles equivalent to 6 copies of PDV standard, to
25,118 infectious particles with an equivalent of 479,656 copies PDV standard. Equivalent
copies of PDV plasmid standard are given by each data point for each Log10 TCID50 assessed.
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Figure 2. PBMC isolation. Representative scatterplots of the flow cytometric profile of harbor
seal peripheral blood leukocytes before (2a) and after ficoll gradient centrifugation (2b.)
demonstrates the selective loss of granulocytes and enrichment in mononuclear cells
(lymphocytes and monocytes) in harbor seal cells isolation.
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a. Lymphocyte
b. Monocyte
c. Supernatant
Figure 3. PDV Comparison by Cell Fraction for Each Species. PDV quantity differed
between species in lymphocyte (3a), monocyte (3b) and supernatant (3c) fractions, over the
course of in-vitro infection with *p<0.05. PDV values represented as mean + SD.
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a. Harp seal
b. Harbor seal
c. Gray seal
Figure 4. PDV Comparison between Cell fractions for each Species. PDV quantity differed
between cell fractions in harp seal (4a), harbor seal (4b) and gray seal (4c) with *p<0.05. PDV
values represented as mean + SD.
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Abstract
In the last 30 years, a number of large scale marine mammal mortality events have
occurred, often in close association with highly polluted regions, leading to suspicions that
immunosuppressive contaminants contributed to these epizootics. Many of these recent events
also identified morbilliviruses as a cause of or contributor to death. In the northeast U.S.,
recovering seal populations are exposed to a wide array of persistent and emerging contaminants,
and in 2006 were involved in an Unusual Mortality Event (UME) associated with Phocine
Distemper Virus (PDV USA 2006). The role of contaminant exposures, susceptibility to PDV
and ultimate mortality, is still unclear. Therefore this study aimed to address the potential for a
mixture of PCBs, specifically as Aroclor 1260, to alter harbor seal T lymphocyte proliferation,
and to assess if exposure resulted in changes in susceptibility to PDV exposure in an in-vitro
system. Exposure of peripheral blood mononuclear cells (PBMCs) to Aroclor 1260 did not
significantly alter lymphocyte proliferation at any of the tested concentrations (1,5,10,20 ppm).
However, lymphocytes exposed to 20 ppm Aroclor 1260 exhibited a significant decrease in PDV
replication at day 7 (p<0.001) and a significant increase at day 11 (p=0.003) compared to
unexposed control cells. Similar and significant differences were apparent upon Aroclor 1260
exposure in monocytes, with exposed cells having less virus at day 7 (p=0.002) and more at day
11 (p<0.001). Viral quantity was also significantly lower at day 7 (p=0.005) and higher at day 11
(p=0.005) in the tissue culture supernatant fraction of the exposed cells versus control. The
difference in kinetics of in-vitro infection could be due to several factor, including differences
in host cell activation, expression and activation of cell surface receptors or differences in host
cell chemical signaling. The overall higher viral loads upon in vitro Aroclor 1260 exposure
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suggest the potential for greater viral replication in seals with higher loads of persistent
contaminants.
Introduction
Along the Northeast coast of the United States, the three species of seal most commonly seen
are harbor seal (phoca vitulina concolor), gray seal (Halichoerus grypus) and harp seal (Phoca
groenlandica). Hooded seal (Cycstophora cristata), and less commonly ringed seal (Phoca
hispida), also frequent the area (Hannah et al., 2000; Harris et al., 2001).  Though nearly
extirpated in New England due to bounty hunts, protection in the 1960s and 1970s enabled
harbor seals and gray seals to regain historical grounds in the Northeast U.S. (Gilbert et al., 2005;
Lelli and Harris, 2006; Wood et al., 2007; Lelli et al., 2009; Wood et al., 2011; Waring et al.,
2013). The increase in the seal population has resulted in more opportunity for species overlap to
occur and also the opportunity to document marine mammal strandings and mortality events
through the Northeast US Marine Mammal Stranding Network (Prescott et al., 1990; St Aubin et
al., 1996; Geraci et al., 2005).
With an increasing population of marine mammals so also exists a rise in occurrence of
unusual mortality events (UMEs), which by definition occur when a greater than expected
number of mortalities are recorded (NOAA, 2006). In the last 23 years, 60 formally recognized
marine mammal UMEs in the United States caused by infection, harmful algal toxins, human
interaction, malnutrition or undetermined factors have been investigated (NOAA, 2013). The
most notable of these large scale mortality events in recent history includes one for which half
the population of harbor seals in European waters died in 1988, and again in 2002. The cause of
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these devastating mortality events was a morbillivirus, specifically Phocine Distemper Virus
(PDV) (Osterhaus and Vedder, 1988; Jensen et al., 2002).
Similar large scale events occurred with increasing frequency in marine mammals through
the 1980’s and 1990’s in cetaceans and pinnipeds (Aguilar and Borrell, 1994; Hutchinson and
Simmonds, 1994). Many of these recent events also identified morbilliviruses as a cause or
contributing to death (Geraci, 1989; Aguilar and Raga, 1991; Rima et al., 1992; Barrett et al.,
1993; Lipscomb et al., 1994a; Lipscomb et al., 1994b; Duignan et al., 1996; Kennedy et al.,
2000; Butina et al., 2003; Haerkoenen et al., 2006; Earle et al., 2011; NOAA, 2014) The close
association of these mortality events to highly polluted regions led researchers to suspect that the
immunosuppressive effects of various products of industry contributed to these epizootics (Safe,
1989; Safe, 1992; de Swart et al., 1994; Hutchinson and Simmonds, 1994; Martineau et al.,
1994; Ross et al., 1994; Lahvis et al., 1995; Ross, 2002).
The immunotoxicity of these persistent organic pollutants (POPs) was ultimately quantified
in harbor seals during a pivotal feeding exposure experiments where seals were fed fish captured
in contaminated and less contaminated areas (Ross et al., 1992; de Swart et al., 1994; Ross et al.,
1994; de Swart et al., 1995). Many subsequent in-vitro investigations of cellular immunity in
marine mammals have indicated immunomodulation of the innate and adaptive immune system
does occur upon exposure to a range of persistent contaminants, including effects on natural
killer cell activity, cytokine response, respiratory burst, phagocytosis and lymphocyte
proliferation (De Guise et al., 1996; De Guise et al., 1998; Neale et al., 2005; Mori et al., 2006;
Levin et al., 2007a; Levin et al., 2007b; Dufresne, 2010; Frouin et al., 2010) . Correlative studies
based on immune assays, histopathological findings and measured levels of POPs in tissues also
suggest cellular and humoral immunity and endocrine function can be influenced by these
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contaminants (Brouwer et al., 1989; Beckmen et al., 2003; Beineke et al., 2005; Levin et al.,
2005a; Mos et al., 2006; Schwacke et al., 2011). Epidemiological studies examining the effects
of polychlorinated biphenyls (PCBs) also suggest that animals with higher burdens of
contaminants were at increased risk of dying from infectious disease (Jepson, 1999; Hall et al.,
2006).
Not all studies suggest POPs induce negative impacts on measurable immune system
function. In contrast to the above findings, direct in-vivo experimental exposure of harbor seals
to PCB and subsequent PDV exposure did not result in differences between exposed and non-
exposed groups and resulting infection (Harder et al., 1992). Similarly, no association was found
in gray seals between general infection status and chlorinated biphenyl burdens (Hall et al.,
1997). A recent retrospective study on the 2000-2001 Caspian seal mortality event due to CDV
suggests that levels of organochlorine contaminants had no association to CDV status despite
PCB and organoclorine pesticide levels being similar to levels which result in immune
suppression in harbor seals (Kajiwara et al., 2002; Wilson et al., 2014).
Given these discrepancies, interpretation of results from correlative, in-vivo and in-vitro
studies should consider the class of contaminants being addressed, levels of exposure, age, sex,
nutritional status, species specific susceptibility and environmental parameters (Hutchinson and
Simmonds, 1994; Ross et al., 1996a; Hammond et al., 2005; Levin et al., 2005b; Mori et al.,
2006; Harkonen et al., 2007). While studies generally attempt to decrease confounding factors, it
is impossible to recreate the perfect storm of events and account for all chemical components and
exact epidemiological parameters leading to large scale mortality events (Ross et al., 1996a;
Kajiwara et al., 2008). It remains difficult to understand the relationship between observed
immunosuppression and an increase in susceptibility to infectious disease, yet these studies are
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important in adding to the weight of evidence regarding the effects of legacy and emerging
contaminants on marine mammal health (Ross et al., 1996a; Schwacke et al., 2011).
In the northeast U.S., recovering seal populations are exposed to a wide array of persistent
and emerging POPs, including PBDEs, OC pesticides, hexabromocyclododecanes (HBCDs),
perflourinated chemicals and PCBs (Lake et al., 1995; Shaw, 2003; Shaw et al., 2005; Shaw et
al., 2006; Shaw et al., 2008; Shaw et al., 2009; Shaw et al., 2012; Shaw et al., 2014; Weijs et al.,
2014). Levels of PCBs measured in the blubber of harbor seals from the northeast U.S. region
were 5.1 to151 µg/g (ppm) lipid weight (Shaw et al. 2005). Based on the increasing wealth of
knowledge on correlative and in-vitro studies, as well as direct measures of persistent pollutants
in seals in the northeast U.S., it has become evident that the levels present in these seals are
above the 17 ug PCB/g lw threshold for adverse effects including alterations in immune response
(De Swart et al., 1996; Ross et al., 1996a; Kannan et al., 2000; Shaw, 2003).
In 2006, a new North American strain of Phocine Distemper Virus (PDV USA 2006) was
isolated and determined to be the cause of mortality of harbor seal and gray seals during the
Northeast U.S. Pinniped Unusual Mortality Event (Matassa et al., 2008; Earle et al., 2011). As in
the 1988 and 2002 mortality of European seals, the role of contaminant exposures, susceptibility
to PDV and ultimate mortality, is still unclear.  This study aims to address the potential for a
mixture of PCBs, specifically as Aroclor 1260, to alter harbor seal T lymphocyte proliferation,
and to assess if exposure can result in changes in susceptibility to PDV upon in vitro infection.
MATERIALS AND METHODS
Aroclor 1260
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Aroclor 1260 (Pcb 1260) Lot Number: NT01023 (Ultra Scientific, North Kingstown, RI)
stock solution was initially suspended in DMSO at 5000 ppm (50 mg/10 ml). The highest
concentration of Aroclor 1260 used for the experiment was 20 ppm with a maximum DMSO
concentration of 0.4%. Therefore, Aroclor 1260 dilutions used in all experiments were diluted to
the appropriate concentration using complete media with equivalent concentrations of DMSO
(0.4%) in all experimental and control dilutions.
Seals and Blood Sampling
Blood samples from wild capture harbor seals were collected as part of an ongoing
population assessment by the National Marine Fisheries Service (NMFS) Northeast Fisheries
Science Center (NEFSC) between 2011 and 2012. Blood samples from stranded seals were
collected from seals before release from the University of New England Marine Animal
Rehabilitation and Conservation Program (UNE MARC) and the Riverhead Foundation for
Marine Research and Preservation (Riverhead) (Table 1).  Blood was collected from the
extradural vein or plantar venous plexus of the hind flipper collected into sterile Vacutainer tubes
containing sodium heparin (Becton Dickson, Franklin Lakes, NJ), shipped overnight on cold
packs and processed within 24 hrs. RNA from peripheral blood mononuclear cells (PBMCs) was
processed as stated below to detect PDV in PBMCs prior to use in the lymphocyte proliferation
and infection experiment.
PBMC isolation
Prior to isolation and cryopreservation of PBMCs, 1 ml of heparinized whole blood was
lysed to compare leukocyte percentage in blood before and after density gradient PBMC
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isolation as previously described (Chapter 3). PBMCs were collected from heparinized blood by
Ficoll density gradient centrifugation as previously described (Chapter 3). The purity of
mononuclear cells was determined by flow cytometry based on the forward and side scatter
profile.
Lymphocyte proliferation
Cryopreserved PBMCs from four wild capture and six stranded harbor seals (n=10) were
washed in complete Dulbeco’s Modified Eagle Medium (DMEM) and plated (1x106 cells/ml
final concentration, 100 µl per well) in triplicate in 96 well flat bottom tissue culture plates
(Falcon, Becton Dickinson, Franklin Lakes, NJ). Cell count was based on percentage of
lymphocytes present as determined by flow cytometry. Cells from the same individual seal were
exposed to Aroclor 1260 in vitro at 1,5,10 and 20 ppm or DMSO vehicle only (0 ppm).  The
selection and range of Aroclor 1260 used was based on toxicity and previously published in-vitro
PBMC exposures using Aroclor 1254 and 1260 (Davis and Safe, 1989; Hammond et al., 2005;
Brousseau and Fournier, 2010; Dufresne, 2010).  One plate contained no mitogen, while the
second contained mitogen.  As the removal of pathogens is largely dependent on T cell
activation, proliferation, and differentiation into effector and memory cells, the T cell mitogen
concavalin A (Con-A) (Sigma, St Louis, MO) was selected, and used at the suboptimal
concentration (0.1 µg /ml), which was shown to be more sensitive in detecting immunotoxicity
than higher, or optimal, concentrations (Mori et al., 2006). Cells were incubated at 37⁰C with 5%
CO2 for a total of 66 hours. Lymphocyte proliferation was evaluated by the incorporation of 5-
bromo-2’-deoxyuridine (BrdU), added for the last 18 hours of incubation, and detected with a
monoclonal antibody and a colorimetric enzymatic reaction (Cell Proliferation ELISA BrdU
(colometric), Roche Diagnostics GmbH, Mannheim, Germany) as per manufacturer’s
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instructions using an ELISA plate reader (Multiskan EX v 1.0) at 690 nm with a reference
wavelength of 450 nm. Stimulation index was calculated as the ratio of the measured optical
density between un-stimulated versus stimulated cells.
Infection of Seal PBMCs with PDV pre-exposed to Aroclor 1260
Cryopreserved cells from four wild capture harbor seals and one stranded harbor seal (n=5)
were washed thrice in DMEM/F-12 supplemented  with L-glutamine and HEPES (Gibco), 10%
Cosmic Calf Serum (CCS, Hyclone, Logan, UT)  supplemented with (all from Gibco) 200 µg/ml
penicillin/streptomycin and 0.25 µg/ml Fungizone. Cells were plated in triplicate (5x104 cells per
well) with 20 ppm Aroclor 1260 and 0.1 µg /ml Con-A in order to stimulate proliferation in a 96
well round bottom plates (Falcon, Becton Dickinson, Lincoln Park, NJ).  Infected and non-
infected cells were incubated in two separate incubators at 37°C with 5% CO2 for 72 hours
(Siebelink et al., 1992; Visser et al., 1993). Cells were then washed. Plates were centrifuged for 5
minutes at 500 G, medium  replaced, cells pipetted to mix, and kept for 24 hours in medium with
10% CCS and human recombinant IL-2 (IL-2hr) at 100IU/ml (Sigma) to activate IL-2 receptors
as previously described (Siebelink et al., 1992). Plates were then washed (5 minutes at 500 G)
and medium removed for infection at a multiplicity of infection (MOI) of 1.0. Cells were
infected with PDV USA 2006 for 1 hour at 37°C with 5% CO2. Controls underwent similar
procedure with the equivalent volume of medium added (100 µl) and placed in second incubator.
Virus or media control was then removed from cells. Wells were gently mixed with 200 µl
medium, centrifuged (5 minutes at 500 G) to remove remaining virus or control media and gently
mixed with 200 µL of new medium. Cells were maintained in 200 µl complete medium
supplemented with 100 IU/ml IL-2hr.  Media used for virus infection contained 2% serum,
double the concentration of penicillin/streptomycin (400 µg/ml) and an additional 0.5 µg/ml
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gentamicin. Cells were maintained by adding 20 ul of the media supplemented with IL-2 at days
5, 7 and 9.
Collection of Samples for RNA Extraction
Control and infected plates were sampled for RNA in separate biosafety cabinets. For
RNA collection, three samples were collected from each of the three wells:  tissue culture
supernatant (S), lymphocytes (L) derived from the supernatant pellet after centrifugation for 30
seconds at 8,000 rpm, and monocytes (M) which adhered to the bottom of the well, collected
using 200 µl of trypsin (Hyclone). Plates were placed in the corresponding incubator at 37°C
with 5% CO2 for 7-10 minutes. Trypsin was subsequently removed by centrifugation for 30
seconds at 8,000 rpm.  RNA samples were re-suspended with RLT buffer (Qiagen, Valencia,
CA).
RNA extraction
PBMCs from each cell fraction was extracted using an RNeasy plus mini kit (Qiagen) after
tissue homogenization on dry ice, and further processing through a Qiashredder column
(Qiagen). This kit includes a DNA eliminator column for DNAse treatment.  RNA quantity
(ng/µl) was determined using a Nanodrop 1000 Spectrophotometer (Thermo Scientific). Samples
were cryopreserved at -80˚ C until analysis.
Duplex RT-qPCR
The PDV and GAPDH primers and probes were used in a duplex reaction using Qiagen
Quantifast Duplex RT-PCR +R in MicroAmp Optical 96 well reaction plates (Applied
Biosystems) in the Applied Biosystems 7500 Real Time Cycler as previously described (Chapter
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3, Bogomolni et al., in review). Copy numbers of PDV and GAPDH were determined using 50
ng/ul of sample RNA in duplicate.  For each run, at least eight log dilutions of each plasmid
standard were used as the positive control.  Samples, no template control (NTC), and standards
were also run in duplicate. Each 20 ul sample reaction contained:  10 ul Quantifast Master mix,
0.4 ul ROX, 0.6 ul PDV forward primer (5'-ACC TCG ATG GGC AAT GTG TT-'3) and 0.6 ul
PDV reverse primer (5'-GTC TTA CCG TAG ATC CCT TCT GAG AT-'3)   at 300 nm, 0.4 ul
PDV Taqman probe (5'-[FAM]CAT GTC CCT CAT ATC AAA ACC TTC GGA GG
[TAMRA]-'3)  at 50 nm, 0.4 ul GAPDH forward primer (5'-GTC TTC ACT ACC ATG GAG
AAG G-'3)  and  0.4 ul GAPDH reverse primer (5'-TCA TGG ATG ACC TTG GCC AG-'3) at
200 nm, 1.92 ul GAPDH Taqman probe with LNA bases (5'-
[HEX]G[+C]CA{+A]GAGGG[+T]C[+A]T[+C]A[TAMRA]-'3)  at 240 nm, 0.2 ul RT-mix and
up to 5 ul of RNA with sterile RNAse free water. Standards were run under the same conditions
with an additional 3.08 ul water and 1 ul of each of the PDV and GAPDH standard ds-DNA
plasmid in 10-fold serial dilutions from 1 to 108 copies.  The reaction initiated with a reverse
transcription step at 50 ⁰C for 20 minutes, followed by denaturation step at 95⁰C for 5 minutes,
and amplification for 40 cycles each of annealing at 95⁰C for 15 seconds and an annealing and
extension at 60 ⁰C for 32 seconds. Each fluorescent reporter signal was measured against ROX,
an added reference dye designed to normalize the fluorescent reporter signal. The lowest level of
detection was determined to be that of the lowest amplification dilution of the standard. The
baseline cycle threshold value was manually set to be at the exponential increase phase of the
reaction for each of the two standards detected.
Assay Sensitivity based on TCID50 Equivalents of standard PDV ds-DNA plasmid standard
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The log10 TCID50 of PDV USA 2006 was calculated using 10-fold dilutions of virus grown
on SLAM transfected vero cells and results analyzed using the Spearmann-Karber Titre
calculator. The known TCID50 stock virus was then made into 10-fold dilutions and RNA
extracted using the Qiagen Mini Viral RNA Isolation Kit from these dilutions. PDV RNA was
then run in a duplex RT-qPCR reaction as described above from these dilutions and used to
calculate TCID50 equivalents from measured ds-DNA standards, and therefore infectious PDV
equivalents in duplex reaction samples. The PDV virus isolate was calculated to have a TCID50
of 5.72 (log10TCID50/ml), equivalent to 331,131 infectious particles per ml. The limit of
detection and sensitivity of the assay was 0.5 infectious particles, equivalent to 12 copies of PDV
standard, to 524,807 infectious particles with an equivalent of 46,445,300 copies PDV standard.
(Figure1).
Statistics
As seals used for the lymphocyte proliferation assay were derived from both wild capture
and stranded animals, to determine if proliferation was influenced by the source of seal PBMCs,
a T-test or Mann Whitney Rank Sum was performed between the stimulation index for each
concentration of Arolcor 1260 between stranded and wild capture seals. No significant difference
was found and samples were then analyzed together.  For lymphocyte proliferation, a one-way
repeated measures analysis of variance was performed to compare the exposed to the unexposed
treatments using p<0.05 for statistical significance. Dunnet’s method was used for multiple
pairwise comparisons versus control (0 ppm).  For the infection study, outliers were determined
using Minitab (Minitab Inc., State College, PA) for each run on the ABI 7500. A generalized
linear mixed model two-way repeated measures analysis of variance was performed for each cell
fraction (S, L, M) to compare within means of treatment (exposed or unexposed to Aroclor 1260)
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and between day of infection (days 5,7,9,11). Statistics were analyzed using SigmaPlot 12.5
(Systat Software, San Jose, CA). Datasets that lacked normality and equal variance were
transformed using a Johnson transformation using Minitab. The Johnson transformation
determines an optimal transformation from three different distribution families (Kotz and
Johnson, 1993). All error bars represented as mean +/- SD.
RESULTS
Seal Samples
RT-qPCR of PBMC samples indicated that no animals used in the study had detectable PDV
RNA  i.e considered evidence of current infection. GAPDH copies in PBMCs were within range
of detection of the standards indicating suitable quality RNA for subsequent amplification tests.
Leukocyte flow cytometry profile
Flow cytometry was used to determine the proportions of cell sub-populations upon
purification of mononuclear cells using Ficoll gradient centrifugation. Sub-populations can be
distinguished by relative size (forward scatter) and complexity (side scatter). Granulocytes are
large and complex (granular), lymphocytes were smaller and less complex and monocytes were
slightly larger than lymphocytes and less complex than granulocytes. Ficoll gradient
centrifugation allowed for selective loss of granulocytes and enrichment in mononuclear cells
(lymphocytes and monocytes) in harbor seal samples. This purification resulted in 71-98%
mononuclear cells following Ficoll gradient centrifugation.
Lymphocyte Proliferation
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Exposure of PBMCs to Aroclor 1260 did not significantly alter lymphocyte proliferation at
any of the tested concentrations when compared to controls. Subsequently, a level of 20 ppm was
used for infection experiments, based on previously published literature and sum PCB exposure
levels in tissues from harbor seals of the northeast U.S. and in blood of harbor seals in the
western U.S. (Addison and Brodie, 1977; Young et al., 1998; Hammond et al., 2005; Shaw et al.,
2005; Brousseau and Fournier, 2010).
Quantity of PDV during in-vitro infection
Aroclor 1260 exposed lymphocytes exhibited a significant 3.9 fold decrease in PDV (average
difference of 1185 copies of PDV plasmid) at day 7 (p<0.001) and a significant 2.4 fold increase
at day 11 (average difference of 1177 copies of PDV plasmid) (p=0.003) compared to unexposed
control cells (Figure 3a).  PDV quantity in Aroclor 1260 pre-exposed cells increased
significantly through the experiment with more virus at day 9 (p=0.019) and 11 (p=0.048)
compared to day 7 in the exposed lymphocytes. PDV quantity in unexposed lymphocytes did not
change significantly over time.
Significant differences were apparent between the Aroclor 1260 pre-exposed and control
monocytes, with pre-exposed cells having 1.7 times less virus (average difference of 524 copies
of PDV plasmid) at day 7 (p=0.002) and a 4.1 fold increase (average difference of 12,474 copies
of PDV plasmid) at day 11 (p<0.001) (Figure 3b).  In Aroclor 1260 pre-exposed monocytes,
virus increased significantly between day 5 and day 11 (p=0.005), day 7 and 9 (p=0.015), as well
as day 7 and 11 (p=0.001). PDV quantity in monocytes that were not exposed to Aroclor 1260
did not change significantly over time.
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Viral quantity was also significantly lower at day 7 with a 1.7 fold decrease with an average
of 56 copies PDV plasmid (p=0.005) and a 1.7 fold increase at day 11 (p=0.005) with an average
of 87 copies PDV plasmid for the pre-exposed versus control supernatant fraction (Figure 3c).
The supernatant from pre-exposed cells had significant increases in virus throughout the time
course of infection between days 5 and 9 (p=0.048), 5 and 11 (p=0.008), 7 and 9 (p=0.011) and 7
and 11 (p=0.001), but no such increase was observed in supernatant from control cells.
The difference in viral quantity between unexposed and exposed monocytes at day 7 was
1.7 fold, with an average difference of 524 copies of PDV plasmid. For lymphocytes at day 7,
this was 3.9 fold, with an average difference of 1,185 copies.
DISCUSSION
Since the first investigation in 1988 into what had become a growing number of
epizootics due to morbillivirus, there has been extensive research to understand the relationship
between anthropogenic contaminants and disease due to underlying immune suppression.
Simmonds (1992) suggested that the evidence pertaining to the scale, frequency, location,
correlation to contaminant burden, clinical signs and our understanding of toxicology of these
contaminants, warranted these events as something other than natural occurrences (Simmonds,
1992).  Therefore, the goal of this study was to test the hypothesis that exposure to an
anthropogenic contaminant can influence the functioning of T lymphocytes, an important
component of the acquired immune system necessary for combating viral infection, and also
directly influences viral replication after contaminant exposure. T lymphocyte proliferation in
*P=0.02
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harbor seals was assessed after exposure to Aroclor 1260, a mixture of highly chlorinated PCBs,
and the effects on PDV viral replication were also measured.
T lymphocyte proliferation using a sub-optimal Con-A concentration of (0.1 µg /ml) was
not significantly altered from the control for any of the tested concentrations of Aroclor 1260
(1,5,10,20 ppm). In comparison, in-vitro proliferation of gray seal T lymphocytes upon exposure
to 15 ppm Aroclor 1254 resulted in a decrease in proliferation (Dufresne, 2010).  Studies in a
single gray seal indicate that Aroclor mixtures, specifically Aroclor 1260, can cause a decrease in
T lymphocyte proliferation of blood and lymph derived T-cells at levels between 50 and 100
ppm, and an increase of 30% for proliferation in lymph derived T-cells at 6.25-12.5 ppm
(Brousseau and Fournier, 2010). Levin et al. (2005) reported PCBs to cause an increase in
lymphocyte proliferation in T-cells derived from harbor seal blood. These conclusions were
based on correlative findings of PCBs measured in blubber, with dioxin toxicity based Toxic
Equivalency Factors (TEQs) and with in-vitro lymphocyte proliferation using PHA, but, not with
Con-A at sub- or optimal Con-A concentrations.   At suboptimal Con-A levels, an increase in T-
cell proliferation was also noted in sea otters with several mixtures of PCBs, and no modulation
with other mixtures (Levin et al., 2007a).  A general lymphosuppressive effect was noted on
exposure of harbor seal PBMCs to PCB 156 and PCB 80, but not significantly (Neale et al.,
2002).
The importance of species differences in interpreting immune response to chemicals, as
well as real life exposures consisting of various chemicals and their synergistic and antagonistic
effects, was demonstrated by Mori et al (Mori et al., 2006). Species differences in immunotoxic
response upon exposure to PCBs were evident for eight species of marine mammal. In addition,
non-coplanar PCBs were shown to modulate immune function indicating a non-aryl hydrocarbon
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receptor (AhR) mediated mechanism of action for these PCBs on immune cells. Therefore TEQs,
commonly used to assess toxicity of PCBs, did not capture non-dioxin like immunotoxic effects
in marine mammals. For example, in mice, more highly chlorinated Aroclors were shown to be
more toxic (David and Safe 1989). In gray seals, studies have shown that immune toxicity based
on T-cell proliferation does not follow this pattern. Aroclor 1260, an Aroclor mixture of lower
toxicity in mice, was shown to have the greatest toxic potential in gray seal based on inhibition
of 50% of proliferative response (Brousseau and Fournier, 2010).  Tissue matrix dependent
effect of PCBs, as well as species differences in immunotoxic response and the importance of
mixtures of chemicals, should be taken into account when attempting to understand the effects of
chemicals on immune response.
During the infection experiment, there was a significant decrease in PDV upon exposure
to Aroclor 1260 at day 7 in monocytes and lymphocytes as well as in the supernatant.  Reasons
for this decrease are not likely due to cytotoxic effects. Potential cytotoxicity caused by levels of
Aroclor 1260 used during in-vitro exposures was considered for this experiment. Levels were
chosen to be environmentally relevant and those that were less likely to cause cytotoxic effects.
In guinea pigs, Aroclor 1260 at 50 ppm was immunosuppressive reducing humoral and cell
mediated immunity including decreased leukocyte counts in peripheral blood.  This was thought
to be caused by direct PCB effects on immune cells (Vos and Driel-Grootenhuis, 1972). Levels
assessed here were below this value, and the results of our lymphocyte proliferation assay did not
support cytotoxicity. In addition, GAPDH measured in cells were within detectable levels
throughout the experiment, though they were minimal at day 11. Previous studies indicate that in
control exposure to harbor seal PBMCs (without stressor, without virus), cellular GAPDH is
reduced at day 11, which was attributed to the attrition of cells from the primary culture (Chapter
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3). Similarly, PBMCs in this study exhibited diminished GAPDH at day 11 in control and in
infected cells. All other time points exhibited high levels of GAPDH. It is therefore unlikely that
the decrease in PDV at day 7 is due to the lack of viable host cells, especially since PDV
increased at a later time point.
The decrease in virus is also not believed to be due to immunotoxic effects. This in-vitro
system likely fails to provide the cellular interactions and micro-environment (such as a lymph
node) to optimize the generation of a primary immune response, and the relatively small number
of cells used (5x104 cells per well) is unlikely to encompass PDV-specific cells given the
diversity of T cells. Further, no effects on T cell proliferation were observed upon in-vitro
exposure to similar doses in our study.
The delay in infection could be due to several factors including differences in host cell
activation, expression and activation of cell surface receptors or differences in host cell chemical
signaling. After in-vitro stimulation with antigen or mitogen, activated T cells express SLAM,
or CD150, which enables an increase in morbillivirus infection (Farina et al., 2004; Yanagi et al.,
2009). PDV USA 2006 may similarly preferentially bind to these SLAM expressing immune
cells (Ohishi et al., 2012). The importance of this activated receptor was illustrated when a
laboratory modified strain of CDV which was unable to recognize the SLAM receptor, was not
able to spread infection (Von Messling et al., 2006). Activation of other cell receptors such as
IL-2R can also influence morbillivirus infection (Yanagi et al., 2009). It is therefore possible that
differences in virus replication in Aroclor-exposed cells could be explained by transient
suppression of, delay, or other alteration in the timing of cell activation and cell surface
expression of receptors relevant to infection with PDV.
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Documentation exists for the ability of PCBs and polycyclic aromatic hydrocarbons
(PAHs) to interfere with the production of IL-2 and T-cell receptor signaling in laboratory
animals as well as harbor seals (Exon JH, 1985; Neale et al., 2005).  Exposure of Con A-
stimulated harbor seal PBMC to both PAHs and PCB significantly decreased expression of
protein tyrosine kinases and cytokines produced through T-cell receptor (TCR) signaling,
specifically IL-2, needed for the activation and clonal expansion of T-cells (Neale et al, 2005). In
relation to subsequent exposure to PDV, activation of T-cells from a naïve state is important for
the activation of other host receptors, specifically CD150, the host receptor necessary for the cell
to be receptive to PDV infection (Tatsuo and Yanagi, 2002).
AhR is another important host cell receptor with growing interest for its role in
contaminant exposures, viral replication and immune suppression (Lawrence and Kerkvliet,
2006; Head and Lawrence, 2009; Stockinger et al., 2014). AhR regulates the gene expression of
cytochrome P450 enzymes, or CYPs, and the induction of these enzymes is involved in the
metabolism of various endogenous and exogenous substances known to be immunosuppressive
including PCBs and PAHs.  Activation of AhR with TCDD also has been shown to suppress the
clonal expansion and differentiation of influenza virus-specific CD8+ T lymphocytes (cytotoxic
T cells) important for the production of IFN-γ (BP et al., 2005) as well as CD4+ T lymphocytes
(T helper cells) (Lawrence et al., 2000). The mechanism that induces these changes is not
known, but is believed to be due to differences in gene expression (Head and Lawrence, 2009).
Aroclor 1260 may be suppressing clonal expansion and activation of T cells through AhR-
mediated mechanisms which in turn, reduces infection, at least transiently, by preventing the
activation of cell surface receptors necessary for PDV to infect the cell.
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At day 11, the increase in viral load could have occurred if the effects of Aroclor were
transient in nature, or affected the timing of activation. It is also possible that another mechanism
such as cytokine expression is involved in later time points. In-vivo morbillivirus exposures
indicate that cytokine profiles can change dramatically during infection. Transcripts of pro-
inflammatory cytokines were up-regulated in CDV infection in dog with no change in measured
anti-inflammatory cytokines (Markus et al., 2002). In CDV-exposed ferrets, those that mounted a
greater anti-inflammatory response survived (Svitek and von Messling, 2007). It was noted that
changes before day 7 did not predict outcome as well as later time points. In these ferrets, viral
load in PBMCs did not differ significantly until after this point. At day seven, 30% of T cells,
13-21% of B cells and 3-4 % of monocytes were infected in both lethal and non-lethal CDV
infection. Neutralizing antibody levels also did not vary between groups before this time point.
In stark contrast, ferrets that that died of CDV infection had suppressed cytokine responses
within the first days of infection compared to those that survived. This was similarly found in
mink infected with CDV (Nielsen et al., 2009).
While host response is critical, the accessory proteins encoded by the P gene of
morbilliviruses also have the ability to interfere with the IFN signaling pathway. The
inflammatory cytokines needed to fight viral infection, Type I IFN (IFN-α/β) and type II IFN
(IFN-γ), are suppressed by morbillivirus infection (Fontana et al., 2008).  In conjunction with the
known immunosuppressive effects of PCBs on T-cell receptor pathways, it is possible that a
similar mechanism may be responsible for the delayed pattern in viral replication seen in this
study.
Two seminal in-vivo exposures of seals to PDV, alone and simultaneously with PCBs,
were undertaken soon after the 1988 European epizootic (Harder et al., 1990; Harder et al.,
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1992). The duration of cell-associated viremia, PDV-antigen distribution in tissues of fatally
infected seals and the humoral immune response to PDV showed no differences between PCB
exposed and un-exposed seals (Harder et al., 1992). While these studies provide evidence for the
lack of immunosuppressive effects of some PCBs on susceptibility to disease in-vivo, our recent
understanding of the complex nature of mixtures and immunomodulation underscores the utility
and ethical approach of in-vitro exposures over future in-vivo studies to understand this
relationship. Future studies measuring secreted cytokines in supernatant during the time course
of in-vitro infection may provide more insight to the host level changes between exposed and un-
exposed PBMCs and may be a better predictor than simply levels of contaminants. These
indirect cellular level signals measured in-vitro could also help explain differences in PDV
infection between species (Chapter 3). Recent validation of canine cytokine assay for TNFα,
INFγ,  IL-10, IL-6 and IL-8, important signals in balance of Th1 and Th2 response against
pathogens, could be used for the assessment of secreted cytokines, a method which would be
directly representative of these proteins circulating in the blood (Levin et al., 2014).
The health risks of PCBS in humans and wildlife are well described including their action
as carcinogens, as immunotoxins, as well as their role in compromising reproduction and overall
health through their effects on endocrine function and toxin metabolism (Ross et al., 1996b;
Holmstrup et al., 2010). Most studies on toxic effects focus on select groups or congeners of
PCBs either measured directly in liver or blubber, or through experimental exposure (de Swart et
al., 1994; Ross et al., 1994; De Guise et al., 1998; Levin et al., 2005a). Studies that have focused
on mixtures of contaminants, rather than single chemicals, give us an insight into what may
actually occur in real world exposures (Levin et al., 2005b; De Guise et al., 2006; Mori et al.,
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2006; Levin et al., 2007a). Fewer studies exist to demonstrate the influence of these
contaminants on susceptibility to infection, let alone with real world exposures.
In-vitro infection studies utilizing PBMCs derived from seals have contributed to our
understanding of innate and adaptive immune responses upon exposure to POPs, and have
allowed for studies on susceptibility and for PDV antigen quantification over the time course of
in-vitro infection (de Swart et al., 1993; Visser et al., 1993; Lu et al., 2003; Mori et al., 2006).
This study builds upon the growing list of in-vitro studies and addresses both the exposure to
mixtures of POPs (Aroclor 1260) and subsequent susceptibility to infection by PDV. The results
here indicate that in harbor seals there are significant differences between Aroclor 1260 exposed
and control cell fractions, with exposure resulting in a reduction in virus early during infection,
and an increase during late infection. In a previous experiment, blood derived PBMCs from harp
seal, a potentially subclinical asymptomatic carrier of PDV, exhibited a similar decline in PDV at
day 5 of an 11 day infection, with similar increase at later time points during infection (Chapter
3).  In light of a recent study on differences in host susceptibility to PDV (Chapter 2), the
consequences of this contaminant induced infection pattern in a highly susceptible host could be
devastating. The result could be a more systemic infection with greater viral load, and could
explain the correlative findings seen in wild populations suffering from morbillivirus epizootics
that are exposed to a range of persistent contaminants.
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Table 1. Seal Blood samples. Samples from wild capture harbor seals denoted as Northeast
Fisheries Science Center (NEFSC). Blood samples from stranded seals were collected from seals
before release from the University of New England Marine Animal Rehabilitation and
Conservation Program (UNE MARC), the Riverhead Foundation for Marine Research and
Preservation (Riverhead), and Mystic Aquarium & Institute for Exploration (Mystic). Assay
denotes samples used for PDV infection (PDV) or lymphocyte proliferation (LP), no data or
samples available noted with NA.
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Figure 1. Assay Sensitivity based on TCID50 Equivalents of standard PDV ds-DNA plasmid
standard. The PDV USA 2006 virus isolate used in the experiment was calculated to have a
TCID50 of 5.72 (log10TCID50/ml), equivalent to 331,131 infectious particles per ml. The limit of
detection and sensitivity of the assay was 0.5 infectious particles, equivalent to 12 copies of PDV
standard, to 524,807 infectious particles with an equivalent of 4.64x107 copies PDV standard.
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Figure 2. Lymphocyte Proliferation. Exposure of harbor seal PBMCs (n=10) to Aroclor 1260
with 0.1 µg/ml Con-A did not modulate lymphocyte proliferation significantly at any tested
concentration between unstimulated and stimulated PBMCs (mean, + SD, RM ANOVA,
*p<0.05).
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Figure 3. Quantity of PDV during in-vitro infection. PDV quantity measured by RT-qPCR
(copies PDV plasmid) in (a) lymphocyte, (b) monocytes and (c) supernatant fractions from
harbor seal cells exposed to 20 ppm Aroclor 1260 (PDV+, Aroclor 1260+) and unexposed
control cells (PDV+, Aroclor 1260-).  Samples were taken at day 5,7,9 and 11 post infection.
Results are presented as mean, + SD (n=5) *(p<0.05).
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Abstract
Several marine mammal epizootics have been closely linked to infectious disease as well as to
the toxins produced by harmful algal blooms (HABs). In two of three events associated with
saxitoxin (STX) , Dolphin morbillivirus (DMV) or Phocine Distemper Virus (PDV) was isolated
in affected individuals. While STX is notorious for its neurotoxicity, immunotoxic responses
have also been described at low levels. Therefore, this study was designed to investigate if levels
of STX could alter immune functions in harbor seals (Phoca vitulina concolor), specifically T
lymphocyte proliferation, and if exposure to saxitoxin could alter susceptibility to infection by
PDV. Saxitoxin caused an increase in harbor seal lymphocyte proliferation at 10 ppb and
exposure to STX significantly increased the amount of virus present in lymphocytes. These
results suggest that low levels of STX within the range of those present in northeast U.S. seals
may potentially affect the likelihood of systemic PDV infection upon in vivo exposure in
susceptible seals. Given the concurrent increase in morbillivirus epizootics and HAB events in
the last 25 years, the relationship between low level toxin exposure and host susceptibility to
morbillivirus needs to be further explored.
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Introduction
Red tides caused by massive blooms of marine phytoplankton have long been recognized as a
source of risk for human consumers of fish and shellfish as well as for wildlife (Van Dolah et al.,
2001). These harmful algal blooms (HABs) are responsible for deaths, loss of income, sickness
and discomfort (Carmichael, 2001; Etheridge, 2010). The potential for exposure to HAB toxins
on both humans and wildlife is better and more frequently recognized and concern is growing
over not only the overt effects of high levels of toxin, but also for the consequences of low level
exposure (Hiolski et al; Van Dolah, 2000; Pierce et al., 2005; Levin et al., 2010; Lefebvre et al.,
2012; Fauquier et al., 2013; Hiolski et al., 2014).
Saxitoxins (STX) are a class of water soluble neurotoxins produced by three genera of
dinoflagellates: Alexandrium, Pyrodinium and Gymnodinium and several cyanobacteria (Pearson
et al., 2010). The toxin accumulates in the tissues of animals and can be biomagnified through
the food web, most notably in suspension feeding shellfish which are largely resistant to the
toxin. Seafood poisoning caused by the ingestion of STX causes Paralytic Shellfish Poisoning
(PSP) with affected individuals first experiencing tingling of lips, tongue and throat, numbness
of the face, vomiting and diarrhea within the first 30 minutes of ingestion.  In more severe
poisoning, loss of motor coordination and paralysis are evident with cardiovascular failure due to
respiratory muscle paralysis in cases of acute lethal poisoning (Llewellyn, 2006; Pearson et al.,
2010). During acute illness, patients exposed to PSP had STX levels of 2.8-47 nM in serum and
65-372 nM in urine, with clearance from serum within 24 hours (Gessner et al., 1997). Saxitoxin
binds to site 1 of voltage dependent sodium and potassium channels (Catterall et al., 1980).
These channels are important in neurotransmission.  Blockage of channels prevents
depolarization of the membrane, prevents impulse-generation in muscles and peripheral nerves
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causing paralysis (Kao et al, 1993). Hence, the effects of the toxin are responsible for its
classification as a potent paralytic toxin (Faber, 2012). The toxin can also block calcium
channels, and can prolong the gating of potassium channels in heart muscle cells (Su et al., 2004;
Llewellyn, 2006; Pearson et al., 2010).
Shellfish are often used as indicator species for real time monitoring of STX for human
health safety (Etheridge, 2010).  The limit of STX imposed for seafood safety is
80 μg STX eq 100 g−1 tissue (Etheridge, 2010). As the toxin bio-accumulates in shellfish and
other potential vectors, the effects can be devastating to wildlife leading to acute toxicity and
mortality in fish, shore birds, and marine mammals (Nisbet, 1983; Geraci et al., 1989; Anderson
and White, 1992; Reyero et al., 1999; Fire et al., 2010; Fire et al., 2012).
Three marine mammal mortality events have been associated with exposure to STX.  The
toxin most likely produced by Alexandrium tamarense was implicated in the death of 14
humpback whales (Megaptera novaeangliae) off the coast of Cape Cod, MA between November
1987 and January 1988 (Geraci 1989).  STX was not recovered from whales from this die-off
event, although mouse bioassays conducted from liver, stomach contents and kidney indicated
the potency of the toxin. Levels were measured based on the presence of the toxin found in
mackerel sampled where whales were feeding (Geraci et al 1989). Further studies have also
supported the hypothesis for bioaccumulation of the toxin in mackerel as a vector for STX
ingestion in these large whales (Haya et al., 1989; Castonguay et al., 1997).
In May and June of 1997, a devastating mortality event occurred in Mediterranean monk
seals (Monachus monachus) along Cape Blanc on the western Sahara coast killing over 70% of
the local population and a third of the worlds’ population of this species (Hernandez et al., 1998;
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Reyero et al., 1999). Among the toxins identified in dead animals, STX was found in seal liver,
kidney, muscle and brain tissues as well as in their prey.  Adults were disproportionally affected
during this mortality event leading to long term changes in population structure of this critically
endangered population.
The deaths of bottlenose dolphins in the Indian River Lagoon, Florida during 2001 and
2002 are believed to be related to exposure to STX from the dinoflagellate Pyrodinium
bahamense (Landsberg 2002). Dolphins affected appeared in poor body condition with severe
skin lesions and with puffer fish, an unlikely prey, in their stomachs. The fish were shown to
have high levels of STX (Quilliam et al 2002, Van Dolah et al 2000).
In the latter two events, morbillivirus was also implicated as a potential cause of
mortality (Osterhaus et al., 1998; Bossart, 2011). The virus isolated from Mediterranean monk
seals was determined to be most similar to an isolated Dolphin Morbillivirus (DMV) rather than
known sequences of PDV or CDV (Osterhaus et al., 1998). While the morbillivirus was
identified and isolated, clinical signs and histopathological findings in monk seal mortalities
suggest that STX, not morbilllvirus, was the proximal cause of the die-off (Hernandez et al.
1998).  Clinical signs observed included horizontal floating, paralysis, lethargy, and lack of
motor coordination (Hernandez et al. 1998). Lungs were congested and the lungs and airways
were filled with fluid.  Final histolopathological diagnosis was drowning caused by paralysis due
to poisoning without evidence of primary viral damage or secondary opportunistic infections in
lung (Hernandez et al 1998). These findings led the authors to suggest that the death of affected
monk seals were influenced by STX poisoning, though it is unknown if the levels of STX
measured alone were sufficient to cause death (Hernandez et al. 1998).
170
Saxitoxin has yet to be implicated in the mortality of other pinnipeds and the role of STX
as a potential contributing factor to the development of infectious disease is unclear.  While STX
is notorious for its neurotoxicity, immunotoxic effects have also been described (Pípole et al.,
2011; Mello et al., 2013). Voltage-gated sodium channels (VGSC) targeted by STX are widely
expressed on lymphocytes and macrophages (Roselli et al, 2006). Normal sodium influx through
these channels is necessary for lymphocyte activation and proliferation (Roselli et al, 2006).
Several VGSC blockers have been shown to modulate immune response, specifically
suppressing Th1-mediated response to favor the Th2 response in mice (Roselli et al., 2006). In
mollusks, haemocytes, the immune cells of invertebrates, have also been identified as a target for
the effects of STX exposure, with genes related to immune response being up-regulated upon
exposure to STX in bivalves (Nunez-Acuna et al., 2013; Galimany et al., 2008).
It has previously been suggested that levels of STX in the Northwest Atlantic may be
causing detrimental health effects in marine vertebrates.  Exposure to STX in North Atlantic
Right whales has been suggested as a factor for the decrease in reproductive success in this
highly endangered species (Reeves et al., 2001; Durbin et al., 2002; Doucette et al., 2006).
Evidence that seals are also exposed to STX (12-400 ng/g STX equivalents) in the Northwest
Atlantic was recently documented (S Fire, unpublished data). These STX levels were measured
in feces, bile, urine and gastrointestinal content. In addition, STX was recovered from harbor and
gray seals that were also infected with Phocine Distemper Virus (PDV) and died during the 2006
Northeast US Pinniped Unusual Mortality Event (UME) (S Fire, unpublished data, Chapter 3).
Large scale red tide events and the mortality of farmed salmon directly attributed to STX
produced by Alexandrium spp. were also spatially and temporally related to the 2006 seal UME
(Burridge et al., 2010).
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Given the presence of STX during the 2006 UME and the mortality of seals due to PDV,
it is unclear whether saxitoxin exposure could have escalated the die off event. The objective of
this study was to determine whether saxitoxin can cause changes in immune response in harbor
seals and assess whether levels of exposure within the range likely encountered by these animals
could contribute to an increase in PDV infection.
MATERIALS AND METHODS
Saxitoxin
Saxitoxin dihydrochloride (NRC CRM-STX-f, Lot # 20110316, NRC Canada Institute for
Marine Biosciences, Halifax, Nova Scotia, Canada), designed for both bioassay use and
analytical calibration, was used in STX exposure experiments.  STX stock solution was
suspended in 0.5 ml of 3 mM HCl.
Seals and Blood Sampling
Blood samples from wild capture harbor seals were collected as part of an ongoing
population assessment by the National Marine Fisheries Service (NMFS) Northeast Fisheries
Science Center (NEFSC) Blood samples from stranded seals were collected from seals before
release back into the wild from the University of New England Marine Animal Rehabilitation
and Conservation Center (UNE MARC) (Table 1). RNA from peripheral blood mononuclear
cells (PBMCs) was processed as stated below to detect infection in PBMCs prior to use in the
infection experiment. Blood was collected from the extradural vein or hind flipper and collected
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into sterile Vacutainer tubes containing sodium heparin (Becton Dickson, Franklin Lakes, NJ),
shipped overnight on cold packs and processed within 24 hrs.
PBMC isolation.
Prior to cryopreservation of peripheral blood mononuclear cells (PBMCs), 1 ml of
heparinized whole blood was lysed to compare leukocyte sub-populations in blood before and
after density gradient PBMC isolation as previously described (Chapter 4). PBMCs were isolated
as previously described (Chapter 4). Briefly, PBMCs collected from heparinized blood by Ficoll
density gradient centrifugation. The cells were counted and viability assessed using the exclusion
dye trypan blue. The proportion of leucocyte sub-populations was assessed by flow cytometry
and cells cryopreserved in ice cold fetal bovine serum (Hyclone, Logan, UT)  with  10% DMSO
(Sigma, Sigma-Aldrich, St. Louis, MO). Cyropreserved PBMCs were washed three times in
complete Dulbecco's Modified Eagle Medium/Nutrient Mixture F-12, HEPES (DMEM/F-12,
HEPES, Gibco BRL, Grand Island, NY) supplemented with 200 µg/ml penicillin/streptomycin,
0.25 ug/ml Fungizone and with 10% cosmic calf fetal bovine serum (Hyclone), hereafter referred
to as complete DMEM.  The purity of mononuclear cells was determined by flow cytometry
based on the forward and side scatter profile.
Lymphocyte proliferation
PBMCs from seven wild capture harbor seals were resuspended in complete Dulbeco’s
Modified Eagle Medium (DMEM) and plated  (1x106 lymphocytes/ml final concentration) in
triplicate in 96 well flat bottom tissue culture plates (Falcon, Becton Dickinson, Franklin Lakes,
NJ). Cell counts were adjusted to take into account the percentage of lymphocytes present as
determined by flow cytometry. Cells from the same individual seal were exposed to STX in vitro
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at 0.1, 1, 10,100, 500 ppb or media only (0 ppb).  Levels of STX assayed were based on levels
measured in fecal, gut, bile and urine samples from seals in the northeast U.S. (Fire, pers.
comm.). As STX was dissolved in HCl, all cells in control wells were given equal concentrations
of HCl (8% of total volume or 0.06 mM) in complete media. Cells were incubated at 37˚C with
5% CO2 for a total of 66 hours with the T cell mitogen concavalin A (Con-A) (Sigma, St Louis,
MO). Con-A was used at the suboptimal concentration of 0.1 µg /ml, as suboptimal
concentrations of mitogens have shown to increase the sensitivity of detection of immunotoxicity
while maintaining specificity (Mori et al., 2006). Lymphocyte proliferation was evaluated as the
incorporation of 5-bromo-2’-deoxyuridine (BrdU), added for the last 18 hours of incubation, and
detected with a monoclonal antibody and a colorimetric enzymatic reaction (Cell Proliferation
ELISA BrdU (colometric), Roche Diagnostics GmbH, Mannheim, Germany) as per
manufacturer’s instructions using an ELISA plate reader (Multiskan EX v 1.0) at 690 nm with a
reference wavelength of 450 nm. Stimulation index was calculated as the ratio of the measured
optical density between stimlated and unstimulated cells.
Infection of Seal PBMCs with PDV following STX exposure
Cryopreserved cells from five stranded pre-release seals were washed 3x in complete
DMEM. Before infection with PDV, cells were pre-exposed to 10 ppb STX and 0.1 µg /ml Con-
A.  Cells were plated in quadruplicate (5x104 cells per well) in 96 well round bottom plates
(Falcon, Becton Dickinson, Lincoln Park, NJ). Infected (PDV + STX +; PDV + STX -) and non-
infected control cells (PDV- STX -) were incubated in two separate incubators at 37°C with 5%
CO2 for 72 hours (Siebelink et al. 1992, Visser et al.1993). Cells were then washed, with plates
centrifuged for 5 minutes at 500 G, medium replaced, cells pipetted to mix, and kept for 24 hours
in medium with 10% CCS and 100IU/ml human recombinant IL-2 (IL-2hr) (Sigma) to activate
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IL-2 receptors as previously described (Siebelink et al 1992). Plates were then centrifuged for 5
minutes at 500 G and media removed for infection at a multiplicity of infection (MOI) of 1.0.
Cells were infected with PDV USA 2006 for 1 hour at 37°C with 5% CO2. Control plates
underwent similar procedure with the equivalent volume of medium added and were placed in a
second incubator.  Cells were then washed (5 minutes at 500 G) to remove virus or control media
and gently mixed with 200 µl new medium.  Cells were maintained in 200 ul complete medium
supplemented with 100 IU/ml IL-2hr.  Media used for virus infection contained 2% serum,
double the concentration of penicillin/streptomycin (400 µg/ml) and an additional 0.5 µg/ml
gentamicin. Cells continued to be maintained by adding 20 µl of the media supplemented with
IL-2 at days 3, 5, and 7.
RNA collection
Control and infected plates were sampled for RNA in separate biosafety cabinets. Three
fractions were collected from each well: tissue culture supernatant (S), lymphocytes (L) and
monocytes (M). Tissue culture supernatant was carefully pipetted along with suspended cells,
and lymphocytes were isolated from the supernatant using centrifugation for 30 seconds at 8,000
rpm. Monocytes which adhered to the bottom of the well were then collected from the plates
using 200 ul of 0.25% (1x) trypsin (Hyclone). Plates were placed in the corresponding incubator
at 37°C with 5% CO2 for 7-10 minutes to re-suspend adhered cells. Trypsin was subsequently
removed by centrifugation for 30 seconds at 8,000 rpm.  Samples for RNA were re-suspended in
RLT buffer (Qiagen, Valencia, CA) and used in RNA extraction.
RNA extraction
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Cryopreserved PBMCs from each seal and samples from each fraction of the experiment
were extracted using an RNeasy plus mini kit (Qiagen) after tissue homogenization on dry ice,
and further processed through a Qiashredder column (Qiagen). This kit includes a DNA
eliminator column for DNAse treatment.  RNA quantity (ng/ul) was determined using a
Nanodrop 1000 Spectrophotometer (Thermo Scientific). Samples were kept at -80⁰C until
analysis.
Duplex RT-qPCR
The PDV and GAPDH primers and probes were used in a duplex reaction using Qiagen
Quantifast Duplex RT-PCR +R in MicroAmp Optical 96 well reaction plates (Applied
Biosystems) in the Applied Biosystems 7500 Real Time Cycler as previously described (Chapter
2, Bogomolni et al., in review). Copy numbers of PDV and GAPDH were determined using 50
ng/ul of sample RNA in duplicate for each sample as previously described (Chapter 5). The
reaction initiated with a reverse transcription step at 50˚C for 20 minutes, followed by
denaturation step at 95˚C for 5 minutes, and amplification for 40 cycles each of annealing at
95˚C for 15 seconds and an extension at 60˚C for 32 seconds. The baseline cycle threshold value
was manually set to be at the exponential increase phase of the reaction for each of the two
standards detected.
Assay Sensitivity based on TCID50 Equivalents of standard PDV ds-DNA plasmid standard
The log10 TCID50 of PDV USA 2006 was calculated using 10-fold dilutions of virus grown
on (VeroDogSLAMtag) expressing canine signaling lymphocyte activation molecules (SLAM)
transfected cells and results analyzed using the Spearmann-Karber Titre calculator as previously
described (Chapter 5). The PDV virus isolate was calculated to have a tissue culture infectious
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dose (TCID50) of 5.52 (log10TCID50/ml), equivalent to 331,131 infectious particles per ml. The
limit of detection and sensitivity of the assay was 12 infectious particles, equivalent to 0.25
copies of PDV standard, to 4.6x107 infectious particles with an equivalent of 524,807 copies
PDV standard (Figure1).
Statistics
For lymphocyte proliferation, a mixed model one-way repeated measures analysis of
variance was performed to compare the exposed to the unexposed cells using p<0.05 for
statistical significance. Dunnet’s method was used for multiple pairwise comparisons versus
control (0 ppb).  For the infection study, outliers were determined using Minitab (Minitab Inc.,
State College, PA) for each separate run. A generalized linear mixed model two-way repeated
measures analysis of variance was performed for each fraction (S, L, M) to compare the effects
of treatment (exposed or unexposed to STX) and time (Days 3,5,7 and 9 post-infection).
Statistical analyses were performed using SigmaPlot 12.5 (Systat Software, San Jose, CA).
Datasets that lacked normality and equal variance were transformed using a Johnson
transformation using Minitab. The Johnson transformation determines an optimal transformation
from three different distribution families (Kotz and Johnson, 1993). All error bars represent
mean +/- SD.
RESULTS
Animal Samples
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RT-qPCR of PBMC samples indicated that no animals used in the study had active PDV
infection. GAPDH of PBMCs were within range of detection of the standards indicating suitable
quality RNA to support subsequent amplification tests.
Leukocyte flow cytometry profile
Flow cytometry was used to determine the proportions of cell sub-populations upon
purification of mononuclear cells with Ficoll gradient centrifugation. Sub populations can be
distinguished by relative size (forward scatter) and complexity (side scatter). The purification
resulted in 71-95% mononuclear cells following Ficoll gradient centrifugation.
Lymphocyte Proliferation
PBMCs from seven wild captured harbor seals were used to assess the effects of STX on
harbor seal lymphocyte proliferation.  Exposure of PBMCs to 10 ppb STX significantly
increased ConA-induced lymphocyte proliferation compared to control (P=0.029) representing a
78% increase over control (Figure 2).
Quantity of PDV during in-vitro infection
Experimental in vitro infections were performed to assess the potential influence of STX
exposure on viral growth in harbor seal PBMCs. The STX exposed lymphocyte fraction had
significantly higher PDV loads at day 5 (p=0.041) , compared to cells unexposed to STX (Figure
3a) representing an eight fold difference in viral quantity. There were no significant differences
in viral loads between time points in lymphocytes exposed to STX. However, in cells unexposed
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to STX, there was significantly more virus in the lymphocyte fraction between day 9 and days 3
(p <0.001), 5 (p=0.001) and 7 (p=0.019).
Exposure to STX did not significantly affect the viral loads in the monocyte fraction
following infection with PDV (Figure 3b). There were no significant differences in viral loads
between time points in monocytes exposed to STX. However, in cells unexposed to STX, there
was significantly more virus in the monocyte fraction at day 9 than at days 3 (p=0.049) and 5
(p=0.014).
STX exposure significantly (p=0.022) increased the viral loads in the supernatant fraction on
day 9 post-infection (Figure 3c), representing a 2.5 fold increase in virus. However, time did not
significantly affect the viral loads in the supernatant in either STX-exposed or unexposed control
samples. GAPDH levels were reduced in both control and infected samples in all fractions at day
9.
DISCUSSION
Blooms of the dinoflagellate Alexandrium fundyense are common along the New England
coastline between April and September with shellfish closures commonly occurring later in the
summer months (Anderson, 1997; Martin et al., 2014). The cysts produced by the dinoflagellate
and the quantity of STX accumulated in shellfish have been monitored extensively due to the
significant risk to human health (Anderson et al., 2014; Kleindinst et al., 2014; Martin et al.,
2014). The highest level of STX recorded in New England was found in Maine shellfish (80,000
ng/g, or ppb) in 2009. This is 100 times higher than the level accepted by the US federal
government for human consumption (Martin et al., 2014). While these levels not only exceeded
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human safety limits, the contribution to mortality in endangered sturgeon and other marine
vertebrates during this event was attributed to the high levels of STX, 73-2300 ng/g STX
equivalents, in the gut contents of these dead animals (Martin et al., 2014). Despite these
findings, little work has been done to assess the consequences of STX exposure in seals in the
same region.
In our study, exposure to 10 ppb STX increased mitogen-induced T cell proliferation. The
effects were observed at the lower to middle end of the range of concentrations tested, which
were based on those measured in seal tissues/fluids in the Northeast US and were, therefore,
environmentally relevant. As suggested by the National Toxicology Program, any chemically-
induced disturbance of immune functions (up- or down-regulation) has the potential to be
deleterious and increase susceptibility to infectious diseases (Luster et al. 1992, 1993).
Specifically, an increase in the stimulation of T cells has the potential to result in anergy, a state
of unresponsiveness, autoimmune disorders or cancer (Ichihara et al., 2003; Levin et al., 2007).
Therefore, it is possible that in vivo exposure to STX may increase the susceptibility of seals to
morbillivirus infections, through immune dependent mechanisms.
Further, exposure to STX increased the ability of PDV to replicate in cells of seal in-vitro.
Although the effects on lymphocytes occurred early (day 5) and appeared transient, these effects
in lymphocytes resulted in an increase in free virus in the supernatant on day 9, which may
suggest the potential for increased systemic virus dissemination upon in-vivo infection.
Several factors may explain the increased virus replication in lymphocytes exposed to STX.
It is possible that the cell activation associated with increased lymphocyte proliferation resulted
in differences in the dynamics of expression of cell receptors such as IL-2R or CD150,
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facilitating the entry of PDV into host cells (Farina et al., 2004; Yanagi et al., 2009). It is also
possible that the increased proliferation of T cells detected 66 hours following exposure to STX
would have increased the number of host cells available for replication, as detected 5 days
following exposure. However, it is unlikely that the increased replication of PDV would be
associated with changes in antigen-specific immune response, which requires complex cellular
interactions in specific environments (such as lymph nodes). Such interactions would be difficult
in our in vitro system, and the very low likelihood that antigen-specific cells (with the
appropriate T cell receptor) would be found consistently in our in vitro system, given the low
number of cells used (5x104 cells per well) and considering the diversity of T cell receptor.
GAPDH levels were undetected at the end of the experiment indicating host nucleic acid was
minimal, whereas viral quantity increased. The duplex RT-qPCR reaction may favor the more
abundant target and be unable to detect the remaining low levels of the host nucleic acid.
However, the duplex assay has previously been determined to have a sensitivity of detection for
GAPDH of 100 to109 copies with an R2 of 0.9865 (Bogomolni et al, in review). It is therefore
more likely that in our in vitro system, viable host cells are the limiting factor to virus
replication, with cytopathic effect resulting in cell death following viral infection and replication.
If this is the case, the transient nature of the increase in virus replication in lymphocytes may be
the result of earlier use by virus of viable cells and underrepresent the potential effects of STX
on viral replication upon in vivo exposure, where the pool of available target cells would not be
exhausted as quickly.
Several studies have reported that morbillivirus detected early during infection of
lymphocytes results in a lethal infection. Ferrets, mink and dogs experimentally infected with
CDV show increased risk of death in animals with a lowered host immune response during early
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infection (Gröne et al., 1998; Von Messling et al., 2006; Svitek and von Messling, 2007; Nielsen
et al., 2009). Early immune suppression by morbillivirus allows for the infection of receptive
cells expressing the signaling lymphocyte activation molecule (SLAM) receptor, and destruction
of these cells which are needed to fight viral infection (Minagawa et al., 2001; Tatsuo and
Yanagi, 2002; Von Messling et al., 2006).  STX appears to enhance the infection of cells in-vitro
and could contribute to earlier infection in-vivo whereby the host could be more susceptible to a
more lethal, early infection. In light of those studies, it is reasonable to expect that in seals
exposed to STX and infected with PDV, the immune alterations suggested by the observed
effects on T cell proliferation upon in vitro STX exposure would combine with the immune-
independent effects on host cells resulting in an increased viral replication upon in vitro STX
exposure, and likely exacerbate the infection and ensuing disease.
The complex relationship between large scale mortality events where morbillivirus co-occurs
with HAB toxins has led to many discussions on the ultimate cause of mortality and the impact
of one or the other on the survival of the affected populations (Harwood 1988).  During the 1997
die off of the highly endangered Mediterranean monk seal, both STX and a morbillivirus were
isolated from seals.  As the authors suggest, without baseline information on the prevalence of
virus antibodies, or on levels of algal toxins in seals and prey before the event, it is impossible to
make a definitive diagnosis (Hernandez et al, 1998). The intake of STX which induces PSP
symptoms also varies greatly due to differences in susceptibility among individuals (Krogh,
1983; Bricelj et al., 2010). Despite the difficulty associated with understanding the relationships
between exposure to biotoxins and outcomes of viral infections at the population level in seals,
our results support potentially relevant effects and pathways that may be highly relevant to the
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current situation, since current estimates of harbor seal populations in the northwest Atlantic
show a potential decline of nearly 30% (Waring et al., 2013).
This study represents the first in-vitro exposure of seal cells to STX and the first to determine
the effects of exposure and resulting changes in morbilllivirus replication. These results suggest
that it is critical to monitor environmental levels of STX within the context of marine mammal
health and as a potential facilitating factor in the development of PDV-related disease and
mortality events.
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Table 1. Seal blood samples. Seals from wild capture harbor seals were collected as part of an
ongoing population assessment by the National Marine Fisheries Service Northeast Fisheries
Science Center (NEFSC) Blood samples from stranded seals were collected from seals before
release back into the wild from the University of New England Marine Animal Rehabilitation
and Conservation Center Program (UNE MARC).
Source ID Sex Length
(cm)
Age
Class
Stranding/Capture
Location
Assay PDV
Titers
PBMC
PDV
UNE
MARC
MARC10-
096
Male 72 Yearling Cape Nedick, ME STX negative negative
UNE
MARC
MARC10-
093
Female 86 weanling Moody Beach, Wells,
ME
STX negative negative
UNE
MARC
MARC10-
086
Male 86 weanling Hampton Beach, NH STX negative negative
UNE
MARC
MARC10-
094
Female 82 weanling Cape Elizabeth, ME STX negative negative
UNE
MARC
MARC10-
099
Male 95 yearling Prout's Neck,
Scarborough ME
STX negative negative
NEFSC 030 Female - adult Chatham, MA LP not
available
negative
NEFSC 47 Male - adult Mark Island,
Rockland, ME
LP 1:32 negative
NEFSC 19 Male 133 adult Rockland, ME LP not
available
negative
NEFSC 27 Female - adult Chatham, MA LP not
available
negative
NEFSC 22 Female 94 adult PB Dix Island, ME LP not
available
negative
NEFSC 12 Female 168 adult Chatham, MA LP 1:128 negative
NEFSC 32 Male - adult Chatham, MA LP not
available
negative
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Figure 1. Assay Sensitivity based on TCID50 Equivalents of standard PDV ds-DNA plasmid
standard. The PDV USA 2006 virus isolate was calculated to have a TCID50 of 5.72
(log10TCID50/ml), equivalent to 331,131 infectious particles per ml. The limit of detection and
sensitivity of the assay was 0.5 infectious particles, equivalent to 12 + 8 copies of PDV standard,
to 524,807 infectious particles with an equivalent of 46,445,300 + 231,364,674) copies PDV
standard.
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Figure 2. Lymphocyte Proliferation. Exposure of harbor seal PBMCs to 10 ppb saxitoxin
(STX) significantly increased spontaneous Con-A induced lymphocyte proliferation of
stimulated versus unstimulated PBMCs (mean, + SD, RM ANOVA, *p<0.05).
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a. Lymphocytes
b. Monocytes
c. Supernatant
Figure 3. Quantity of PDV during in-vitro infection. PDV quantity measured by RT-qPCR in
a. lymphocyte, b. monocytes and c. supernatant fractions from harbor seal cells exposed to 10
ppb STX (PDV+ and STX+) and unexposed control cells (PDV+ and STX-). Samples taken at
day 3,5,7 and 9 post infection. Results are presented as mean, + SD (n=5) *(p<0.05).
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Chapter 7
DISCUSSION AND CONCLUSIONS
Understanding the effects morbilliviruses have on a host or population requires an
understanding of a triad of factors: the host, the pathogen, and environment; or essentially the
ecology of this infectious disease (Aguirre et al., 2002; Keesing, 2010). Factors influencing
morbilliviral disease presentation could include intrinsic differences in susceptibility of the
individual host, differences between species, differences in virus-host interactions and/or
changes in susceptibility of the host upon exposure to environmental stressors in the marine
environment including natural toxins and anthropogenic contaminants.
Marine mammals have long been recognized as sentinels of ocean health, intrinsically
connected to the ocean and the anthropogenic factors influencing the marine environment
(Reddy et al., 2001).  The recent emergence of morbilliviruses in marine mammals as the
etiologies behind several large scale mortality events raised questions about the role of
immunosuppressive persistent organic pollutants in the severity of events.   Many marine
mammals have shown strong associations between disease and persistent organic contaminants
(POPs) (Aguilar and Borrel, 1991; Hall et al., 1992; De Guise et al., 1995; Ross et al., 1996). In
addition, several of these large scale mortality events have been associated with naturally
occurring harmful algal toxin blooms (HABs) and morbillviruses (Van Dolah et al., 2003). The
increase in HABs in the last three decades due to nutrient input from human activity
(Hallegraeff, 2014), and the apparent involvement of biotoxins during events, also calls into
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question the role of human activity on the health of marine mammals (Van Dolah, 2000;
Anderson et al., 2002; Hallegraeff, 2014).
Phocine distemper virus (PDV), the first identified marine mammal morbillivirus, was
identified in an epizootic in 1988 when approximately 23,000 harbor seals in Northern Europe
succumbed to the effects of the virus or to resulting secondary infection (Osterhaus et al., 1990;
Haerkoenen et al., 2006).  Since this time, several pivotal in-vivo studies in seals have
contributed to our understanding of the course of infection and humoral response to PDV in
harbor seals and gray seals (Harder et al., 1990), to immunological parameters affected during
POP exposure in long term feeding exposure studies (de Swart et al., 1994; Ross et al., 1994;
Ross et al., 1995) and to the relationship between POPs and the course of PDV infection (Harder
et al., 1992).  Model species susceptible to the virus have also given us insight into the
pathogenesis of PDV (Blixenkrone-Møller et al., 1989).
Numerous in-vitro studies have followed to understand the mechanisms responsible for
immunomodulation and to determine specific effects of individual classes and mixtures of
contaminants on specific species of marine mammals. This in-vitro approach has proven
extremely valuable in elucidating how contaminants may influence immune functions (De Guise
et al., 1995; Levin et al., 2005; Mori et al., 2006; Levin et al., 2007) and in assessing
susceptibility of various marine mammal-derived PBMCs to morbilliviruses (Visser et al., 1993).
These studies add to our growing understanding of the complex relationship between host,
pathogen and environment.  However, despite these efforts, the reason for differences in species
susceptibility described during European and North American PDV mortality events are still
unclear (Hall et al., 2006; Earle et al., 2008; Earle et al., 2011). Similarly, it is difficult to explain
the mechanisms behind the effects seen in-vivo in seals exposed to PCBs in conjunction with
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PDV infection described by Harder et al. (1992).  The recent North American PDV mortality
event gave us a means to test several hypotheses developed to increase our overall understanding
of the different effects of PDV USA 2006 on harbor, harp and gray seal, and the relationship
between PDV susceptibility and both natural and anthropogenic chemical stressors.
One critical question related to all PDV mortality events is why some species are more likely
to succumb to disease. In testing our first hypothesis: All species of seal are equally susceptible
to PDV 2006 USA upon in-vivo and in-vitro infection, differences in species susceptibility to
PDV USA 2006 between harp, harbor and gray seal PBMCs were evident in the quantity of virus
produced over the time course of infection. In addition, quantity of virus and disease differed in
naturally infected seals. The development and validation of a duplex RT-qPCR assay allowed for
sensitive and PDV specific detection as well as dual evaluation of the condition of host RNA by
utilizing GAPDH.
In-vitro infection of PBMCs suggests that infection is delayed in harp seals while gray seal
infection is rapid, producing significantly more virus at day 5 of infection.  The slower, lower
viral infection of harp seal then increased significantly by the end of the experiment.  These
differences in timing and quantity of viral replication early during infection in lymphocytes and
monocytes could explain some of the species differences seen during natural infection. One
interpretation of the outcome of this effect in-vivo may be that if the PDV-cell-associated viremia
is more profound early, as found in gray seals, without the spread of virus to other tissues, a
susceptible host may be able to mount a stronger and more targeted cellular and humoral
immune response rather than after the systemic spread of lower levels of virus.
The interpretation of the in-vitro results are supported by our studies on seals naturally
infected with PDV USA 2006 during the North Atlantic Pinniped Unusual Mortality Event
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(UME). The overall differences observed among species in tissue distribution and abundance of
virus in naturally infected seals in the U.S. Northeast suggests that harbor seals might be the
most susceptible host, with systemic dispersion of high loads of virus, and associated
characteristic lesions. Grey seals appear to experience some disease, and therefore are
susceptible to PDV, with more limited tissue distribution of virus. Harp seals were identified as
potential asymptomatic carrier with high viral load. A host with an asymptomatic infection able
to produce high viral load through an extended period of time, would make an ideal reservoir and
source for enzootic infection, with the potential to initiate periodic epizootic infections in more
susceptible host species. Our findings suggest that harp seals may present with sub-clinical
findings. The theory that harp seals played an important role in the 1988 European epizootic has
been presented by several authors and supported by serological evidence and the rare occurrence
of disease in the species (Markussen and Have, 1992; Daoust et al., 1993; Lipscomb et al., 2001).
When considering the ecology of PDV, it is believed that 300,000 seals are necessary to maintain
PDV (Swinton et al 1998).  At over 7.1 million, there are sufficient numbers of harp seals in the
north-west Atlantic to maintain the virus (Waring et al., 2013). The pattern of PDV infection
over time and the amount of virus quantified during in-vitro infection coupled with the levels of
PDV detected in naturally infected seals, supports the argument that harp seals are important
carriers of PDV that may present with sub-clinical infection or asymptomatic carriers.
Gray seals in the northwest Atlantic appear to be susceptible to PDV.  In-vitro infection
suggests that susceptibility in gray seals differs from harp or harbor seal, as they present with a
greater viral load earlier. Given the results of natural infection, the mode of transmission from
gray seals may be more likely during early infection through coughing or sneezing. This is an
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important consideration in the transmission of the virus both in natural settings as well as in
marine mammal rehabilitation facilities.
Given the differences found in species susceptibility, future studies should focus on the
affinity of PDV to each of these three species specific CD150 receptor.  Quantifying the number
of receptors expressed on PBMCs may reflect the degree of possible susceptibility.  Measuring
the ability of cells to express cell surface receptors could indicate an important difference in host
susceptibility. Development of antibodies to detect seal species specific CD150 could be useful
in basic quantitative studies and experimental infection.
To address the pressing question of the role of contaminants on disease outcome upon PDV
infection first presented after the 1988 PDV epizootic, PBMCs from harbor seals were exposed
to Aroclor 1260 and subsequently infected with PDV USA 2006.  The role of HAB toxins was
also addressed.  Results from testing our second hypothesis: natural and man-made toxins do not
alter susceptibility to PDV 2006 USA, indicate that both these natural and anthropogenic
stressors can alter harbor seal susceptibility to PDV during the course of infection.
Prior to infection, it was determined that Arolcor 1260 did not modulate T lymphocyte
proliferation. Viral quantities measured during in-vitro infection did indicate that Aroclor 1260
(20 ppm) suppressed viral infection at day 7 post infection and increased PDV levels at the end
of the infection study. This disruption in the timing of viral replication, resulting in higher virus
loads, could have consequences in highly susceptible hosts. A similar pattern of infection was
seen in harp seal, a species which PDV does not seem to affect greatly, and which can maintain
and sustain high levels of viral replication. A similar pattern of suppression and alleviation of
viral replication in harbor seals, could result in a more systemic infection with greater viral load,
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and could explain the correlative findings seen in wild populations suffering from morbillivirus
epizootics that are exposed to a range of persistent contaminants.
The differences in virus replication in Aroclor 1260 exposed cells could be explained by
suppression or differential cell activation and cell surface receptor expression.  Documentation
exists for the ability of PCBs and polycyclic aromatic hydrocarbons (PAHs) to interfere with the
production of IL-2 and T cell receptor signaling in laboratory animals as well as harbor seals
(Exon JH, 1985; Neale et al., 2005). Activation of AhR with TCDD also has been shown to
suppress the clonal expansion and differentiation of influenza virus-specific cytotoxic T cells
important for the production of IFN-γ (Lawrence et al., 2005).
In contrast to the Aroclor exposure, STX at 10 ppb increased mitogen-induced T cell
proliferation and exposure increased the ability of PDV to replicate in seal cells in vitro.
Although the effects in lymphocytes occurred early (day 5) and appeared transient, these effects
in lymphocytes resulted in a significant increase in free virus later (day 9) in the supernatant,
which may suggest the potential for increased systemic virus dissemination upon in-vivo
infection.
Investigating mechanistic factors that may indicate an altered affinity to receptors would
provide insight into the effects of environmental stressors and host susceptibility. Variability in
the genes of SLAM (CD150), IL-8 and the vitamin A receptor (RARa) were found in harbor
seals affected in the 1988 and 2002 European PDV epizootics (McCarthy et al., 2011).  Similar
investigations into the gene expression in experimentally exposed PBMCs may offer insight into
species differences in susceptibility. Cellular signals which may alter the ability of PDV to infect
cells may also be different between species through the course of infection. Gene expression
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could be measured from RNA isolated from PBMCs during the infection, or secreted cytokines
could be assessed in the supernatant fraction to define key cellular signals expressed, or
suppressed, in the host response to infection and stressors.
In summary, these investigations are the first to address differences in susceptibility to PDV
(PDV USA 2006) between harp, harbor and gray seal of the northwest Atlantic using a
combination of in-vivo and in-vitro approaches, including the sampling of tissues from animals
naturally infected with PDV, the adaptation of an in-vitro infection model, and the development
and validation of a duplex Taqman technology based RT-qPCR to detect PDV and host GAPDH.
We demonstrated that species differences in susceptibility do exist in the quantity of virus
produced during the course of infection. We also determined that these differences in-vitro
correspond to findings in seals naturally infected with PDV USA 2006. Quantity of virus and
tissue distribution of PDV in naturally infected seals supports the theory of harp seals may be
asymptomatic carriers of PDV and identifies gray seals of the northwest Atlantic as PDV
susceptible hosts. In addition, we described the effects of Aroclor 1260 on harbor seal PBMC
susceptibility in-vitro and show a disruption in the timing of the infection eventually resulting in
a more severe infection, in contrast to the effects of low levels of STX which induce a transient
increase in PDV replication during early infection and affects T cell proliferation. This study
represents the first in-vitro exposure of seals to STX and the first to determine an
immunomodulatory effect of STX in a marine mammal. We also describe for the first time the
effects of exposure to STX and resultant changes in quantity of a morbilllivirus during in-vitro
exposure in harbor seal PBMCs. Further studies on the effects of STX on other immune
functions related to combating viral infection, such as measuring NK activity or IFN-γ
production, may reveal other effects of STX on the immune system and their relevance to PDV
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infection. While it is impossible to assess all factors, this research contributes to our
understanding of why we might see seals with different outcomes during PDV infection, with
new insights into factors that might not have otherwise been considered in the environment of
these animals.
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